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ABSTRACT 
Ishmael Baperi Masesane 
PhD-August 2003 
The literature structure of the natural product oryzoxymycin and an array of 3-mono-, 
3,4-di- and 3,4,5-tri-hydroxylated derivatives of 2-aminocyclohexane-1-carboxylic 
acid (ACHC) were stereoselectively prepared from oxanorbomene adducts derived 
from the Diels Alder reaction of ethyl (E)-3-nitroacrylate and furan. The central 
reaction for these syntheses was the base mediated P-elimination of the oxygen btidge 
of the oxanorbomene adducts or their derivatives. 
The asymmettic synthesis of the literature structure of oryzoxymycin involved chiral 
HPLC or enzyme catalysed kinetic resolution of the endo-carbamate oxanorbomene 
adduct. KHMDS promoted P-elimination of the oxygen bridge of the optical pure 
adduct afforded a 5,6-dihydro-5-hydroxyanthranilate which was converted to 
oryzoxymycin through CsF mediated coupling to a lactate and deprotection. 
Alternatively, the double bonds of the dihydrohydroxyanthranilates were 
stereoselectively reduced to give the 3-hydroxylated ACHC derivatives. The di- and 
trihydroxylated ACHC derivatives were prepared from the oxanorbomene adducts 
through selective oxidation sequences that took advantage of substrate 
stereocontrolled processes. The oxidation reactions which feature in the synthesis of 
the polyhydroxylated ACHC derivatives were epoxidation and Os04 catalysed 
dihydroxylation. 
The structures of intermediates and final products were characterised by NMR, IR and 
MS. The X-ray-structures of the crystalline compounds were also recorded. 
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CHAPTER ONE 
GENERAL INTRODUCTION 
1 
1.1 INTRODUCTION 
The central theme of this thesis is the description of asymmetric routes employed in 
the synthesis of the natural product oryzoxymycin 4 and an anay of hydroxylated 
cyclohexane based P-amino acid derivatives of type 5 based on the Diels-Alder 
reaction of ethyl (E)-3-nitroacrylate 1 and furan as summarized in Figure 1.1. 
1 
~O!fOH y··,,,NH
3 
+ -o
2
CCF
3 
OH 
4 
2 
Figure 1.1: Overview of the project 
\ 
r(lC02Et 
y··,,,NHBoc 
OH 
3 
RYI,C02Et 
R~·.,,,NHBoc 
OH 
5 
Numerous methodologies for the synthesis of cyclic P-amino acid derivatives have 
emerged over the last ten years and these are reviewed in Chapter 1 together with the 
uses of 3-nitroacrylates in Diels-Alder reactions. Subsequent Chapters are devoted to 
the discussion of the work directed towards oryzoxymycin chemistry and 7-
oxanorbomene routes to cyclic P-amino acid derivatives of type 5. Chapter 5 
documents the reaction procedures employed in the study together with spectroscopic 
and analytical data. 
1.2 USES OF 3-NITROACRYLA TES IN DIELS-ALDER REACTIONS 
3-Nitroacrylates are potent dienophiles, and they generally reqmre low reaction 
temperatures for the Diels-Alder reaction to occur. Several examples reported in 
literature have shown that the nitro group is also very effective at controlling the 
regiochemistry of the reaction with unsymmetrical dienes. 1•2 
2 
Danishefsky and eo-workers have studied the Diels-Alder reaction of nitroacrylate 6 
with vanous heteroatom-substituted dienes. 3 Cycloaddition of trans-1-
trimethylsilyloxy-1,3-butadiene 7 to 6 gave the corresponding adduct 8 in good yield 
with high regioselectivity, Figure 1.2. Subsequent treatment of 8 with DBU gave the 
dihydrobenzene derivative 9 in 71 % yield. This sequence of reactions was used as an 
alternative method for the Diels-Alder reaction of methyl propiolate with 7. The 
advantage of using methyl ~-nitroacrylate lies in the ability of the nitro function to 
control the regiochemistry. 
OSi(Meb 
C ,Benzene, 25°C 
7 
92% 
Figure 1.2: Danishefsky's synthesis of 9 
OSi(Meb 
~N02 DBU 
u .. ,,C02Me 70% 
8 
Similarly, the Diels-Alder reaction of nitroacrylate 6 with amino substituted dienes 
has been applied to the synthesis of isogabaculine 13.4 To this end, the reaction of t-
butyl 1,3-butadiene-1-carbamate 10 with 6 gave the adduct 11 in good yield, Figure 
1.3. Treatment of 11 with DBU gave the dihydrobenzene derivative 12, which upon 
hydrolysis afforded isogabaculine 13 in moderate yield.4 
Hydrolysis 
Figure 1.3: Synthesis of isogabaculine 13 
3 
12 
11 
/nBU,THF 
70% 
Corey's reaction of 2-trimethylsilyloxy-1,3-butadiene 14 with nitroacrylate 6 at 
room temperature gave adduct 15 as the only isomer in quantitative yield.5 
Treatment of 15 with aqueous acetic acid afforded trans-4-nitro-3-
carbomethoxycyclohexanone 16 in 72% yield. Reaction of 16 with DBU in THF 
afforded the cyclohexenone 17 in good yield, 5 Figure 1.4. 
DBU, THF 
99% 
Figure 1.4: Corey' s synthesis of 17 
Further studies by Corey involved the Diels-Alder reaction of nitroacrylate 6 with the 
hindered 1,1-dimethoxy-3-trimethylsilyloxy-1,3-butadiene 18 and this afforded 
cyclohexenone 19.5 DBU mediated elimination of nitrous acid from 19, then gave the 
resorcinol detivative 20 in excellent yield, Figure 1.5. 
6 19 
Figure 1.5: Synthesis of the resorcinol derivative 20 
;:(Meb 
HOA)lC02Me 
20 
Starting with the Diels-Alder reaction of nitroacrylate 6 and furan, Just and 
coworkers have reported the synthesis of 3,4-isopropylidene-2,5-anhydroallose 27 
in 14% overall yield.6 The Diels-Alder reaction at room temperature gave a 3:1 
4 
mixture of adducts 22 and 21 respectively, Figure 1.6. This mixture was 
dihydroxylated with Os04 and then treated with acetone in the presence of p-
toluenesulfonic acid to give acetonides 23 and 24. Subsequent DBU mediated 
elimination of nitrous acid gave 25. Ozonolysis of 25 and subsequent reduction 
with NaBRt gave the trio! 26, which was converted into 3,4-isopropylidene-2,5-
anhydroallose 27.6 
6 
25 
1. 03 
2. NaBH4 
36% 
21 22 
1. Os04 
2. Acetone, H+, 95% 
~~N02 + 
C02Me 
24 
~0>-l~ 
o~Lo 
OH 
27 
+00 
02Qco2Et 
N02 
23 
Figure 1.6: Synthesis of 3,4-isopropylidene-2,5-anhydroallose 27 
1.3 SUMMARY OF APPLICATIONS OF 3-NITROACRYLATES 
It is evident from the examples discussed above that the sequence of the Diels-
Aider reaction of 3-nitroacrylates and elimination of nitrous acid has been used as 
an alternative method for the Diels-Aider reaction of methyl propiolates. The 
advantages of using 3-nitroacrylates is their greater reactivity as dienophiles and 
ability of the nitro group to control the regiochemistry. Even though it is 
conceivable that the reduction of the nitro group would give entry to P-amino acid 
intermediates, to the best of our knowledge this chemistry has not been explored. 
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1.4 SYNTHESIS OF CYCLIC ~-AMINO ACIDS-A LITERATURE REVIEW 
1.4.1 INTRODUCTION 
The last few years have seen a surge of interest in cyclic ~-amino acids and this has 
been accompanied by a proliferation of novel procedures for their synthesis.7 This 
class of compounds have received so much attention due to their biological activity 
and lately because of the properties of their oligopeptides. There are a few naturally 
occurring cyclic ~-amino acids with various biological properties, hence the interest 
m synthesis of derivatives. (JR, 25)-2-Aminocyclopentanecarboxylic acid 
(cispentacin) 28 is found, for example, in the antibiotic amipurimycin 29 and has also 
been isolated in the free form from strains of Streptomyces and Bacillus. S-ll A 
synthetic derivative of cispentacin with a 3-exo-cyclic double bond (compound 30) 
has been shown to have a favourable activity-tolerability profile against yeast cells 
and has been selected for clinical studies as a novel antifungal agent for the oral 
treatment of yeast infections. 12 In contrast, tilidine 31, a cyclohexenyl synthetic ~­
amino acid derivative is an opioid analgesic used to control moderate to severe pain. 11 
Another synthetic cyclic ~-amino acid 32 showed a less favourable toxicogical profile 
but higher activity against the yeast Candida albicans. 12 
28 29 30 
31 
Figure 1.7: Biologically active cyclic ~-amino acid derivatives 
In recent years interest in cyclic ~-amino acids has resulted from the pioneering work 
of Gellman 13. 17 and Seebach 18•19 who have found that oligomeric structures derived 
from ~-amino acids adopted defined secondary structures analogous to those observed 
6 
in proteins. Gellman has gone further and shown that ~-17 oligomer 33 has significant 
activity against four species of bacteria including vancomycin resistant Enterococcus 
faecium and methicillin resistant staphylococcus aureus.20 
H H N~N H H 
"'---!'!---\ 11 ~ _,...N~N H 
H 0 ~IT ~!'!---\ 11 ~/N 
o H o~TI 
0 0 
33 3 
Figure 1.8: Gellman' s ~-17 oligomer 33 
Given the significance of cyclic ~-amino acids, it is not surpnsmg that the 
development of synthetic routes to these compounds has become an important 
challenge for organic chemists. Numerous methodologies for the synthesis of ~-amino 
acids have emerged and in this review these will be summarised under five broad 
approaches, namely; reductive amination, Curtius rean-angement, Michael addition, 
cycloaddition approaches and miscellaneous strategies. 
1.4.2 REDUCTIVE AMINA TION 
Cyclic ~-amino acids have been prepared by the reduction of enamines prepared 
easily from the corresponding cyclic ~-ketoesters. The reductive amination studies of 
Xu and eo-workers culminated in the preparation of the enantiopure ethyl cis-2-
amino-1-cyclohexanecarboxylate 36, Figure 1.9.21 To this end, ~-ketoester 34 was 
allowed to react with with (S)-a-methylbenzylamine in the presence of acetic acid, 
and the resulting enamine 35 was reduced in situ with NaBH4 . The highest 
diastereoselectivity was achieved when the reaction was run in isobutyric acid with 
NaBH4 as the reducing agent?1 The diastereomeric purity of 36 was enriched through 
recrystallization as its HBr salt. 
7 
Figure 1.9: Xu's synthesis of 36 
NaBH4/Acid 
67% from 34 
99% de 
Inspired by Xu's work, Gellman and coworkers have intensively exploited the 
reductive amination methodology in the synthesis of 3-aminopyrrolidine-4-carboxylic 
acid (APC) 39 and 2-aminocyclopentanecarboxylic acid (ACPC) 44 using optically 
pure (R)-a-methylbenzylamine as a chiral auxiliary.22•23 For the synthesis of 44, the 
reduction of the enamine with sodium in THFiPrOH afforded the amino alcohol 42 
and after the removal of the auxiliary and protection of the resulting amino group, 
oxidation of the primary alcohol provided 44, Figure 1.11.22 This route was found to 
suffer from low yields in the enamine reduction step and to overcome this difficulty, 
NaBH3CN was used instead as the hydtide donor in the synthesis of 39, Figure 1.10.23 
)-Nwco2Et 
Ph (_-) 
37 
2. NaH3BCN 
3. HCl 
4. Recrystallization 
40% 
~ 
Boc 
38 
Figure 1.10: Gellman's synthesis of APC 39 
O"f-{C02Et _P_h_/'--._._N_H_2 -~prNwC02Et 
V TsOH V 
1. NaiPrOH/THF 
2. HCI 
85% 
40 
-
_1_. _H_c_o_z_NH_4_FmocHN,Q·-. oH 10% PclJC ·. 
2. Fmoc-OSu 
NaHC03 85% 43 
41 
3. Recrystallization 
20% 
NaOCI, nBu4NBr 
TEMPO, NaCI, K.Br 
NaHC03 
70% 
Figure 1.11: Gellman' s synthesis of ACPC 44 
8 
39 
42 
44 
------------------
In his most recently published work, Gellman has extended his reductive amination 
protocol to the synthesis of trans-4-aminopiperidine-3-carboxylic acid (APiC) 47.24 
Starting with commercially available B-oxo ester 45, a short, practical and scalable 
synthesis of APiC was achieved. Thus, hydrogenolytic removal of the benzyl group of 
45 and reaction with di-tert-butyl dicarbonate provided the Boc-protected B-oxo ester, 
which was allowed to react with (R)-( + )-a-methylbenzylamine in refluxing benzene in 
the presence of a catalytic amount of p-toluenesulphonic acid to afford enamine 46 in 
71% yield, Figure 1.12. Reduction of the enamine with NaBfu gave a 4:1 ratio of the 
two cis diastereomers of the expected B-amino ester. This mixture was then treated 
with sodium ethoxide in ethanol, causing epimerisation to the trans-B-aminoester 47. 
Through a two-stage crystallization protocol, a single trans diastereomer was isolated 
in 16% yield from enamine 46 and its absolute configuration was established by 
crystallographic analysis. 24 
--l 0 1. 10% PcVC, HC07NH4 Ph NH 
aCO,Et 2. Boc20, NaHC03- &C02Et 
~ .HCI 3. ~ 'p-TsOH ~ 
Bn Ph NH2 Boc 
45 71% 46 
/ 
1. NaBH4, isobutyric acid 
I 2. Na, EtOH 
Ph~NH +cl· 3. HCl/diox_ane_ 
62 4. recrystalhzat10n _,,,D02Et 16% ~ 
Boc 
47 
Figure 1.12: Gellman's synthesis of 47 
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1.4.3 CURTIS REARRANGEMENT AND HOFMANN DEGRADATION 
Cyclic 1 ,2-dicarboxylates are ideal precursors for the synthesis of cyclic P-amino 
acids by conversion of one of the carboxy groups into an amine by Curtis or Hofman 
reanangements. The Curtis protocol, which involves alkyl migration to an electron-
deficient nitrogen is one of the most popular procedure employed by chemists in the 
synthesis of cyclic P-amino acids. 
Kobayashi and eo-workers have investigated the Curtis methodology in the 
preparation of P-amino acid 50 from cyclic diester 48.25 Kobayashi's strategy was 
adopted by Gellman and eo-workers in the synthesis of 51.26 To this end, the PLE-
catalysed hydrolysis of the meso diester 48 furnished the monoester 49 quantitatively 
and with excellent enantioselectivity (>96 % ). The monoester 49 was then converted 
to the P-amino ester 51 by the Curtis protocol followed by reduction of the double 
bond,25 ·26 Figure 1.13. Optically pure monoesters of type 48 could also be accessed by 
cinchona alkaloid mediated enantioselective desymmetrization of meso-anhydrides. 27 
It is worth noting that 51 could be converted to its trans isomer by base mediated 
. . . 26 
ep1mensat10n. 
PLE/pH 8.0 phosphate 
buffer, 10% acetone 
1. H2 , Pd-C, MeOH 
2. Boc20, K2C03 
31% from49 
1. ClC02Et, Et3N, Acetone 
2. NaN3 
3. C6H6, reflux 
4. BnOH, cat. p-TsOH 
C6H6 reflux 
(XNHC02Bn 
C02 Me so 
Figure 1.13: Kobayashi-Gellman's synthesis of 51 
Kobayashi and eo-workers then went further and prepared a monohydroxyl derivative 
53 of P-amino acid 52.28 To this end, hydrolysis of ester 52 and iodolactonization 
under two-phase conditions gave an iodolactone which upon base-mediated 
10 
dehydrohalogenation and methanolysis furnished the allylic alcohol 53. Starting with 
53, Gellman and eo-workers prepared P-amino acid 55 with an extra amino group in 
place of the hydroxyl group.26 The key steps included the SN2 reaction of an activated 
hydroxyl derivative of 53 with an azide, reduction and protection, Figure 1.14. 
1. Hydrolysis 
2. lz, NaHC03, 
H20-CH2Cl2, 98% 
3. DBU/C6H6, retlux, 
94% 
ONHBoc 
HO C02Me 
4. NaOMe, MeOH 
99% 
53 
1. MsCl, NEt3 
2. Bu4N+ N3-
3. P(nBuh, H20 
4. Boc20, 88% from 53 
(XNHBoc 
BocHN''··· C02Me 54 
100% 
Figure 1.14: Kobayashi-Gellman's synthesis of 55 
In their approach to the hydroxylated trans-aminocyclohexane P-amino acid 59, Wipf 
and Wang began with adduct 57 available from the titanium catalysed asymmetric 
Diels-Alder reaction of butadiene and asymmetric fumarate 56.29 The Curtis 
rearrangement proceeded with retention of stereochemistry to give unsaturated P-
amino acid 58, Figure 1.15. In three steps, namely hydrolysis, epoxidation and 
methanolysis, 58 was elaborated to the polyhydroxyl P-amino acid derivative 59. 
0 0 
Butadiene )lNJ1 ... 0 .. . o0 I Ti(O-'Pr)2Cl2 Meo2c 
56 T AD DOL, 97% 57 
Ph Ph 
Ph o-._/<-oH X J... = T AD DOL 
0 )<OH 
Ph Ph 
Figure 1.15: Wipf and Wang's synthesis of 59 
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1. Li0HIH20 2 BocHNX)''•· I
2. DPP A/Et3N MeO c 
tBuOH 2 
63% from 57 58 
3 steps l 
BocHNXXOH 
Me02C OH 
59 
Recently, Couche and eo-workers have developed a method for the synthesis of 
monohydroxylated cyclohexyl P-amino acid derivative 64 as outlined in Figure 
1.16.30 Starting from bicyclic hemiester 60 obtained by enzymatic hydrolysis of the 
corresponding mesa diester, the polyfunctionalised cyclohexane 64 was prepared with 
high stereoselectivity. The synthetic strategy involved a Cmtis reaction followed by 
retro-Michael ring opening reaction and reduction to give 64 in good yield. 30 
60 
i. CIC02Et, NEt3 
Acetone CON 
i. Refluxing Toluene NHCO CH G( 3 3h G( 2 3 
° C02Me ii. MeOH, reflux ° C02Me 
61 66% from60 62 
LiHMDS, THF 
-10°C, 53% 
~ Pd/C, H2, CH3C02Etl 
UNHC02Me _M_eo_H_C_ll_l_),_8_7_%_ 
C02H 
64 
Figure 1.16: Couche's synthesis of 64 
The Curtis reatTangement protocol was also employed by Mangelinckx and De Kimpe 
in the synthesis of the strained a-substituted cyclopropyl P-amino acid derivatives 67. 
Starting from the corresponding 1-aryl and 1-alkylcyclopropane-1 ,2-dicarboxylates 
65, selective monosaponification and subsequent Curtis reaction led to cyclopropyl P-
amino acids derivatives of type 67 in moderate yields, Figure 1.17.31 It is worthwhile 
to note that the regioselective monosaponification is controlled by steric effects, hence 
the bigger the a-substituent R, the better was the regioselectivity. 31 
D_,R Hydrolysis D_,R 
Me02C''··· ···,co2Me 
65a: R =Me (42%) 
65b: R = Et (82%) 
65c: R = Ph (82%) 
HO C',,.· ···,eo Me 
2 66 2 
1 equiv. DPPA 
1 equiv. Et3N 
tBuOH 
90-95°C, 5 h 
38-40% &R 
BocHN''··· ···'C02Me 67 
Figure 1.17: Mangelinckx and De Kimpe's synthesis of 67 
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Berkessel has utilised a Hofmann degradation approach in the synthesis of 71 as 
illustrated in Figure 1.18.32 The diacid precussor 68 was readily obtained m 
enantiomerically pure form by crystallization of the commercially available racemate 
with the auxiliary (R)-1-phenylethylamine. The advantage of this route is that all three 
steps from the diacid 68 to the amino acid 71 could be carried out in a one-pot 
procedure. First, the diacid 68 was heated to reflux in acetyl chloride and then 
concentrated. The residue was taken up in dichloromethane and conversion into the 
amide 70 was effected within minutes by pumping gaseous ammonia through the 
solution. Subsequent treatment of amide 70 with the oxidant phenyliodine (Ill) 
bis(trifluoroacetate) (PIFA) led to the Hofmann degradation product 71 in good 
yields, Figure 1.18. 
CXC02H ----------AcCI 
'C02H 92% 
68 
2. NH3 l AcCl L~ 
3. PIFA 
74% 
Figure 1.18: Berkessel' s synthesis of 71 
1.4.4 MICHAEL ADDITION 
Conjugate addition of chiral amine nucleophiles to cyclic a,p-unsaturated carboxylic 
acid de1ivatives represents one of the most attractive methods for the stereoselective 
synthesis of cyclic P-amino acids. Therefore, it is not surprising that asymmetric 
synthesis of cyclic P-amino acids via conjugate addition of chiral metallated amines 
has attracted the interest of several research groups. 
Davies and eo-workers have studied the stereoselective conjugate addition of 
homochiral lithium (a-methylbenzyl)benzylamide to tert-butyl 1-cyclopentene-1-
carboxylate and 1-cyclohexene-1-carboxylate. 33 These studies culminated in the 
synthesis of cis-2-aminocyclopentane-1-carboxylic acid and cis-2-aminocyclohexane-
13 
!-carboxylic acid derivatives with over 98 % diastereomeric selectivity, Figure 1.19. 
This methodology also provided the trans isomers since the cis-products 72 and 74 
were isomerised to their C-l epimers 73 and 75 respectively in good yield and 
excellent d.e. 33 
72 73 74 75 
Figure 1.19: Davies's conjugate addition studies. 
In a similar manner, Enders and eo-workers have developed a highly enantioselective 
protocol for the conjugate addition of lithiated (S)-(-)-2-methoxymethyl-1-
trimethylsilylamino-pyrrolidine (TMS-SAMP) to eo-halo-substituted a,p-unsaturated 
enoates followed by subsequent ring closure of the intermediate ester enolate to give 
trans-2-aminocycloalkanecarboxylic acid derivatives of type 79, Figure 1.20.34 This 
method therefore provides a direct entry to the trans-isomers while the Davies method 
is cis selective. 
1. TMS-SAMP, nBuLi CCOCH 
THF -78°C 3 
0 2. HMPA, -78°C N,N/Si(CH3b 
~ ~)l 3. NaHC03, H20 = 
Br \)n ~ OR qco,R 
76 77 
j Si07 , EtOAc 38-54% from 76 
Raney-Ni!H2, MeOH H CO 
69 7117£ 3 1 lrll C02R 
- 0 GN~:·q 
Figure 1.20: Enders synthesis of cyclic P-amino acids of type 79 
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1.4.5 CYCLOADDITION APPROACHES 
The [4 + 2] cycloaddition (Diels-Alder reaction) remains one of the most frequently 
employed synthetic methods for the construction of six-membered ring systems. The 
high regio- and stereoselectivity typically displayed by this reaction and the ease of 
execution have contributed towards its popularity. Therefore, it is not suprising that 
the reaction of 1-aminodiene and acrylate derivatives has been explored by a large 
number of chemists as a route to cyclohexyl ~-amino acid derivatives. 
Overman and eo-workers have employed the Diels-Alder approach utilizing 
carbamate 80c as the diene in the synthesis of analgesic tilidine Sla, Figure 1.21.35 
The cycloaddition of diene 80c with ethyl atropate was stereospecific and afforded a 
single crystalline cycloadduct Slc in 84% yield. Cleavage of the amino protecting 
group in Slc and subsequent methylation yielded tilidine Sla in 64% overall yield 
starting from SOc. Use of benzyl trans-1,3-butadiene-1-carbamate gave adducts Slb 
and 82b in yields of 71 and 20% respectively. In contrast, the cycloaddition of trans-
1-(dimethylamino)-1,3-butadiene 80a with ethyl atropate occurred in the opposite 
stereochemical sense to afford tilidine as the minor stereoisomer in a 3:1 mixture with 
isomer 82a. 35 
+ 
Toluene, 
80-ll0°C 
78-85% 
y02Et 
' Ph 
CXNR1R2 
+ 
8la: R 1 = R2 =Me 82a: R 1 = R2 =Me 
8lb: R 1 = H; R2 = C02CH2Ph 82b: R
1 
= H; R2 = C02CH2Ph 
81c: R 1 = H; R2 = C02CH2CCI3 
Figure 1.21: Overman's synthesis of tilidine derivatives 82 and their isomers. 
In a related study, the dihydroxylated trans-aminocyclohexane ~-amino acid 86 was 
recently prepared in three steps by Wipf and Wang from the asymmettic Diels-Alder 
reaction of oxazolidinone 83 and aminodiene 84?9 In the presence of Kobayashi 's 
chiral scandium catalyst the endo product 85 was isolated in 92% yield and 90% ee, 
15 
Figure 1.22. After saponification of 85 and benzyl ester formation, dihydroxylation 
proceeded smoothly to give diol 86 in 74% yield from aminodiene 84.29 
83 84 
Sc(OTfh 
(R)-BINOL 
92% 
Figure 1.22: Wipf and Wang's synthesis of 86 
0 0 ~HCBz o)l,o 
85 
j l.Transesteri fication 2. Dihydroxylation 
In their approach to a potential inhibitor of the chorismate-utilizing enzymes, 
Kozlowski and eo-workers featured the Diels-Alder reaction of aminodiene 87 and 
ethyl propiolate 88 to give unsaturated intermediate 89, Figure 1.23?6 Compound 89 
is a potentially versatile intermediate to an array of cyclohexyl P-amino acid 
derivatives of type 90 through reduction oxidation of the double bonds. 
R 
85°C CCC02Et qco,Et ~ + C02Et TeocHN 89% NHTeoc R NHTeoc 
R 
87 88 89 90 
Figure 1.23: Potential of Kozlowski's Diels-Alder reaction of 89 and 90. 
Aitken and eo-workers have described a shmt synthesis of cis-2-amino-1-
cyclobutanecarboxylic acids 94 on the basis of the photochemical [2 + 2] 
cycloaddition reaction between ethylene and uracil 91, Figure 1.24.37 To this end, 
irradiation of a solution of uracil 91 under an ethylene atmosphere afforded the 
expected cyclobutane adduct 92 in 75% isolated yield. Hydrolysis of the heterocyclic 
moiety and the resulting urea function gave cyclobutane P-amino amino acid 94 in 
52% overall yield.37 This short synthesis from readily available starting materials 
16 
illustrates a useful strategy which could be developed further to give ring substituted 
cyclobutane B-amino acids through use of other uracils and/or olefins. 
Acetone-H20 
uv light, 3 h 
75% 
H q:co,H 
H NH2 
NaN02, 
3.5 MHCl 
rt, 12 h 
85% 
94 
Figure 1.24: Aitken's synthesis of 94 
1.4.6 MISCELLANEOUS STRATEGIES 
c[za 
H H 
92 
0.5Mjrt,l2h 
NaOH 82% 
H 
r--Yco2H 
L} NH2 
H ~~0 
93 
The obvious route to ACHC 96 involves the reduction of anthranilic acid 95, Figure 
1.25. Indeed, when a solution of anthranilic acid in iso-amyl alcohol was treated with 
sodium, amino acid 96 was isolated?2 However, the method has been reported to be 
tedious and low yielding necessitating the need for more effective methods. 
Na 
iso-amyl alcohol 
20-40% 
Figure 1.25: Reduction of anthranilic acid 96 
Among the variety of synthetic methods for cyclic B-amino acids classified as 
miscellaneous, the most interesting and having the greatest potential for general 
application is the ring closing metathesis approach recently reported by Abell and 
Gardiner.38 This methodology was used to prepare the unsubstituted trans cyclic B-
amino acid derivative 100 from the precursor 97 which is readily available from 
allylation reactions, Figure 1.26. Treatment of 97 with Grubbs ruthenium catalyst 98 
afforded 99 as a single diastereoisomer in 96% yield. Hydrogenation in the presence 
17 
of 10% Pd/C followed by re-protection with benzyl chloroformate gave the trans 
ACHC derivative 100 in good yield?8 
CbzHN& 
C02 Me 
97 
Cl-< rcy3 
Ru~ 
er·· ~cy3 Ph 
_B_e_n_z-:-n!-,-r_e_fl_u_x_,._ CbzHND 
96% C02Me 
99 
H2, Pd/C, MeOH 
then DIPEA, CbzCl 
CH2Cl2, 84% 
CbzHND 
C02 Me 
100 
Figure 1.26: Abell and Gardiner's synthesis of ACHC derivative 100 
Another interesting protocol for the synthesis of cyclic ~-amino acids by Miyata and 
eo-workers involved sulfanyl radical addition-cyclization of oxime ethers connected 
with alkenes. 39 In this method the sulfanyl radical attacks the terminal alkenyl group 
in the substrate 101 to give the cyclic species 104, Figure 1.27. The reaction proceeds 
via the aminyl radical 103 which is a product of 5-exo-trig cyclization of 102. 
Subsequent reduction of the oxime function and conversion of the 
phenylsulfanylmethyl group into a carboxyl group gives the desired cyclic amino 
acids of type 105 including ( -)-cispentacin and 4-amino-3-pyrrolidinecarboxylic 
acid. 39 This approach has the potential to provide routes to both carbocyclic and 
heterocyclic cyclic ~-amino acids. 
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PhSo) SPh 
SPh 
,f\IQR ~ 0f~OR l f. _A_d_d_i_ti_o_n_l l :/". Cyclisation 
X X 
:UN oR 
101 102 
HOOC~NH2 ----------
X 
105 
X 
103 
PhSHj 
SPh bNHOR 
X 
104 
Figure 1.27: Miyata's synthesis of cyclic P-amino acid derivatives of type 105 
Ftilop and eo-workers have reported the synthesis of the cispentacin benzologue 1-
aminoindane-2-carboxylic acid 110 starting from an intact ring structure.40 Addition 
of chlorosulphonyl isocyanate (CSI) to indene 106 followed by ring opening and 
isomerization gave both cis- and trans-1-aminoindane-2-carboxylic acids 108 and 
110, Figure 1.28. 
1. CSI eo 2.Na2S03 
106 
H 
N ~-_):::: aq. HCI l)J 0 __ _ 
107 
j EtOH/HCl NH2 ·HCI ~C02 Et 
109 
1. NaOEt 
2. aq. HCI 
Figure 1.28: FUIOp's synthesis of 108 and 110 
NH2 ·HCI ~co,H 
108 
NH2 ·HCI 
cO·"oC02H 
110 
In contrast to Flilop's method, a Smlz-promoted aziridine ting opening protocol was 
described by Kawahata and Goodman in the synthesis of P-amino acids 112 and 
113.41 To this end, treatment of aziridine 111 with with Sml2 and subsequent 
protection of the resulting amine gave a 1: 1 mixture of the two P-amino acids 112 and 
113 (Figure 1.29), separated by column chromatography. 
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1. Sm12 
C02Bn 
2
· ~6o/;0 ~,, 
VV··'''NH 
111 
Figure 1.29: Kawahata and Goodman Aziridine ring opening reaction 
Also starting from a pre-formed ring, Matthews and eo-workers have prepared novel 
cyclic sila-substituted ~-amino acids through nucleophilic ring opening of an 
intermediate aziridine with an umpolung synthon for the carboxylate anion.42 This 
route involved the Sharpless aziridination43 of the silacyclopent-3-ene 114 followed 
by ring opening to give the cyano compound 116, Figure 1.30. Amine deprotection 
and nitrile hydrolysis afforded the target ~-amino acid 117. 
114 
Chlorarnine-T 
cat.PTAB ~ 
------- Ph2Si~NTs 
MeCN, rt 
5 h, 81% 115 
Et2AICN 
PhMe, 100°C 
17 h, 73% 
Figure 1.30: Matthews' synthesis of 117 
1.4.7 SUMMARY OF SYNTHETIC METHODS REVIEW 
Considerable progress has been made in the synthesis of cyclic ~-amino acid 
derivatives. Many strategies are now available for the preparation of these ~-amino 
acids and each of the strategies discussed has its own advantages and limitations. 
Rapid progress is therefore expected in the synthesis of substituted and optically 
active derivatives of cyclic ~-amino acids in the next decade. 
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CHAPTER TWO 
STEREOSELECTIVE SYNTHESIS OF THE 
STRUCTURE OF ORYZOXYMYCIN 
OH 
4 
0 
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2.1 INTRODUCTION 
In 1968, Hashimoto and eo-workers reported the isolation of a novel anthranilate, 
oryzoxymycin 4 from a soil sample of Streptomyces venezuelae, var. 
oryzoxymyceticus and this compound was shown to exhibit moderate activity against 
Xanthomonas oryzae.44 On the basis of spectroscopic and degradation studies, the 
structure of oryzoxymycin was elucidated as a composite of (R)-lactic acid and (SS, 
6S)-dihydrohydroxyanthranilic acid 118 (DHAA), a compound previously isolated 
from Streptomyces aureofaciens.45 '46 The absolute stereochemistry of oryzoxymycin 
was also established through degradation reactions and subsequent comparison with 
known substances.47 Oryzoxymycin is structurally interesting in that the position of 
the lactate moiety differs from the common C-5 enoylpyruvate substitution of related 
structures 119 and 120 (Figure 2.1) which are intetmediates in the biosynthesis of 
anthranilates.48-50 The proof of the structure of oryzoxymycin therefore presents a 
special synthetic challenge. 
4 118 
Figure 2.1: Structure of Oryzoxymycin 4 and related structures 
2.2 RETROSYNTHETIC ANALYSIS FOR ORYZOXYMYCIN 
Our general strategy for the synthesis of oryzoxymycin is based on the retrosynthetic 
analysis shown in Figure 2.2. Disconnection at the ester bond furnished the lactic acid 
unit and dihydroanthranilic acid 118 as key building blocks. Dihydroanthranilic acid 
118 could be generated from the base induced fragmentation of the bicyclic amino 
ester 2 which in turn could be derived from a Diels-Alder reaction between ~­
nitroacrylate 1 and furan. From this retrosynthetic analysis, a plan for a stepwise and 
stereocontrolled total synthesis of oryzoxymycin was evolved. 
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Figure 2.2 : Retrosynthetic analysis for oryzoxymycin 4 
2.3 PREVIOUS WORK ON ORYZOXYMYCIN IN OUR GROUP 
Prior to this work, a PhD student in our group did some preliminary work on the 
synthesis of oryzoxymycin based on the retrosynthetic analysis shown in Figure 2.2.51 
To this end, nitroacrylate 1, prepared through a modification of the McMurry 
method52, reacted with furan in CHCh at room temperature to give a mixture of 
oxanorbornenyl adducts favouring the required endo-nitro isomer 123. Enhanced 
selectivity was obtained by running the reaction at -20 °C to give a separable 4:1 
mixture of the two isomers in over 90% yield. Subsequent selective conversion into 
the protected aminoester 2 was achieved in a single pot by reduction with Zn/HCl 
followed by addition of a large excess of iPr2NEt and (BochO. KHMDS induced 
fragmentation of 2 allowed the isolation of cyclohexadiene 3 in a reproducible 71% 
yield together with variable amounts of ethyl 3-hydroxybenzoate. 
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1 
Furan, CHC13, 0 
-20°C 120 h a=rC02Et 
, I 
90% 
(123:124; 81:19) N02 
+ 
123 
1. Chromatography 
n. Zn/HCl, EtOH 
0 iii. iPr2NEt, (BochO, 77% 
a=rco,Et 
NHBoc 
2 
Figure 2.3: Synthesis of diene 3 
Although the transformation summarised in Figure 2.3 secured the correct relative 
stereochemical relationship of the hydroxyl and amine groups in the cyclohexadienyl 
moiety of oryzoxymycin, all the chiral intermediates described thus far were racemic. 
It was apparent, however, that the racemic material could be resolved after the 
introduction of the chiral lactate side chain of oryzoxymycin. To this end, anthranilate 
ester 3 was hydrolysed with KOH and the resultant acid treated with CsF and 
mesylate 126 in DMF to give the desired lactate coupled product 127 as a mixture of 
two diastereoisomers, which, unfortunately proved impossible to separate. It is 
instructive to draw attention to the fact that attempts to couple the Hoc-protected 
dihydroanthranilic acid 125 to lactic acid methyl ester in the presence of DCC or 
EDCI proved unsuccessful. 51 
NC02Et 
y··''NHBoc 
OH 
KOH, THF, 
H?O, 68% 
3 
- 0 = 
CO H 126: (S)-MsOCH(CH3)C02Me, ~ : N 2 CsF, DMF, 50 °C, 83% I ~ . O~C02Me 
y··,,'NHBoc .,,'NHBoc 
OH OH 
125 127 
Figure 2.4: Racemic synthesis of oryzoxymycin 
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2.41 SYNTHETIC CHALLENGE§ 
Asymmetric synthesis was among the tasks remaining m the preparation of 
oryzoxymycin and the bicyclic adduct 2 presented a very convenient opportunity to 
carry out resolution at that stage of the synthesis. Indeed, there are numerous literature 
examples of resolution of bicyclic adducts similar to 2 by enzyme mediated kinetic 
resolution or chiral HPLC.53·54 Another challenge was to select a protecting group for 
the lactic acid which could be removed selectively. 
Building on the work already done in our laboratory, efforts towards addressing the 
listed challenges will be discussed in subsequent sections of this chapter. 
2.5 SYNTHESIS OF ETHYL (E)-3-NITROACRYLATE 1 
The general strategy for the synthesis of oryzoxymycin (see retrosynthetic analysis in 
Figure 2.2) identified nitroacrylate 1 as a major intermediate from which the bicyclic 
adduct 2 could be generated. Consequently, the first experiment to be undertaken was 
the synthesis of 1 on the basis of precedent in our laboratory. 51 It was also known 
from the work of McMurry that 1 could be prepared in two steps from acrylates.52 
Thus, treatment of ethyl acrylate 128 with iodine and N20 4 gave iodonitro ester 129 in 
quantitative yield (93%), Figure 2.5. Elimination of HI with Hunig's base in ether 
afforded exclusively the title compound in 73% yield. The selectivity for the Z-isomer 
can be explained by considering the relative stability of conformations 129a and 129b 
that are suitable for anti-elimination, Figure 2.6. Thus, on the basis of the 
confotmations of 17, it was anticipated that the Z-isomer ought to be the major 
product. With this sequence of reactions, nitroacrylate 1 could be generated in 10-20 g 
batches and contrary to repotts that highlights the instability of nitroalkenes,55 ethyl 
(E)-~-nitroacrylate 1 was found to be stable for months when stored in a refrigerator. 
The NMR ('H, 13C) spectra of both compounds 1 and 129 were consistent with the 
proposed structures and comparable to those reported in literature.52 The 1H NMR 
spectrum of compound 1 showed the presence of two vinylic hydrogens with a 
characteristic trans-coupling (J = 13.6 Hz) assigned to H-2 and 3. 
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Figure 2.5: Synthesis of nitroacrylate 1 
iPr2NEt, Et20 
84% 
1 
Bulky groups eclipsing 
in the transition state-
Unfavoured 
Figure 2.6: Conformations leading to the (E)- and (Z)-isomers 
2.6 REACTION OF NITROACRYLATE 1 AND FURAN 
The preparation of nitroacrylate 1 set the stage for the crucial cycloaddition reaction 
with furan as the diene. The ability of furan to undergo [4+2]-cycloadditions with 
various n-bonds is well established56·57 and has attracted the attention of many 
research groups as it allows for the construction of valuable synthetic intermediates. 
The initial cycloaddition affords a substituted 7-oxabicyclo[2.2.l]hept-5-ene (7-
oxanorbomene) that can be manipulated with impressive selectivity to give interesting 
target molecules. In the event, execution of the Diels Alder reaction of 1 and furan 
proceeded smoothly and delivered the target molecule efficiently and 
stereospecifically. Thus, subjection of nitroacrylate 1 to cycloaddition reaction with 
furan in CH2C]z at -20°C for five days afforded an 80:20 mixture of adducts 123 and 
124 respectively in 90% yield, Figure 2.3. When the temperature of the reaction was 
increased to room temperature, considerable acceleration of the reaction was observed 
but was accompanied by a significant reduction in diastereoselectivity (2: 1 mixture of 
123 and 124 respectively). The two isomers were easily separated by column 
chromatography. 
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.---------------------------------------------------------------------
Having achieved the expedient synthesis of bicyclic intermediate 123, we were in a 
position to address the reduction of the nitro group to an amine. To this end, treatment 
of 123 with concentrated hydrochloric acid and zinc powder afforded the bicyclic ~­
amino ester 121. Subsequent addition of a large excess of iPr2NEt and Boc20 gave 
protected aminoester 2 in 77% yield over the two steps. 
The 1H and 13C spectra of 2 exhibited all the features consistent with the bicyclic 
structure including the singlet at 8 1.30 assigned to the Boc protons and two doublets 
at 8 6.46 and 6.59 with coupling constant J = 5.7 assigned to the vinylic protons. The 
proposed structure of 2 was finally confirmed by X-ray crystallography (see X-ray 
structure in Appendix 1) 
0 
~C02Et 
N02 
123 
1. Chromatography f ;;~~co2Ej 
11. Zn/HCl, EtOH ~ 
NH2 
121 
iii. iPr2NEt, (BochO 
77% from 123 
0 
~C02Et 
NHBoc 
2 
Figure 2.7: Reduction of the nitro group of adduct 123 
2.7 RESOLUTION OF THE OXANORBORNENE ADDUCT 2 
2.7.1 ENZYME-CATALYSED KINETIC RESOLUTION 
Enzymes, as biocatalysts, have captured an impmtant place in orgamc synthesis. 
Arguably, esterases, such as pig liver esterase (PLE), have proved to be the most 
widely successful enzymes in asymmetric synthesis.53 Esterases are cheap, stable, do 
not require a coenzyme and tolerate a wide range of substrates and chemical 
conditions. It appeared of interest therefore to examine the use of these enzymes for 
the resolution of the oxanorbornene adduct 2. 
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To set the stage for the kinetic resolution of the oxanorbomene adduct 2, screening 
reactions were first examined with PLE in various solvents (i.e. CH30H, CH3CN, 
(CzHs)zO and CH2Ch). Among the solvents studied, diethyl ether proved suitable for 
the PLE enantioselective hydrolysis of substrate 2. Thus, treatment of a solution of 2 
in diethyl ether and pH 7.8 phosphate buffer with PLE at room temperature afforded 
acid (-)-130 and ester (+)-2, Figure 2.8. The reactions were stopped at 50% 
conversion and the products were purified by column chromatography. The success of 
this resolution hinged on the ability of the enzymes to react preferentially with the(-)-
ester. 
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~co,Et 
NHBoc 
2 
PLE 
pH 8 phosphate buffer 0 
Et20, r.t, 4 d ~co,H + 
NHBoc 
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42% 
22 [a] 0 -57 (c,l; CHC13) 
Figure 2.8: PLE mediated kinetic resolution of 2 
0 Eto,c~ 
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48% 
[a]0 22 +136 (c,l; CHC13) 
2.7.2 CHIRAL HIGH-PERFOMANCE LIQUID CHROMATOGRAPHY 
RESOLUTION 
High perfmmance liquid chromatography (HPLC) on chiral stationary phase has 
become a reliable method for the separation and determination of optically active 
isomers. Direct chiral separation using cyclodextrin-based and macrocyclic antibiotic-
based HPLC columns continue to be common and enantioseparation on many novel 
chiral stationary phases has also been reported.54 Successful HPLC methods for the 
resolution of cyclic ~-amino acids include chiral crown ether stationary phases58 and 
glycopeptide antibiotic teicoplanin stationary phases. 59 On the basis of these literature 
observations, and to complement the enzyme mediated resolution, we turned our 
attention to an investigation of the enantiomer separation of bicyclic ~-amino ester 2 
using preparative chiral HPLC method. To this end, subjection of 2 to a Chiralpak AD 
HPLC column eluting with a 95:5 mixture of hexane and ethanol gave both 
enantiomers of 2 together with the retro-Diels Alder product 131 (see Appendix 2 for 
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the chromatogram). The chiral HPLC separation was done in collaboration with Mr 
Steve Jackson at GlaxoSmithKline. 
Figure 2.9: Retro Diels-Alder product 131 
2.8 SYNTHESIS OF THE STRUCTURE (-)-ORYZOXYMYCIN 
In the event that the oxygen bridge of oxanorbomene systems could be eliminated, 
optically pure (+)-2 could serve as a potential precussor to the cyclohexadiene moiety 
of oryzoxymycin. Indeed, LiHMDS induced fragmentations of oxanorbomane 
systems were first reported by Brion.6° Further work by Campbell and eo-workers 
demonstrated that the LiHMDS induced fragmentation can also be effected on 
oxanorbomene 132 and the substituted oxanorbomane adduct 134 to give 
cyclohexadiene 133 and cyclohexene 135 respectively, Figure 2.10.61 -65 On the basis 
of these important precedents, it was presumed that adduct (+)-2 could be fragmented 
using LiHMDS or related bases. 
132 
-t~CO,Me LiHMDS, THF, -78 "C 
49% 
134 
YC02Me 
OH 
133 
Figure 2.10: Campbell's fragmentation of bicyclic adducts 132 and 134 
Using a protocol previously established in our laboratory,51 the oxygen bridge of 
adduct (+)-2 was eliminated using KHMDS, which was found to be more effective 
that LiHMDS. In the event, treatment of (+)-2 with KHMDS in THF afforded 
substituted diene (-)-3, ([a] 0 22 -269) in acceptable yields together with ethyl 3-
hydroxybenzoate as a by-product, Figure 2.11. The 1 H NMR of (-)-3 showed 
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characteristic resonances at (:) 6.26 integrating for two protons and a doublet at (:) 7.17 
with coupling constant J = 4.8 Hz assigned to H-3, H-4 and H-1 respectively. It is 
instructive to note that the product from this easily executed fragmentation reaction 
already has much in common with the targeted cyclic intermediate 118. To set the 
stage for the crucial esterification reaction, ester (-)-3 had to be hydrolysed. To this 
end, treatment of (-)-3 with excess KOH in THF and water afforded acid (-)-125 
([a] 0 22 -332) in 68% yield. 
0 Eto,c? 
NHBoc 
(+)-2 
KHMDS, THF Et02C:y 
-50 to 25°C I 
,,~·· 
71% BocHN 
OH 
(-)-3 
Figure 2.11: Synthesis of acid (-)-125 
KOH, THF, H02C:y 
H20, 68% I 
BocHN'''. 
OH 
(-)-125 
In a parallel sequence of reactions, the hydroxyl group of t-butyllactate was activated 
to make it amenable to the esterification step. Thus, treatment of a solution of 
commercially available lactate 136 in CH2Ch with triethylamine followed by cooling 
(0°C) and addition of MsCl afforded mesylate 137, [a] 0 205 +49 in 99% yield. 
MsCI, Et3N, CH2Cl2 
99% 
Figure 2.12: Synthesis of mesylate 137 
Having achieved the expedient synthesis of intermediates (-)-125 and 137, attention 
was then focused on formation of the ester bond between the two substances by a 
procedure developed in our laboratory in the preliminary studies towards 
oryzoxymycin.51 Consequently, treatment of acid (-)-125 with CsF and mesylate 137 
in DMF gave the desired lactate coupled product 138 as a single isomer, [a] 0 22 ; -171 
(c; 1, CHCh), Figure 2.13. It is instructive to discuss the mechanistic profile of the 
CsF mediated coupling reaction. Otera and eo-workers suggested that the reaction 
proceeds on the surface of solid CsF, since fluoride anions could not be detected 
during the course of the reaction.66 Hydrogen bonding between CsF and an active 
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hydrogen of the nucleophile (the acid hydrogen m this case) was thought to be 
responsible for the smooth reaction. 
Both the 1D and 2D NMR spectra of 138 displayed all the features consistent with the 
proposed structure. Most noticeable was the HMBC correlations between the 
cyclohexadienylcarboxylate carbonyl carbon and the lactate H-2 which confirmed the 
point of attachment of the lactate unit, Figure 2.14. 
H02CY) 
BocHN''··Y 
OH 
(-)-125 
137, CsF, DMF, 50 °C 
83% 
Figure 2.13: Coupling of the lactate 137 to (-)-125 
Figure 2.14: Selected HMBC correlations of 138 
0 ~ ~o co,'Bu 
, NHBoc 
OH 
138 
As indicated in Section 2.4, the selection of the t-butyl protecting group for the lactic 
acid was not arbitrary; it was reasoned that since it is acid labile, its removal would be 
coupled to that of the Boc group. Indeed, exposure of 138 to TFA in CH2Ch achieved 
complete deprotection to afford(-)-oryzoxymycin salt 139 in good yield, [a] 0 21 -199 
(c; 1, H20). Unlike the literature natural product, 139 showed appreciable stability 
when stored at 0°C or in solution of water at room temperature. However, when kept 
at room temperature in a dry state, 139 gradually decomposed, but, unlike the 
literature compound, no dimeric product was detected.45 One characteristic of the 
synthetic (-)oryzoxymycin comparable to that of the literature compound was its 
solubility in methanol and water, but insolubility in most organic solvents. 
High resolution mass spectrometry established the molecular formula C 10H 11N04 for 
structure 139. TheIR spectrum featured a hydroxyl band at 3413 cm- 1, a broad acid 
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band at 3550-2800 cm- 1 and bands at 1726 and 1679 cm- 1 due to the carbonyls of the 
ester and the acid. The 1H NMR spectrum exhibited a doublet integrating for three 
protons at 8H 1.57 with coupling constant h_3 7.2 Hz and this was assigned to lactate 
methyl hydrogens. A multiplet at ()H 4.44 integrating for two hydrogens was assigned 
to H-5' and H-6', whilst a quartet at ()H 5.17 with coupling constant h_3 7.2 Hz was 
assigned to H-2. A multiplet at ()H 6.49 integrating for two hydrogens was assigned to 
H-3' and H-4' while a doublet at 8H 7.57 with coupling constant J = 5.5 Hz was 
assigned to H-2 of the cyclohexadiene moiety. The 13C NMR spectrum was also 
consistent with the proposed structure with the two carbonyls resonances at be 166.2 
and 176.3. 
0 ~ ~o co,'su 
, NHBoc 
OH 
138 
TFA,DCM 
89% 
Figure 2.15: Deprotection of both the Boc and t-butyl groups 
The processes desctibed thus far have culminated m the first synthesis of the 
enantiomer of the structure of the reported in literature as oryzoxymycin. 
Unfortunately, as the results show, the optical rotation values of the two compounds 
were inconsistent (139 [a] 0 21 -199 (c; 1, H20); Literature oryzoxymycin [a] 0 21 +349 
(c; 1, H20)).47 Significant differences were also observed in the infrared spectrum 
both in the carbonyl region and the characteristic fingerprint region, Figures 2.16 and 
2.17. 
4000 3000 2000 1800 16"00 14{.)0 1200 rooo aoo cm-' 
Figure 2.16: Literature IR spectrum of oryzoxymycin44 
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Figure 2.17: IR spectrum of oryzoxymycin 
On the basis of these results, the assumption at this stage was that the correct structure 
for oryzoxymycin was the isomeric C-5 lactate ester 140, Figure 2.18. It is instructive 
to draw attention to the fact that related structures have this pattern of substitution.48-50 
Another possibility considered was a diastereomeric structure isomeric at C-2 of the 
lactate side chain. 
0 
c(oH 
-'rrc) NH2 
0 
140 
Figure 2.18: Possible structure of oryzoxymycin 
To test the assumption stated above, a study towards the synthesis of 140 was 
undertaken. During the planning stages of this synthesis, the task of achieving the 
coupling of the lactate unit to the cyclic moiety was not regarded as being too 
difficult. After all, in situ activations of the carboxylic groups with coupling reagents 
like EDCI followed by reaction with nucleophiles are routinely carried out in organic 
synthesis.67·68 Below we repmt preliminary results towards synthesis of 140. 
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To set the stage for the crucial coupling reaction, the hydroxyl-function of (S)-lactic 
acid 141 had to be protected. To this end, addition of TBSCl and imidazole to a stirred 
solution of acid 141 afford the OH-TBS protected lactic acid 142 in good yield, 
Figure 2.19. The choice of the HF labile TBS protecting group was based on the 
assumption that its removal could be coupled to that of the Boc group. 
TBSCl, imidazole QTBS 
CH2Cl2 ~C02H 
88% 142 
Figure 2.19: Protection of the (S)-lactic acid 142 
Unfortunately, when ester 3 was treated with lactic acid 142 in the presence of EDCI 
and DMAP at 25 °C, all that was isolated was the fully protected anthranilic acid 
derivative 144 in 82 % yield, Figure 2.20. Repeating the reaction at low temperature 
(0 °C) did not change the outcome. This results suggested that intermediate 143 was 
itself an unstable substance under the reaction conditions, hence the aromatisation to 
144. Repeating the reaction with acid 125 instead of ester 3 led to isolation of N-Boc 
protected anthranilic acid. 
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BocHN''··y 
OH 
3 142 
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82% 
Figure 2.20: EDCI Coupling of the lactate 142 to 3 
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The disappointing results forced us to look at other ways of activating the carboxylic 
acid of the lactic acid 142. One of the widely used methods for the activation of 
carboxylic groups is conversion into acid chlorides using thionyl chloride.69· 70 In the 
context of the synthesis of intermediate 143, acid 142 was treated with thionyl 
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chloride in THF and after 12 h 3 was added to the reaction mixture. Unfortunately, the 
only detectable product was again the protected anthranilic acid derivative 144. The 
instability of the coupled product 143 was attributed to steric interaction between the 
bulky Boc group and the lactate side chain. Indeed, when the less sterically 
encumbered isobutyric acid 145 was used instead of lactic acid 142 ester 146 was 
isolated in 90% yield, Figure 2.21. 
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Figure 2.21: Synthesis of 146 
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At this point, we suspended the attempts towards synthesis of 140 and with the 
appropriate intermediates and strategy in hand, we set out to synthesise the ( + )-
diastereoisomer of the literature structure of oryzoxymycin. The results of this work 
will be discussed in the subsequent section. 
2.9 SYNTHESIS OF (+)-DIASTEREOISOMER OF ORYZOXYMYCIN 
The readiness of oryzoxymycin to dimerize into 147 was reported by Hashimoto and 
co-workers.45 On the other hand, the synthesised (-)-oryzomycin salt 139 showed 
appreciable stability at low temperature and in solution but still decomposed when 
kept at room temperature as a solid. In the search for a more stable structure of 
oryzoxymycin, we considered the synthesis of its (+)-analog, isomeric at C-2 of the 
lactic acid. Below, we therefore report the synthesis of (+)-diastereoisomer of 
oryzoxymycin that took advantage of the versatile methodologies developed during 
the synthesis of (-)-oryzoxymycin. 
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Figure 2.22: Diels-Aider Dimer of oryzoxymycin 
Through our previously established synthetic pathway, oxanorbomene system (-)-2 
could be fragmented in the presence of a base to give a cyclohexadiene system. In the 
event, treatment of the bicyclic adduct (-)-2 with KHMDS in THF afforded diene (+)-
3, [a] 0 22 +266 (c; 1, CHCh) in 71% yield. Hydrolysis of the ester of(+ )-3 with KOH 
in THF/H20 gave acid (+)-125, [a] 0 22 +348 (c; 1, CHCh) in 68% yield, Figure 2.23. 
° CO E KHMDS, THF y:C02Et 2 t -50 to 25°C I 
71% .. ,,NHBoc 
NHBoc OH 
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Figure 2.23: Synthesis of the acid (+)-125 
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With the required building blocks in hand, attention was then turned to the convergent 
union of lactate 137 and intermediate (+)-125 on the basis of the procedure 
established in the synthesis of (-)-oryzoxymycin. To this end, treatment of acid(+)-
125 with lactate 137 in the presence of CsF in DMF at elevated temperature (50°C) 
gave the protected (+)-isomer of oryzoxymycin 148 [a]0 +181 (c; 1, CHC13) in 
excellent yield. The point of attachment for the lactate, as in the previous case, was 
confirmed by HMBC correlation experiments. Final deprotection of both the Boc and 
t-butyl groups was effected by treatment with TFA in CH2C]z to give the (+)-isomer 
salt of oryzoxymycin 149 [a] 0 +165 (c; 1, H20), Figure 2.24. Unfmtunately, this salt 
also decomposed when left in a solid state at room temperature. 
Oryzoxymycin isomer 149 was confirmed as the product of the sequence of reactions 
described above by elemental analysis which established the molecular formula 
C10H 13NOs.CzH02F3. TheIR spectrum featured two bands at 1703 and 1677 cm·' due 
to the two carbonyls, whilst a broad band at 3350-2800 cm·' was characteristic of the 
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acid group. The 1H and 13C spectra displayed all the features consistent with the 
proposed structure. 
NC02H 
y··''NHBoc 
OH 
(+)-125 
137, CsF, DMF, 50 °C, 
83% 
Figure 2.24: Synthesis of ( + )-diastereomer of oryzoxymycin 149 
It is appropriate, at this juncture, to note that the synthesis of both compounds 139 and 
149 did not achieve our aim of proving the reported structure of oryzoxymycin. While 
the literature oryzoxymycin was characterised as an HCl salt, 139 and 149 were 
characterised as TFA salts. Whether this discrepancy could be responsible for the 
differences observed between the optical rotations of the synthesised compounds and 
the literature oryzoxymycin is not obvious. It is worth noting that addition of a few 
drops of 5 M HCl to a water solution of either 139 or 149 did not significantly change 
the observed rotation. 
Among the tasks remammg m this synthesis was ascertaining the absolute 
stereochemistry of the cyclohexadiene moiety of oryzoxymycin. It was known from 
the work of McCorrnick and coworkers that (+)-trans-2,3-dihydro-3-
hydroxyanthranilic acid (DHAA) can be hydrogenated in the presence of Palladium to 
give 2-amino-3-hydroxycyclohexane-1-carboxylic acid [a]0 21 -35 (c;l, H20).71 The 
reduction was repeated by Hashimoto to prove the absolute stereochemistry of 
oryzoxymycin.47 Thus, on the basis of these precedents, acid (+)-125 was reduced by 
treatment with Pd/C in ethanol under a hydrogen atmosphere and subsequently treated 
with TFA to remove the Boc and give substituted cyclohexane 151 [a] 0 21 -32 (c;l, 
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H20) in excellent yield. Alternatively, 125 was treated with TFA to give 152 [a] 0 21 + 
339 (c;l, HzO) and subsequent reduction gave 151 in 93% from 125. On the basis of 
the consistency of the results with literature data, the absolute structure of 149 must 
be (2S)-[(5S, 6S)-6-arnino-5-hydroxy-1,3-cyclohexadiene-l-carbonyloxy ]-propionic 
acid TFA salt. 
y:C02H Pd/C, H2, ethanol 
'NHBoc 
OH 
(+)-125 
]
TFA, CH2Cl2 
95% 
Figure 2.25: Reduction and deprotection of (+)-125 
2.10 SUMMARY 
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The reaction processes described in this chapter have culminated in the synthesis of 
the enantiomer and the ( + )-diastereoisomer of the literature structure of 
oryzoxymycm. This is the first reported synthesis of the structure described by 
Hashimoto as oryzoxymycin.72 Memorable highlights of this route include the 
demonstration of the Diels-Alder reaction of nitroacrylates and furan as an efficient 
method for the construction of highly functionalised cyclohexyl rings, the utility of 
enzymes in kinetic resolution and the use of CsF in the formation of ester bonds in the 
presence of a free hydroxyl group. This achievement bodes well for the future 
application of this chemistry to the total synthesis of other related structures of· 
biological or structural interest. 
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CHAPTER THREE 
SYNTHESIS OF THE 3,4,5-TRIHYDROXYL 
DERIVATIVES OF ACHC 
44 
3.1 INTRODUCTION 
During the course of the synthesis of the structure of oryzoxymycin discussed in 
Chapter 2, it was recognised that cyclohexadiene 125 could be functionalised in a 
controlled and selective fashion taking advantage of substrate stereo-controlled 
processes to give derivatives of 2-aminocyclohexane-1-carboxylic acid (ACHC). In 
this chapter, the synthesis of an array of 3,4,5-trihydroxyl derivatives of ACHC, 
which took advantage of the above observations will be discussed. 
Trans-2-aminocyclohexane-1-carboxylic acid (trans-ACHC) 96 is a member of a new 
class of compounds called cyclic ~-amino acids. Along side 2-
aminocyclopentanecarboxylic acid (ACPC) 153 and 4-aminopyrrolidinecarboxylic 
acid (APC) 154, ACHC 96 represent an interesting structure that has been the target 
of a number of syntheses. 11 '73 As discussed in Chapter 1, most of the published 
syntheses of trans-ACHC and its derivatives are based on the following reactions; 
d . f h 'l' 'd 32 c . 26 d . . 23 d re uctwn o ant ram 1c ac1 , urt1s rearrangement, re ucti ve ammatwn an 
Diels Alder reaction of amino dienes and acrylates. 29 
aC02H 
''NH2 
ACPC 153 
Figure 3.1: Trans-ACHC 96 and related structures 
~C02H 
HN\.--J. 
-.. ,,NH
2 
APC 154 
Much of the interest in ACHC 96 and related compounds is a consequence of the 
ability of their oligomers to form well-defined secondary structures analogous to 
those of natural peptides.15 In this respect, Gellman and eo-workers have recently 
examined the tetramer 155 and the hexamer 156 (Figure 3.2) of optically active tram;-
ACHC, using crystallography and 2D NMR and these revealed perfect 14-helical 
conformations. 13 Oligomers of ACHC and other cyclic ~-amino acids therefore have a 
particular appeal for extending our understanding of protein structure and 
stabilization. 
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~~l ~~rO,C(CH,), 
Tetramer 155, n = 3 and hexamer 156, n = 5 
Figure 3.2: Gellman' s tetramer 155 and hexamer 156 
Recently, increasing work has been devoted to the synthesis of cyclic ~-amino acids 
with extra functionalities appended at specific positions around the rings. A few 
examples of these substituted cyclic ~-amino acids were discussed in Chapter 1. 
Subsequent studies will undoubtedly be focused on the effects of the functionalities 
on the stability of the oligomers derived from the substituted cyclic ~-amino acids. 
In view of the importance of ~-peptides, there is a need for the synthesis of their 
building blocks, ~-amino amino acids. In particular, water-soluble hydroxylated or 
aminated derivatives of ACHC have attractive properties and a high intrinsic 
. f h 1· I f Id. 14 17 26 C 1 . h h h propensity or e tea o mg. ' · onsequent y, we report m t is c apter t e 
synthesis of an array of 3,4,5-trihydroxy derivatives of ACHC that took advantage of 
the Diels-Alder reaction of (E)-3-nitroacrylate and furan described in Chapter 1 for 
synthesis of the structure of oryzoxymycin. 
3.2 PREPARATION OF THE OXANORBORNENE INTERMEDIATES 
In Chapter 1, the endo-nitro adduct was accessible as the major product through a 
reaction of nitroacrylate 1 and furan in CHCh at -20 °C. Realising that the exo-nitro 
adduct was as important in the synthesis of DHAA derivatives, a study of the effects 
of temperature and solvents on the Diels Alder reaction was conducted in the hope of 
shifting selectivity towards the exo-nitro adduct. Thus, repeating the reaction of 
nitroacrylate 1 and furan at 25 °C and 40 °C gave a 2:1 mixture of adducts 123 and 
124 respectively. When the reaction was carried out in other solvents such as CH3CN, 
MeOH, (CF3)2CHOH and toluene at both 25 °C and elevated temperatures, the 2: 1 
ratio was maintained, Figure 3.3. These observations can be attributed to the preferred 
endo-nitro transition state geometry. Just and eo-workers have reported the preference 
for the exo-nitro adduct when the reaction of methyl 3-nitroacrylate and furan was 
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canied out without a solvent.6 However, in our case, this reaction afforded a 3:1 
mixture in favour of the endo-nitro adduct 123. 
Furan, solvent 0 0 
02N~C02Et temperature 
qco,Et 
£l2No I 2 
N02 C02 Et 
1 123 124 
Yield of 
Solvent Tem~erature {°C} 123{% }/124 {% l 
CHCb -20 72 18 
CHCh 25 60 30 
CHCI3 40 60 30 
CH3CN 25 60 30 
Toluene 25 60 30 
Toluene 80 60 30 
Me OH 25 60 30 
(CF3)CHOH 25 60 30 
Fur an 25 68 22 
Figure 3.3: Solvents and temperature effects on the Diels Alder reaction 
The Diels Alder adducts were separable by column chromatography and subsequent 
reduction of the nitro group for each adduct as described in Chapter 1 afforded 
oxanorbomene intermediates 3 and 158, Figure 3.4. It was assumed at planning stages 
that it should be possible to functionalise the double bonds of intermediates 3 and 158 
in a controlled and selective fashion by taking advantage of the tigid shape of the 
substrates. The functionalised adducts could then be elaborated to cyclohexyl 
detivatives by base mediated elimination of the oxygen bridge. A complementary 
route would be the reversal of the functionalisation and fragmentation sequence of 
reactions, Figure 3.4. 
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0 y:C02Et HOqCO,Et ~C02Et 
'NHBoc HO ... ,,NHBoc 
NHBoc OH OH 
2 3 157 
0 VCO,Et HOqC02Et 
GNHBoc NHBoc HO NHBoc 
C02 Et OH OH 
158 159 160 
Figure 3.4: General strategy for elaboration of adducts 2 and 158 into ~-amino acids 
of type 157 a,nd 160 
In the first section of this chapter, results on the use of Os04 mediated 
dihydroxylation for the elaboration of bicyclic adducts 2 and 158 to 3,4,5-trihydroxy 
derivatives of trans-ACHC will be discussed. Subsequent sections will then document 
our work towards trihydroxy derivatives of ACHC using epoxidation reactions. 
3.3 CIS DIHYDROXYLA TION 
3.3.1 INTRODUCTION 
Osmium tetraoxide (Os04) is the most reliable reagent available for the cts 
dihydroxylation of alkenes to give the corresponding cis-diols. Although 
stoichiometric osmylation has been reported in the literature,74 it is more usual, for 
reasons of cost and safety, to use osmium tetraoxide catalytically in the presence of 
inexpensive eo-oxidants. Inorganic cooxidants such as sodium or potassium chlorate 
and hydrogen peroxide were the first to be used, but have the disadvantage that 
appreciable over-oxidation can occur to give keto or acid products.75 Amine N-oxides 
and organic peroxides on the other hand have been found to be very effective as eo-
oxidants in the dihydroxylation reactions.74'75 Minato and eo-workers have also 
described the use of K2Fe(CN)6 in the presence of K2C03 for the osmium catalysed 
dihydroxylation of alkenes.76 
Figure 3.5 presents a succinct summary of the catalytic cycles in the osmium-
catalysed dihydroxylation of alkenes using NMO as the eo-oxidant. Through the work 
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of Sharpless and eo-workers, two catalytic cycles were deduced.77 Under 
homogeneous conditions the eo-oxidant has constant access to all the catalytic 
intermediates, therefore the turnover for the dihydroxylation is locked into the second 
cycle. Kwong found that that this second catalytic cycle was virtually eliminated by 
performing the reaction under biphasic conditions.78 Under these conditions, 
osmylation takes place in the organic layer and the resulting osmium (VI) 
monoglycolate ester 163 undergoes hydrolysis releasing the diol to the organic layer 
and the Os (VI) to aqueous layer where it is oxidised back to Os (VIII). Entry of the 
osmium glycolate into the second cycle is therefore prevented. 
R 
R ~ 
HO 161 
RJ--yR 
H20 164 OH 
02P-:( // \ 
0 0 
163 R R 0 
o, ~P First ~:l Second x_oy5o~( 'Os, cycle cycle R 0 b Qt '0 165 R 
o_ pxR 
'Os 0/ \ ... 
0 R H20 162 
HO 
R 
RJ--yR ~ 
R 161 OH 164 
Figure 3.5: The two catalytic cycles for osmium catalysed dihydroxylation 78 
3.3.2 SYNTHESIS OF THE ANTI-ANTI-ANTI-SYN ACHC DERIVATIVE 168 
On the basis of the exceptional scope and reliability of the osmmm catalysed 
dihydroxylation reaction, we decided to feature this reaction in the synthesis of 
polyhydroxylated derivatives of ACHC using oxanorbornene systems 2 and 158 as 
starting materials. Thus, on the basis of the precedence set in Chapter 2, adduct 2 was 
treated with KHMDS in THF to give cyclohexadiene 3 in 71% yield. Treatment of 3 
with catalytic Os04 in the presence of Me3NO.H20 as the eo-oxidant afforded the 
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substituted cyclohexene 166 as a single diastereoisomer, which was then characterised 
as its triacetoxy derivative 167, Figure 3.6. 
It is instructive to address the interesting stereochemical outcome of the above 
dihydroxylation reaction. The delivery of the diol on the same face as the carbamate 
and on the face opposite to the allylic hydroxyl group in the osmium catalysed 
dihydroxylation of 3 was certainly not suprising. Dihydroxylation of alkenes that 
contain chiral centres can lead to high levels of stereoselectivity. Indeed, Kishi has 
reported that the Os04 mediated oxidation of cyclic allylic alcohols led to formation 
of a syn-anti triol with high levels of stereoselectivity.79' 8° Furthermore, the ability of 
cyclic homoallylic carbamates to give high levels of syn selectivity in the osmium 
mediated dihydroxylation reactions is well documented. 81 Cyclohexadiene 3 has these 
two chemical processes acting in cooperation, hence the high level of 
s tereose 1 ecti vi ty. 
0 
~C02 Et KHMDS, THF, -50 to 25°C 
71% 
NC02Et 
y··.,,NHBoc 
OH NHBoc 
2 
AcO,,::N,C02Et __ A_c_2o_, _p_yn_· d_i_n_e __ 
AcO'' y···'NHBoc 68% from 3 
OAc 
167 
Figure 3.6: Synthesis of cyclohexene 167 
3 
Os04, Me3NO.H20, 
Acetone 
HO,,::N,C02Et 
HO'' y··,,,NHBoc 
OH 
166 
To complete the synthesis, it was necessary to reduce the double bond in a selective 
fashion. It was anticipated that substrate-stereocontrolled processes could secure the 
vicinal stereochemical relations in the reduction step. Gratifyingly, when a solution of 
167 in ethanol was treated with a catalytic amount of Pd/C under a hydrogen 
atmosphere, ACHC derivative 168 was the only detectable product, Figure 3.7. It is 
noteworthy that the addition of the hydride during the reduction took place on the 
more hindered diastereo-face of the alkene probably due to the coordination of the 
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palladium to the carbamate. It was known from the work of McCormick and eo-
workers on similar systems that the hydride adds preferentially on the same face as 
the amino group.71 Thus, on the basis of this precedent, the selective formation of 168 
was not suprising. The same stereoselective reduction was observed when 166 was 
used as the substrate to give 169, Figure 3.7. Triol 169 was then acetylated under the 
standard conditions to give 168. 
High-resolution mass spectrometry established the molecular formula C20H31 N0 10 for 
ACHC derivative 168. The 1H and 13C NMR featured all the peaks consistent with the 
cyclohexane structure. The relative stereochemistry was confirmed by across the ring 
NOESY correlation between H-1 and and H-3 and that between H-2 and H-4, Figure 
3.8. 
Ac0,,::11:C02Et 
AcO'' y··,,'NHBoc 
OAc 
167 
HO,,:::Il:C02Et 
HO'' y··,,'NHBoc 
OH 
166 
H2, Pd!C, EtOH 
98% 
H2, Pd/C, EtOH 
98% 
Ac0,,:::r"(C02Et 
AcO'' y·'''NHBoc 
OAc 
168 
1Acz0, pyridine 
HO,,:::r"(C02Et 
HO'' y··,,'NHBoc 
OH 
169 
Figure 3.7: synthesis of anti-anti-anti-syn triacetoxy ACHC derivative 168 
Ac00H 
AcO#C02Et 
NHBoc 
OAc 
H H 
\__; 
Figure 3.8: Selected NOESY interactions for 168 
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3.3.3 SYNTHESIS OF THEANTI-ANTI-SYN-SYN ACHC DERIVATIVE 178 
Having achieved the stereoselective synthesis of the anti-anti-anti-syn triacetoxy 
ACHC derivative 168, attention was turned on setting the stereochemistry of the C-4 
and 5 syn-hydroxyl groups on the same face as the allylic hydroxyl group and anti to 
the homoallylic carbamate. Donohoe and eo-workers have carried out extensive 
studies on the directed dihydroxylation of cyclic allylic alcohols and have found that 
the OsO,JTMEDA oxidant delivered the syn-syn isomer through hydrogen-bonding 
mediated processes, Figure 3.9.82 This reaction proceed through a five membered 
chelate of TMEDA with Os04 thereby increasing the electron density on the oxo 
ligands and making them better hydrogen bond acceptors. 
Q Os04, TMEDA, CH2Cl2 -78oC HOX) --98% ( 171:172; 8:1) HO + HO,,,:Q HO''' 
OH 
170 
OH 
171 
OH 
172 
Figure 3.9: Donohoe's OsO,JTMEDA dihydroxylation of 170 
In the context of intermediate 3, hydrogen bonding could either be between the 
chelate and the allylic alcohol or the chelate and the homoallylic carbamate. In the 
event, treatment of a solution of cyclohexadiene 3 in CH2Cb or acetone with one 
molar equivalent of Os04 m the presence of TMEDA afforded 
trihydroxylcyclohexene 166 as the only detectable product, Figure 3.10. The 
dihydroxylation still occurred preferentially on the same diastereoface as under the 
previous conditions without TMEDA. 
NC02Et 
y··''NHBoc 
OH 
3 
Os04, TMEDA, CH2Cl2 
-78 °C 
78% 
HO,,, __ NC02Et 
HO'''. y··,,,NHBoc 
OH 
166 
Figure 3.10: OsOJTMEDA mediated dihydroxylation of 166 
Next, we examined the Prevost reaction62 as a route to dihydroxylation of 3 on the 
upper diastereoface. It is instructive to preface this reaction with a few remarks. The 
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Prevost reaction involves heating the alkene with iodine and a silver salt (usually the 
benzoate or acetate). In this reaction, iodine reacts with the n: bond on the less 
sterically hindered face to afford a transient iodonium ion, which is then intercepted 
by the nucleophilic silver carboxylate to give a trans-iodo-ester. The iodo-ester is then 
hydrolysed to give the cis-diol on the more hindered face. In the case at hand, 
treatment of cyclohexadiene 3 with iodine and silver acetate in acetic acid and water 
gave a synthetically useless mixture of products including diiodo isomers. The above 
observation can be attributed to non facio-discrimination of the iodination reaction 
and the opening of the iodonium ring by an iodide ion. 
The disappointing results forced us to modify our synthetic strategy towards 
functionalising bicyclic adduct 2 before the elimination of the oxygen bridge. 
Employing a known procedure,64 2 was dihydroxylated from the exo-face by 
treatment with catalytic Os04 in the presence of Me3NO.H20 to give diol 173. With 
diol 173 in hand, attention was turned towards elimination of its oxygen bridge. 
Andrio and eo-workers have reported a LiHMDS mediated fragmentation of a 
comparable oxanorbornane system with unprotected hydroxyl groups.83 
Unfortunately, all attempts at the use of either KHMDS or LiHMDS in variable 
equivalences to eliminate the oxygen bridge of 173 failed to give any of the 
anticipated cyclohexenyl products. 
0 Os04, Me3NO.H20, HO 0 ci~C02Et _A_c_e_to_n_e ____ HOIUri~C02Et 
~ 77% ~ -------No Reaction 
Base, THF, 
-50 to 25°C 
NHBoc NHBoc 
2 173 
Base: LiHMDS or KHMDS 
Figure 3.11: Synthesis of 173 and attempts towards its fragmentation 
The failure of the fragmentation reactions of diol 173 was certainly not suprising. The 
addition of the base must have led to the deprotonation of the hydroxyl groups, 
placing more negative charge on the substrate and making the formation of the 
enolate, which leads to ~-elimination of the oxygen bridge very difficult. Diol 173 
therefore had to be converted into a form amenable to the fragmentation step. To this 
end, a solution of 173 in acetone was treated with 2,2-dimethoxypropane in the 
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presence of p-TsOH to give acetonide 174 in 61% yield, Figure 3.12. Although 
fragmentation of related acetonide systems has been reported,65 acetonide 174 was 
inert to both LiHMDS and KHMDS. It seemed reasonable to conclude that the cyclic 
acetonide moiety increased the rigidity of 174 and therefore made the elimination of 
the oxygen bridge less likely. 
o Me2C(OMe)2, 
HOriYC02Et p-TsOHAcetone 
HO~ 61% 
NHBoc 
173 
~~eo, Et Base, THF, 
-50 to 25°C . 
----No ReactiOn 
NHBoc 
174 
Base: LiHMDS or KHMDS 
Figure 3.12: Synthesis of 174 and attempts towards its fragmentation 
At this point, a persilylated derivative of 173 was considered as a possible less rigid 
substrate for the base mediated fragmentation reaction. To prepare this derivative, a 
solution of 173 in CH2Ch was treated with TBSCl in the presence of imidazole to 
give 175 in excellent yield. Initial attempts to fragment 175 using KHMDS were 
futile. Gratifyingly, LiHMDS gave the desired substituted cyclohexene 176 albeit 
accompanied by the unexpected loss of the Boc protecting group, Figure 3.13. It is not 
clear to what the discrepancy between KHMDS and LiHMDS should be attributed. 
The 1H NMR spectrum of 176 exhibited all the features consistent with the proposed 
structure including a characteristic doublet at o 6.87 with coupling constant J = 3.2 Hz 
assigned to H-2. 
0 
Ho'>-lyco2Et 
HO~ 
NHBoc 
173 
TBSCl, CH2Cl2 
imidazole 
86% 
0 
TnsoriYco2Et 
TBSO~ 
NHBoc 
175 
j LiHMDS, THF, -50 to 25°C, 48% 
TBSOYY.C02Et 
TBSO~·,,,NH2 
OH 
176 
Figure 3.13: Persilylation of 173 and fragmentation of bis TBS ether 175 
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In spite of the moderate yields for the fragmentation reaction, 176 was elaborated to 
anti-anti-syn-syn triacetoxy derivative of ACHC through the sequence of reactions 
shown in Figure 3.14. Thus, TBAF mediated desilylation of 176 and subsequent 
peracetylation afforded 177 in 52% over the two steps. Reduction of the double bond 
by treatment of a solution of 177 in EtOH with a catalytic amount of 10% Pcl/C under 
a hydrogen atmosphere proved to be facio-selective and afforded the anti-anti-syn-syn 
isomer 178 as the only product. The hydrogen was delivered to the double bond on 
the same face as that occupied by the carbamate and opposite to the C-3 acetoxy 
group. 
The 1H and 13C spectra of 178 displayed all the features consistent with the proposed 
structure. The relative stereochemistry around the ring was suggested by the NOESY 
interactions shown in Figure 3.15. 
TBSO~C02Et 
TBSO~··,,,NH2 
OH 
176 
i. nBu4NF, THF 
ii. Pyridine, Ac20 
52% 
AcO~C02Et 
AcO~·.,,NHAc 
OAc 
177 
H2, Pcl/C, EtOH 
99% 
AcOYI,C02Et 
AcO~·.,,NHAc 
OAc 
178 
Figure 3.14: synthesis of anti-anti-syn-syn triacetoxy ACHC derivative 178 
~ 
Acoil=fco2Et 
NHBoc 
OAc 
OAc H 
Figure 3.15: Selected NOESY interactions of 178 
55 
3.3.4 SYNTHESIS OF THE SYN-SYN-SYN-SYN ACHC DERIVATIVE 182 
The cis dihydroxylation chemistry discussed thus far employed the endo carbamate 
adduct 2 as the starting material and therefore gave the 2,3-anti geometry in the 
subsequent ACHC derivatives. It therefore appeared attractive to apply the cis 
dihydroxylation protocols on the exo carbamate adduct 158 as a route to ACHC 
derivatives with a 2,3-syn relationship. Thus, subjection of adduct 158 to the action of 
KHMDS in THF afforded cyclohexadiene 159 in 71% yield. Attempts to procure 159 
from 3 through a Mitsunobu reaction84 were thwarted by aromatisation which gave 
the N-Boc protected ethyl anthranilate. Having obtained 158, Os04 mediated 
dihydroxylation and peracylation afforded cyclohexenyl 179 as the only isomer, 
Figure 3.16. It is evident from this reaction that the ability of the homo-allylic 
carbamate to direct delivery of the diol on the upper face overrides the anti preference 
of the allylic alcohol. 
Another route to the cyclohexenyl intermediate 179 involved the sequence of 
reactions shown in Figure 3.16. Thus, dihydroxylation of bicyclic adduct 158 and 
subsequent protection of the resulting diol gave 180. LiHMDS mediated 
fragmentation afforded intermediate 181 and contrary to 176 without the loss of the 
Boc group. Desilylation and acetylation under standard conditions gave the desired 
intermediate 179 in acceptable yield. 
0 
bNHBoc 
I 
C02 Et 
158 
KHMDS, THF, 
-50 to 25°C 
69% 
i. Os04, Me3NO.H20, 
Acetone 
ii. TBSCI, CH2C12 
imidazole, 86% 
(YC02Et 
YNHBoc 
OH 
159 
i. Os04, Me3NO.H20, 
acetone 
ii. Ac20, pyridine ~ 
Ac0yyC02Et 
AcO~NHBoc 
OAc 
179 
TBSnO LiHMDS0 THF, TBSOx;:cCOzEt 
TBSO -50 to 25 C NHBoc _____ _.. TBSO NHBoc 
C02Et 56% OH 
i. nBu4NF, THF 
ii. Ac20, pyridine 
62% 
1~ U1 
Figure 3.16: Two routes to cyclohexenyl intermediate 179 
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The preparation of intermediate :B. 79 set the stage for the reduction of the n: bond to 
afford the triacetoxy derivative of ACHC. Considering the chiral environment around 
the n: bond and results from the previous reduction reactions, it seemed reasonable to 
expect that the reducing agent would discriminate between the two diastereotopic 
faces of the ring. However, predicting from which side of the molecule the reduction 
would occur was difficult. In the event, treatment of a solution of 179 in ethanol with 
a catalytic amount of 10% w/w Pd/C under a hydrogen atmosphere gave the syn-syn-
syn-syn ACHC derivative 182, Figure 3.17. The hydrogen was delivered to the 
double bond from the less hindered face of the molecule and in contrast to related 
systems discussed in the preceding sections, the carbamate did not direct the 
hydrogenation. 
The 1H and 13C spectra of 182 were consistent with the proposed structure. The 
relative stereochemistry was confirmed by NOESY correlations shown in Figure 3.18. 
Acoyyco2Et 
AcO~~Boc 
OAc 
179 
H2, Pd/C, ethanol, 98% AcOYIC02Et 
AcO~~Boc 
OAc 
182 
Figure 3.17: Synthesis of the syn-syn-syn-syn ACHC derivative 182 
irl HrH~ Aco-f-~~co2Et ~~ 
OAc NHBoc 
Figure 3.18: Selected NOESY interactions of 182 
In summary, Os04 catalysed dihydroxylation was found to be an effective method for 
the stereoselective synthesis of cyclohexyl P-amino acids 168, 178 and 182 from 
bicyclic adducts 2 and 158. 
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3.4 EPOXIDATION AS A ROUTE TO TRANS DIHYDROXYLA TION 
3.4.1 SYNTHESIS OF THE ALL ANTI ACHC DERIVATIVE 188 
The dihydroxylation processes described thus far have culminated in the synthesis of 
derivatives of ACHC with a 4,5-syn-dihydroxyl relationship. To introduce 
stereochemical diversity in this synthetic approach, it appeared reasonable to explore 
routes towards the corresponding anti diols. Our strategy towards these intermediates 
with a 4,5-anti relationship identified epoxidation as a central reaction. Thus, 
treatment of a solution of cyclohexadiene 3 in CH2Ch with mCPBA and NaHC03 
resulted in a highly selective oxidation of the remote 1t bond to give a separable 9:1 
mixture of epoxides 183 and 184 respectively, Figure 3.19. Preliminary acetylation of 
the hydroxyl group enhanced the selectivity and allowed the isolation of epoxide 186 
as the only isomer, Figure 3.20. 
There have been sporadic reports on the stereoselective epoxidation of 4-
aminocycloalkenes. For example, highly stereoselective amide-directed epoxidation 
of 4-aminocyclopentenes has been reported by Barrett and co-workers.85 On the other 
hand, the peracid epoxidation of cyclic olefins with allylic directing hydroxyl groups 
is well documented. 86 In the context of the results of the epoxidation of 3, the 
stereochemistry of the peroxide attack and the configuration of the resulting epoxide 
was directed by the homoallylic carbamate. 
C02Et mCPBA, ~aH~O~, CH2Cl2 
'NHB (183.184, 9.1) 
OH 
oc 77% 
3 
Figure 3.19: Epoxidation of 3 
NC02Et 
y··,,'NHBoc 
OH 
3 
Ac20, pyridine 
96% 
NC02Et 
y··''NHBoc 
OAc 
185 
Figure 3.20: Synthesis and epoxidation of 185 
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y··''NHBoc 
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mCPBA, NaHC03, 
CHzClz ··y:C02Et 
-------- 0''' 
65% ''··· .,,'NHBoc 
OAc 
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With intermediate 186 in hand, attention was turned towards the opening of the 
epoxide ring. To this end, treatment of epoxide 186 with aqueous perchloric acid led 
to a single trans diol isomer, albeit accompanied by loss of the Boc group, Figure 
3.21. Characterisation of the fully acetylated derivative 187 suggested that 
nucleophilic attack had occurred at the allylic position. This was subsequently 
confirmed by ring opening of the epoxide with ZnCh in the presence of acetic acid to 
give the crystalline chlorohydrin 189, Figure 3.22. The structure of 189 was 
confirmed by X-ray crystallographic analysis (see Appendix 3). Finally, the reduction 
of the rr bond under the conditions described previously afforded the all anti isomer 
188 in excellent yield. 
,,,··c;xC02Et 
0,,, .. 
.,,'NHBoc 
OAc 
186 
i. HC104, H20/ 
acetone 
ii. Ac20, pyridine 
72% from 186 
AcOYY.C02Et 
AcO'''·y··,,NHAc 
OAc 
187 
j H2, Pd/C, EtOH 98% 
AcOYJC02Et 
AcO'''·y··,,NHAc 
OAc 
188 
Figure 3.21: Synthesis of the all anti isomer 188 
CH2Cl2 ClnC02Et 
HO',,··y··,,NHBoc 
OAc 
189 
Figure 3.22: Opening of epoxide 186 with acetic acid in the presence of ZnClz 
The structural assigment of the all anti isomer 188 was based on ID and 2D NMR 
experiments. The observation of 10.0 Hz HaHb coupling constants in the 1H NMR 
spectrum of 188 for the ring protons (H-1, H-2, H-3, H-4 and H-5) was indicative of 
HaHb anti diaxial relationships and supported the indicated stereochemistry. This was 
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subsequently confirmed by NOESY interactions between H-1 and H-3, H-1 and H-5 
and also H-2 and H-4, Figure 3.23. 
Figure 3.23: Selected NOESY interactions for the all anti isomer 188 
3.4.2 SYNTHESIS OF THEANTI-ANTI-SYN-ANTI ACHC DERIVATIVE 195 
The initial strategy to procure the alternative epoxide involved selective exo face 
epoxidation of the oxanorbomene system 2 and subsequent P-elimination of the 
oxygen bridge. To this end, a solution of adduct 2 in CH2Ch was treated with mCPBA 
and NaHC03 to give a 61% yield of epoxide 190, Figure 2.24. Unfortunately, epoxide 
190 decomposed under the basic conditions required for the P-elimination of the 
oxygen bridge. 
0 mCPBA, NaHC03, 0 Base, THF, 
J/~~co2Et _c_H_2_c_l2 _____ o;l~co2Et -50 to 25oc 
~ 61% ~ 
NHBoc NHBoc 
2 190 
Base=KHMDS 
Figure 3.24: Synthesis of epoxide 190 
Decomposition 
products 
In the event that a regioselective opening of the epoxide ring could be achieved, 
adduct 190 could serve as a precursor to the anti-anti-syn-anti ACHC derivative. 
Unfortunately, when epoxide 190 was subjected to the action of a mixture of acetic 
acid and water, cyclic carbamate 191, which was inert to the action of sodium 
ethoxide, was isolated in 75 % yield, Figure 3.25. Attempts to eliminate the oxygen 
bridge of this system with a large excess of KHMDS were also futile. 
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Ac0HIH20 (9:1) 
75% 
Figure 3.25: Opening of epoxide 190 
The disappointing results forced us to modify our synthetic strategy and methods 
which could override the dominant directing effect of the carbamate group of 
cyclohexadiene 3 were considered. It was known from the work of Sharpless and eo-
workers that the vanadium-based epoxidation of allylic alcohols with t-butyl 
hydroperoxide (TBHP) had a more syn-directive effect than mCPBA. 87· 88 Thus, on 
the basis of these precedents, a solution of cyclohexadiene 3 and catalytic VO(acac)z 
in refluxing benzene was treated with TBHP and the reaction was monitored by TLC. 
Unfortunately, the protected anthranilate 144 was the only product isolated from this 
reaction, Figure 3.26. The readiness of cyclohexadienes related to 3 to aromatise has 
been documented,36 therefore isolation of 144 as the sole product was not suprising. 
Repeating the reaction at low temperature did not change the results. 
NC02Et 
y··.,,NHBoc 
OH 
3 
VO(acach PhH, 
1BuOOH 80°C C(C02Et 
, I 
77% /:- NHBoc 
144 
Figure 3.26: Reaction of 3 with 1BuOOH in the presence of VO(acac)z 
Next, a range of polar solvents were surveyed for the epoxidation of 3 on the 
assumption that they may disrupt the directing effect of the carbamate group. 
Gratifyingly, when a solution of the cyclohexadiene 3, mCPBA and NaHC03 in 
CH3CN was stin-ed at room temperature for 16 h, a separable 2:1 mixture of isomers 
favouring the desired syn epoxyalcohol 184 was isolated in excellent yield, Figure 
3.27. However, when the reaction was carried out in other solvents, such as DMF, 
THF, MeOH, IPA or CF3CH20H instead of CH3CN, a 1:1 mixture of the epoxides 
was isolated. It was known from the work of Shu and Shi on epoxidation in CH3CN 
that the actual oxidant was peroxyimidate 193, formed by nucleophilic attack on the 
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solvent by mCPBA,89 Figure 3.28. The modified steric and electronic properties of the 
oxidant were most likely responsible for the observed reversed stereoselectivity. 
,,.··c;xC02Et 
o,,,,, 
·.,,'NHBoc 
C02Et MCPBA NaHCO CH CN 
' 3' 3 
NHBoc 95% (183:184; 1:2) 
OH OH 
3 183 
Figure 3.27: Epoxidation of cyclohexadiene 3 in CH3CN 
Figure 3.28: Possible route to peroxyimidate 193 
+ 0~C02Et 
y··,,'NHBoc 
OH 
184 
Among the tasks remaining was the opening of the epoxide ring of 184 and reduction 
of then: bond to give hopefully the anti-anti-syn-anti derivative of ACHC. Thus, acid-
catalysed opening of the epoxide ring in 184 was regioselective and after acetylation, 
194 was isolated as the only detectable product in 69 % yield, Figure 3.29. Reduction 
of the double bond under the previously described protocol afforded the anti-anti-syn-
anti ACHC derivative 195 in excellent yield. 
The analytical and NMR data of 195 were consistent with the proposed structure. The 
relative configurations of the cyclohexane substituents were suggested by the 
observation of NOESY effects between H-1 and H-3, and also H-3 and H-4, Figure 
3.30. 
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Figure 3.29: Synthesis of the anti-anti-syn-anti ACHC derivative 195 
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Figure 3.30: Selected NOESY interactions for 195 
3.4.3 SYNTHESIS OF THE ANTI-SYN-SYN-ANTI ACHC DERIVATIVE 198 
It was considered interesting to compare the facio selectivity of the epoxidation of 
cyclohexadiene 3 to that of 159. With both the carbamate and hydroxyl groups on the 
same face in cyclohexadiene 159 and therefore operating in cooperation, it was 
presumed that epoxidation would occur preferentially on the upper face. Thus, 
subjection of a solution of 159 in CH2Ch to the action of mCPBA in the presence of 
NaHC03 at room temperature resulted in the formation of only isomer 196 in 70% 
yield, Figure 3.31. Unlike 3, alternative solvents such as CH3CN, DMF, MeOH and 
H20/acetone or prior acetylation of the hydroxyl group did not affect the facio 
selectivity of the epoxidation of 159. Attempts to protect the hydroxyl group with the 
bigger TBS group led to aromatisation giving the ethyl anthranilate 144. 
Cyclohexadiene 159 was itself a rather unstable substance. Under acidic conditions, 
159 undergoes aromatisation to give again the ethyl anthranilate 144. 
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Figure 3.31: Epoxidation of cyclohexadiene 159 
As with the previous related systems, acid-catalysed opening of the epoxide ring in 
196 was regioselective and after acetylation gave cyclohexene 197 in good yield, 
Figure 3.32. Subsequent reduction of the double bond gave the anti-syn-syn-anti 
ACHC derivative 198. The hydrogen was delivered on the same face as that occupied 
by the carbamate and opposite to the 3-acetoxy group. 
Initial relative stereochemical assignments of 198 were based on the observed 
NOESY interactions as shown in Figure 3.33. The structure of 198 was subsequently 
confirmed by X-ray crystallographic analysis (see Appendix 4). 
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Figure 3.32: Synthesis of the anti-syn-syn-anti ACHC derivative 198 
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Figure 3.33: Selected NOESY interactions for 198 
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In conclusion, epoxidation has proved to be an effective reaction in the synthesis of 
trihydroxyxlated ~-amino acid derivatives 188, 195 and 198 from the Diels-Alder 
adducts of (E)-3-nitroacrylate 1 and furan. 
3.4 SUMMARY 
The stereoselective syntheses of six 3,4,5-trihydroxyl derivatives of ACHC described 
in this chapter are distinguished by the use of substrate-stereocontrolled processes to 
secure stereochemical relationships around the cyclohexane rings. The enforced 
reliance of the syntheses on simple classic reactions at ambient conditions is another 
positive attribute of the strategy worth mentioning. The key reactions employed in 
the syntheses are Diels Alder reaction, Os04 mediated cis-dihydroxylation and 
epoxidation as a route to trans-dihydroxylation. Through these reactions, novel 
trihydroxylated ACHC derivatives were prepared and reported for the first time.90 
This strategy has potential for future application in the synthesis of aminocarbasugars 
and aminoshikimic acid derivatives. 
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CHAPTER FOUR 
FURTHER CHEMISTRY OF ADDUCTS 2 AND 158 
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4.1 INTRODUCTION 
The synthesis of trihydroxyl ACHC derivatives featuring the base mediated B-
elimination of the oxygen bridges of oxanorbomene adducts 1 and 158 as one of the 
main reactions was discussed in Chapter 3. During these studies, interesting 
observations suggested that the oxanorbomene strategy possessed potential as a 
stereoselective approach to mono and dihydroxylated cyclohexyl P-amino acid 
derivatives. It was also realised that employing a transition metal-catalysed ring-
opening reaction for the fragmentation of the oxabicyclic compounds would add 
structural diversity to our oxanorbomene route to cyclohexyl P-amino acid 
derivatives. 
The results of the synthesis of mono and dihydroxylated P-amino acids will be 
discussed in the first section of this chapter. Subsequent sections will document 
results of the reaction of adduct 2 with catalytic amount of palladium complexes in 
the presence of zinc and organic acids. 
Figure 4.1: Oxanorbomene adducts 2 and 158 
0 
~NHBoc 
C02 Et 
158 
4.2 SYNTHESIS OF THE 3-HYDROXYL DERIVATIVES OF ACHC 
4.2.1 INTRODUCTION 
The P-elimination of the oxygen bridges of adducts 2 and 158 to give cyclohexadienes 
3 and 159 respectively and subsequent reduction of the double bonds of these 
cyclohexadienes would furnish 3-hydroxyl ACHC de1ivatives of type 199 and 200. 
The oxanorbomene adducts were derived from the reaction of ethyl (E)-3-
nitroacrylate 1 and furan, Figure 4.2. On the basis of precedence delineated in Chapter 
3, it was anticipated that substrate stereo-controlled processes would control the 
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reduction of the ~ 1 '2 double bond and therefore set the stereochemistry of C-1 in the 
ACHC derivatives 199 and 200. 
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Figure 4.2: Plan for the synthesis of 3-hydroxyl ACHC derivatives 199 and 200 
4.2.2 SYNTHESIS OF THE ANTI-ANTI 3-ACETOXY ACHC DERIVATIVE 
203 
As discussed in Chapters 2 and 3, base mediated ~-elimination of the oxygen btidge 
of adduct 2 to give cyclohexadiene 3 (R = H) was accompanied by variable amounts 
of ethyl-3-hydroxybenzoate. It seemed reasonable to infer that the reduction of the 
double bond of adduct 2 prior to ~-elimination of the oxygen bridge would eliminate 
the by-product. In the event, treatment of a solution of adduct 2 in ethanol with Pd/C 
under a hydrogen atmosphere afforded 201 in 98% yield. Subsequent ~-elimination of 
the oxygen bridge of 201 with KHMDS in THF and acetylation of the crude product 
gave substituted cyclohexene 202 in 68% over the two steps, Figure 4.3. 
The 1H HMR spectrum of 202 showed all the peaks consistent with the proposed 
structure including a singlet at o 2.01 assigned to the acetyl group and the multiplet at 
o 7.14 assigned to H-2. To complete the synthesis, the n bond of 202 was reduced 
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under the standard conditions to give the anti-anti ACHC derivative 203 in 97% yield. 
The relative stereochemistry was assigned on the basis of NOESY correlations, Figure 
4.4. 
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Figure 4.3: Synthesis of the anti-anti ACHC derivative 203 
Figure 4.4: Selected NOESY interactions for 203 
The importance of cyclohexyl P-amino acid derivatives as building blocks for P-
peptides was discussed in Chapter 3. ACHC derivative 203 was considered as the 
simplest member of the oxanorbornene derived ACHC derivatives. Model studies 
were therefore conducted on its suitability in peptide synthesis. As a prelude to 
involvement of 203 in the synthesis of peptides, the reactivity of its amine 
functionality with benzoic acid was investigated. First, 203 had to be converted to a 
form amenable to the crucial coupling step. To this end, a solution of 203 in CH2Ch 
was treated with TFA to give 204 in quantitative yield. Subsequently, a solution of 
204 and benzoic acid in CH2Ch was treated with PyBop in the presence of 
triethylamine (TEA) to give 205 in 84 % yield. The structure of the coupled product 
was confirmed by elemental analysis, mass spectrometry and NMR spectroscopy. 
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Figure 4.5: Synthesis of 205 
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To study the reactivity of the acid group of 203 with amines, it was decided to take 
advantage of the chemistry already discussed in Chapter 1. Consequently, adduct 2 
was subjected to the action of KHMDS to give a cyclohexadienyl intermediate which 
was hydrolysed to afford the acid 125, Figure 4.6. Subsequent acetylation and 
reduction of the n: bonds gave the anti-anti-3-acetoxy ACHC derivative 206 in 75% 
yield from 125. 
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Figure 4.6: Synthesis of the anti-anti ACHC derivative 206 
With B-amino acid 206 in hand, attention was turned to its reaction with amines in the 
presence of coupling reagents. To this end, a solution of 206, benzylamine and 
triethylamine (TEA) in CH2Ch was treated with PyBop to give the coupled product 
(detected by GC-MS), which proved impossible to purify. Fortunately, when the 
coupling reagent HATU was used instead of PyBop, the coupled product 207 was 
isolated as a white solid in 83% yield. The overall process involved initial in situ 
activation of the carboxylic group of 206 by HATU followed by subsequent reaction 
with benzyl amine to give the amide 207, Figure 4.7. One characteristic of amide 207 
worth mentioning is that it was found to be sparingly soluble in most organic solvents. 
The 1H NMR spectrum of 207 displayed all the features consistent with the coupled 
product including a multiplet at o 2.45 assigned to the H-1 proton and two doublets at 
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8 4.25 and 4.47 with coupling constant J = 14.8 Hz assigned to the two prochiral 
benzylic protons. 
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Figure 4.7: Synthesis of the coupled product 207 
For a more relevant model study, acid 206 was coupled to cyclohexylamine in the 
presence of HA TU under the conditions described above to give the coupled product 
208 in 72 %. Surprisingly, 208 was found to be insoluble in most organic solvents 
and its NMR spectra were measured in DMSO. 
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Figure 4.8: Synthesis of couple product 208 
The processes described thus far have culminated in the synthesis of anti-anti ACHC 
derivative 203 and ascertained its suitability as a building block in peptide synthesis. 
The insolubility of amides 207 and 208 in most organic solvents was somewhat 
supnsmg. 
4.2.3 SYNTHESIS OF THE SYN-SYN 3-ACETOXY ACHC DERIVATIVE 
210 
The synthesis of the anti-anti ACHC derivative 203 discussed in the preceding section 
employed the endo carbamate adduct 2 as the starting material. To increase the 
stereochemical diversity of our strategy, it seemed logical to involve the exo 
carbamate adduct 158 as a starting material. To this end, the oxanorbomene adduct 
158 was opened as described in Chapter 2 and subsequent acetylation gave 
cyclohexadiene 209 in good yield, Figure 4.9. Catalytic hydrogenation of the double 
bonds was performed in the presence of catalytic amount of 10 % Pd/C under a 
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hydrogen atmosphere at room temperature to give the syn-syn ACHC derivative 210. 
It was assumed that hydrogen added to the double bond from the least hindered side 
of the molecule. The syn-syn configuration was supported by NOESY correlations 
shown in Figure 4.10 and comparison with literature data of related structures.30 
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Figure 4.9: Synthesis of the syn-syn ACHC derivative 210 
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Figure 4.10: Selected NOESY correlations for 210 
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4.3 SYNTHESIS OF THE 3,4-DIHYDROXYL ACHC DERIVATIVES 
4.3.1 INTRODUCTION 
Through a previously established synthetic pathway (Chapter 3), epoxides 183, 184 
and 196 could be selectively prepared in good yields using oxanorbomene adducts 2 
and 158 as starting materials. Provided that a regioselective reductive ring opening 
could be achieved, these epoxides could serve as precursors to dihydroxyl ACHC 
derivatives. It was known from the work of Danishefsky and eo-workers that 
treatment of vinylic epoxides with Pd/C under a hydrogen atmosphere led to 
homoallylic alcohols. 91 In the course of the synthesis of baccatin Ill and taxol, 
Danishefsky and eo-workers showed that treatment of a solution of epoxide 211 in 
ethanol with Pd/C under a hydrogen atmosphere at low temperature selectively 
opened the epoxide ring without reducing the double bond to give 212 in excellent 
yield, Figure 4.12. The palladium catalysed epoxide opening reaction involves 
oxidative addition of hydrogen to palladium, coordination of the palladium to the 
double bond of the substrate and subsequent opening of the epoxide through 
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formation of the palladium n-allyl cation complex 214. The product is then released 
from the palladium through P-hydrogen elimination, Figure 4.12. 
On the basis of this precedent, it was decided to feature the reductive epoxide ring 
opening reaction as one of the strategies in the synthesis of 3,4-dihydroxyl ACHC 
derivatives using epoxides 183, 184 and 196. Alternative strategies included the use 
of the hydroxyl group of the cyclohexadiene systems to direct oxygenation of the ~3 ·4 
double bond and hydroboration of the oxanorbomene adducts prior to P-elimination 
of the oxygen bridge. 
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Figure 4.11: Epoxides 183, 184 and 196 
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Figure 4.12: Danishefsky's opening of the epoxide ring of 211 
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4.3.2 SYNTHESIS OF THE ANTI-ANTI-ANTI ACHC DERIVATIVE 217 
Initial attempts towards the anti-anti-anti 3,4-dihydroxyl ACHC derivative involved 
setting the relative stereochemistry of the functionalitics on the bicyclic adduct 2 p1ior 
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to the elimination of the oxygen b1idge. To this end, a solution of adduct 2 m 
acetonitrile was treated with iodine to give the tricyclic iodocarbamate 215 m 
moderate yield. The yield was improved by performing the reaction in acetic acid. In 
this reaction, the iodine engages the double bond in adduct 2 from its less hindered 
convex face and elicits an intramolecular attack by the proximal carbamate. A radical 
abstraction of the iodine was then conducted with 2,2' -azobisisobutyronitrile (AIBN) 
as the radical initiator to give tricyclic carbamate 216 in 46% yield. Tris-
(trimethylsilyl)silane served as the chain transfer reagent. With the anti-anti-anti 
stereochemistry around the six membered ring set, attention was turned towards 
hydrolysis of the cyclic carbamate and ~-elimination of the oxygen bridge. As matters 
transpired, attempts to use 216 as an intermediate in the synthesis of the anti-anti-anti 
ACHC derivative were thwarted by the resistance of the cyclic carbamate to the 
action of sodium ethoxide. Attempts to eliminate the oxygen bridge of the tricyclic 
carbamate 216 were also futile, probably due to the extra rigidity conferred by the 
carbamate ring. 
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Figure 4.13: Synthesis of tricyclic carbamate 216 
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The disappointing results forced us to modify our synthetic strategy and consider 
epoxide 183 as an intermediate in the synthesis of the anti-anti-anti ACHC derivative. 
Epoxide 183 was prepared in good overall yield from oxanorbomene adduct 2 by ~­
elimination of the oxygen bridge, acetylation and mCPBA epoxidation, Figure 4.14. 
When a solution of epoxide 183 in ethanol was treated with 10 % Pd/C under a 
hydrogen atmosphere followed by acetylation, the anti-anti-anti 3,4-diacetoxy ACHC 
derivative 217 was isolated in 88% yield over the two steps. 
The structure of the ACHC derivative 217 was determined by IR, MS, 1H and 13C 
NMR. The stereochemical elucidation was based on the analysis of the 1H NMR 
spectrum and NOESY interactions. The 1H NMR spectrum exhibited a doublet at o 
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4.88 with coupling constant J = 9.5 Hz assigned to H-3. The observation of the 9.5 
Hz HaHb coupling constant in the 1H NMR spectrum of 217 was consistent with anti 
diaxial relationships between H-3 and both H-2 and H-4 and this supports the 
indicated stereochemistry. The relative stereochemistry was supported by NOESY 
interactions shown in Figure 4.15. 
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Figure 4.14: Synthesis of the anti-anti-anti ACHC derivative 217 
Figure 4.15: Selected NOESY interactions for 217 
4.3.3 SYNTHESIS OF THE ANTI-ANTI-SYN ACHC DERIVATIVE 218 
With the favourable results on the synthesis of the anti-anti-anti ACHC derivative 
217 in hand, we moved on to apply the epoxide route developed in the preparation of 
the anti-anti-syn ACHC 218 from epoxide 184. The conditions for the procurement of 
epoxide 184 were delineated in Chapter 3. Consequently, treatment of a solution of 
the cyclohexadiene system derived from adduct 2 in acetonitrile with mCPBA and 
NaHC03 gave a 2:1 mixture of isomers favouring the desired syn epoxyalcohol 184. 
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Subjection of epoxide 184 to the action of Pd/C under a hydrogen atmosphere 
followed by acetylation afforded the trans-trans-syn ACHC derivative 218 in good 
yield. It is worth noting that hydrogen added to the enoate double bond exclusively on 
the lower face of the molecule and it seemed reasonable to assume that the carbamate 
was involved in directing this process. 
The 1H NMR spectrum of 218 displayed all the features consistent with the proposed 
structure including the doublet of doublets at 8 4.86 with coupling constants J = 11.5 
and 2.5 Hz assigned to H-3. The big coupling constant (J = 11.5 Hz) was indicative of 
an anti diaxial relationship between H-3 and H-2 while the smaller one (J = 2.5 Hz) 
was consistent with a syn equatorial-axial relationship between H-3 and H-4. The 
stereochemical relationships of 218 were also supported by the NOESY interactions 
shown in Figure 4.17. 
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Figure 4.16: Synthesis of the anti-anti-syn ACHC derivative 218 
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Figure 4.17: Selected NOESY interactions for 218 
An alternative route to the anti-anti-syn ACHC derivative 218 involved the subjection 
of oxanorbornene adduct 2 to the hydroboration/oxidation reaction. Hydroboration 
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was expected to occur on the exo face of adduct 2 but predicting the regiochemistry of 
the reaction was difficult. In the event, a solution of adduct 2 in THF with 9-BBN was 
stirred for 24 h and then 3 M NaOH and H20 2 were added to the reaction mixture to 
afford a 1:1 mixture of the two hydroxyl adducts 219 and 220 in 65 % yield, Figure 
4.18. Unfortunately, these adducts proved impossible to separate. The lack of 
regioselectivity in the hydroboration reaction also made pursuing this strategy less 
attractive. 
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Figure 4.18: Hydroboration oxidation of 2 
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Another alternative method considered for the anti-anti-syn ACHC derivative 218 
was to use the allylic hydroxyl group to direct the substitution of the ~3 •4 double 
bond. It was thought that diethyl phosphate 221 or ethyl formate 222 might react with 
iodine in a manner similar to those observed for substrates studied by Bartlet and 
Jemstedt,92 Figure 4.20. The reaction involves the addition of iodine to the double 
bond eliciting an intramolecular attack by the phosphoryl oxygen to furnish cyclic 
phosphate 225 which would be amenable to fmther transformation. 
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Figure 4.19: Phosphate 221 and ethylformate 222 
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Figure 4.20: Bartlett's synthesis of 225 
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However, attempts to append the diethyl phosphoryl group to the hydroxyl group of 
cyclohexadiene 3 in the presence of K2C03 or triethylamine as the base were 
unsuccessful. Using chloroethylformate led to aromatisation in under 1 h and the 
completely protected anthranilic acid 144 was isolated in 83%. Attempts to perform 
the reaction at low temperatures also led to 144. 
OH 
3 
'NHBoc 83% 
Figure 4.21: Reaction of 3 with chloroethylformate 
144 
4.3.4 SYNTHESIS OF THE SYN-SYN-SYN ACHC DERIVATIVE 226 
The synthesis of dihydroxyl ACHC derivatives discussed thus far employed endo 
carbamate 2 as the starting material and therefore gave the 2,3-anti geometry in the 
ACHC derivatives. The P-elimination of the oxygen bridge of the exo carbamate 
adduct 158 and subsequent elaboration into dihydroxyl ACHC derivatives would 
secure a 2,3-syn configuration. Through a previously established synthetic pathway 
(Chapter 3), epoxide 196 was prepared in three steps from adduct 158, Figure 4.22. 
With epoxide 196 in hand, the palladium catalysed opening of the epoxy ring and 
subsequent reduction of the double bond proceeded smoothly and gave the syn-syn-
syn ACHC derivative 226 as the only product. A stereochemical issue of great 
importance presented itself here. In the reduction of the enoate double bond, the 
addition of the hydrogen took place on the opposite side of the molecule to which the 
carbamate was located. This observation suggested that placing the 3-hydroxyl group 
on the same face as the carbamate completely reversed the directing ability of the 
latter. 
Both the 1H and 13C spectra of 226 displayed all the features consistent with the 
proposed structure. The relative stereochemical relationships around the ring were 
based on the NOESY interactions shown in Figure 4.23. 
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Figure 4.22: Synthesis of the syn-syn-syn ACHC derivative 226 
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Figure 4.23: Selected NOESY interactions for 226 
4.3.5 SUMMARY 
The stereoselective syntheses described in the preceding sections revealed the power 
of oxanorbomene adducts derived from the Diels Alder reaction of ethyl (E)-3-
nitroacrylate and furan in the preparation of oxygenated ACHC derivatives. The most 
interesting feature of the strategy is its reliance on basic reagents to carry out non-
trivial structural transformations. Whilst the chemistry described above was 
conducted on a racemic series, it is pertinent to note that the oxanorbomene adduct 2 
is amenable to an efficient enzyme mediated kinetic resolution and chiral HPLC 
resolution.72 
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4.4 REACTION OF ADDUCT 2 WITH CATALYTIC AMOUNT OF 
PALLADIUM IN THE PRESENCE OF ZINC AND ORGANIC ACIDS 
4.4.1 INTRODUCTION 
The reductive ring opening of oxanorbomene systems catalysed by Ni (II) and Pd (Il) 
complexes in the presence of organic acids and zinc powder was recently reported by 
Cheng and eo-workers, Figures 4.24 and 4.25.93 Prior to Cheng's report, Lautens 
reported a rhodium-catalysed ring opening reaction in the presence of an organic acid 
in which the carboxylate group added to the olefin as a nucleophile.94-96 In Cheng's 
case, the carboxylic acid was the hydrogen source. The key steps for Cheng's 
reductive ring opening reaction are shown in Figure 4.26. The reaction is initiated by 
the reduction of Pd (Il) to Pd (0) by the zinc powder. Oxidative addition of the 
organic acid to Pd (0) led to the generation of the Pd (II) hydride species.97 
Coordination of the double bond of adduct 229 to the Palladium and subsequent 
insertion of the double bond to the Pd-hydride bond led to the formation of 
intermediate 232. ~-Elimination of the oxygen bridge of adduct 232 followed by 
protonation afforded the product 230 and the Pd (Il) species which was reduced to Pd 
(0) by the zinc. 
Ni(binap )12, Zn, 
Me3CCH2C02H 
toluene, 25 °C 
53% 
Figure 4.24: Cheng' s Ni (Il) reductive ring opening of 227 
0 
tto 
229 
Figure 4.25: Cheng's Pd (II) reductive ring opening of 229 
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Pd (0) 
QH CO ~d(O,CR), 
0 ~ 
229 
~ 0 P?-~::~~ RCOO~ 
231 
230 A_ 
RCO,H QPd(02CR) ) 
CO 0 o 
233 ~ (RC02)Pd~ 
232 
Figure 4.26: Catalytic cyclic for Cheng's Pd catalysed reductive ring opening of229 
4.4.2 REACTION OF OXARBORNENE ADDUCT 1 WITH PALLADIUM 
On the basis of the precedent discussed above, it was considered reasonable to apply 
the reductive ring opening conditions to the oxarnorbornene adduct 2 as an alternative 
to the base mediated fragmentation discussed in Chapters 2 and 3. The advantage of 
this approach over the base mediated fragmentation is that all the stereochemical 
relationships set by the Diets-Alder reaction would be preserved. In the event that the 
reductive ring opening reaction is successful, adduct 2 would furnish either 
cyclohexene 234 or 235 (Figure 4.27) which could then be elaborated to ACHC 
derivatives by functionalising the double bond. 
° CO Et Pd(II), Zn, RC02H 2 toluene, 25 °C 
-----------------------· 
NHBoc 
2 
OH 
~C02 Et 
u.,,'NHBoc 
234 
Figure 4.27: Potential cyclohexene systems from 2 
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+ 
NC02Et 
Y''''NHBoc 
OH 
235 
Initial attempts to reductively open 2 usmg (Ph3P)2NiCh or (CH3CNhPdCh in 
toluene were unsuccessful. Suspecting that solubility was responsible for the failure of 
the reaction, it was decided to use a more polar solvent. When acetonitrile was used as 
the solvent, the nickel complex still showed no activity on the oxanorbomene adduct 
2. However, in the presence of benzoic acid, zinc metal and palladium chloride, the 
double bond of 2 was reduced when acetonitrile was used as the solvent and 201 was 
isolated in 94% yield, Figure 4.28. On the basis of the catalytic cycle for the Pd 
catalysed reductive ring opening reaction shown in Figure 4.26, the interesting 
reduction was not suprising. Instead of P-elimination of the oxygen bridge in 
intermediate 236, protonation occmTed and gave oxanomomane system 201, Figure 
4.28. Control experiments indicated that no reaction occurred in the absence of zinc 
powder, benzoic acid or palladium catalyst. 
0 
~C02 Et 
NHBoc 
2 
IfB j (PhCO~~~C02Et 
e)~ 
PhCO NHBoc 2 236 
cat. PdC12, Zn, PhC02H, ~~~CO Et 
acetonitrile, 25 °C ~ 2 
94 % NHBoc 
201 
Figure 4.28: Transfer hydrogenation of 2 
On the basis of the results so far, it seemed PdC}z was an effective catalyst for transfer 
hydrogenation using benzoic acid as the hydride source and zinc as the reducing 
agent. To test if the hydride source had any effect on the reaction, several organic 
acids were tested in the transfer hydrogenation protocol and all afforded adduct 201 in 
excellent yields, Figure 4.29. The type of the organic acid did not affect the yield or 
the duration of the reaction. No reaction was observed when the reaction was 
performed in the presence of either methanol, benzyl alcohol or phenol. Alcohols 
were therefore not appropriate hydride sources for the PdC}z catalysed transfer 
hydrogenation protocol. 
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0 cat. PdC12 , Zn, acid, 0 qco,Et acetonitrile, 25 °C, 16 h qco,Et 
NHBoc NHBoc 
2 201 
Entr,Y Organic acid ,Yield 
1 HCOzH 96 
2 CH3COzH 94 
3 CH3COzN& 97 
4 PhCOzH 93 
Figure 4.29: Effect of various acids on the yields of the transfer hydrogenation of 2 
The palladium catalysed transfer hydrogenation can be extended to other substrates. 
To this end, cinnamic acid 237 was successively reduced to 3-phenylpropanoic acid 
238 in 84 % yield using CH3C02H as the hydride source, Figure 4.30. It is instructive 
to note that cinnamic acid was not reduced in the absence of another organic acid. 
Cinnamic acid could not therefore act as a hydride source to reduce itself under these 
reaction conditions. 
The 1H NMR spectrum of 238 showed the characteristic triplets at 8 2.61 and 2.89 
with coupling constant J = 8.4 Hz assigned to H-3 and H-2 protons respectively. MS 
and IR data were also consistent with the proposed structure. 
10% PdC12, Zn, CH3C02H 
acetonitrile, 25 °C 
84% 
Figure 4.30: Reduction of cinnamic acid 237 
In a similar way to cinnamic acid, eugenol 239 was reduced to give 240 in 98% yield, 
Figure 4.31. The discrepancy in yields of the reduction of cinnamic acid and eugenol 
can be attributed to the different purification steps. While hydroeugenol 240 was 
purified by washing with 2 M HCl, flash chromatography was necessary for the 
purification of 238. 
84 
The 1H NMR spectrum of 240 displayed all the features consistent with the proposed 
structure including a triplet at o 0.95 with coupling constant J = 7.6 Hz assigned to H-
3', a multiplet at o 1.63 assigned to H-2' and another triplet at o 2.53 with coupling 
constant J = 7.6 Hz assigned to H-1 '. 
~ 
HO~ 
OMe 
239 
10% PdC12, Zn, CH3C02H, 
acetonitrile, 25 °C ~ 
98% HO~ 
OMe 
240 
Figure 4.31: Reduction of eugenol239 
The results discussed above suggested that the transfer hydrogenation protocol can be 
used for substrates with electron deficient double bonds comparable to cinnamic acid 
and terminal un-activated double bonds exemplified by eugenol. It is also reasonable 
to conclude that aromatic systems are inert to the transfer hydrogenation conditions. 
It was conceivable that Pd/C could be used as the catalyst instead of the more 
expensive palladium chloride. Treatment of a solution of adduct 2 with a catalytic 
amount of Pd/C, zinc powder and f01mic acid afforded adduct 201 in 97% yield. 
Control reactions indicated that no reaction occurred in the absence of the Pd/C 
catalyst or formic acid. However, when the reaction was performed using a 
quantitative amount of Pd/C, the reduction preceded smoothly in the absence of zinc 
powder. Interestingly, when either benzoic acid or acetic acid was used as the hydride 
source in the Pd/C catalysed transfer hydrogenation, no reaction was observed. 
0 qco,Et 
NHBoc 
2 
Pd/C, Zn, HC02H, 
acetonitrile, 25 °C, 16 h 
97% 
0 qco,Et 
NHBoc 
201 
Figure 4.32: Pd/C catalysed transfer hydrogenation in the presence of formic acid 
85 
4.4.3 SUMMARY 
On the basis of the processes described in the above section, PdC}z has proved to be 
an effective catalyst for transfer hydrogenation with organic acids as hydride sources 
and zinc as the reducing agent. Pd/C is only effective as a transfer hydrogenation 
catalyst when formic acid is used as the hydride source. The reaction conditions 
discussed above should be suitable for the reduction of a wide variety of organic 
substrates. The procedure also offers an economical, safe and convenient alternative 
to available procedures. Future work in this area will include using chiral ligands to 
test the asymmetric version of the catalytic reaction. 
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CHAPTERS 
EXPERIMENTAL PROCEDURES 
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5.1 GENERAL EXPERIMENTAL CONDITIONS 
All reactions were carried out in clean oven-dried glassware (110°C) under a Nitrogen 
or Argon atmosphere. Solvents were purified and dried by standard methods prior to 
use. Cited reaction temperatures refer to the external bath temperatures. The phrase 
'removed under reduced pressure' refers to solvent removal with a BUchi rotary-
evaporator using a laboratory vacuum pump and a bath temperature of 30°C. 
IR spectra were scanned on a Perkin Elmer 1720X Ff Infra-red spectrophotometer. 
Melting points were measured using a Gallenkamp melting point apparatus and are 
uncorrected. All reactions were followed by TLC on 60 F254 silica gel sheets with 
visualization effected by UV illumination and/or KMn04 solution followed by heating 
or iodine vapour. Silica gel 60, 40-63u was used for flash chromatography. 
All Nuclear Magnetic Resonance spectra eH and 13C) were recorded on Varian 
Oxford (300 MHz or 400 MHz or 500 MHz) spectrometers. Chemical shifts are 
reported in ppm (8) relative to tetramethylsilane. 1H NMR data are reported as 
follows: chemical shift (number of protons, multiplicity, coupling constant, proton 
identity) and 13C as: chemical shift (carbon identity). The 1H NMR spectra were fully 
assigned by the use of COSY experiments while those for 13C were assigned by 
HETCOR experiments. NOESY was employed to determine the relative 
stereochemistry where applicable. 
5.2 EXPERIMENTAL PROCEDUCES 
1 
Ethyl (E)-3-nitropropenoate 1: 
A solution of DIPEA (5.8 g, 45mmol) in diethyl ether (10 cm3) was added dropwise 
to a vigorously stirred and cooled (0 °C) solution of compound 129 (10.0 g, 37 mmol) 
in diethyl ether (200 cm3) and the mixture was stirred for 15 minutes. The resulting 
suspension was filtered through a plug of silica. The silica was flushed with 10 % 
diethyl ether in petroleum ether and the solvent was removed under reduced pressure 
88 
to give an orange solid. The orange solid was passed through a short column of silica 
gel using petroleum ether/diethyl ether (9: 1) as the eluent to afford title compound 1 
(4.00 g, 73 %) as a yellow solid; m.p 36-38 °C. Vmax (KBr disk): 3415, 1736, 1638, 
1542 cm- 1; oH (200 MHz, CDCh): 1.35 (3H, t, J = 7.0 Hz, OCH2CH3), 4.32 (2H, q, J 
= 7.0 Hz, OCfuCH3), 7.09 (1H, d, J = 13.6 Hz, H-2), 7.68 (1H, d, J = 13.6, H-3). oc 
(75 MHz, CDCh): 13.9 (OCH2CH1), 62.4 (OCH2CH3), 127.6 (C-2), 148.9 (C-3), 
162.6 (C-l); MS (El): mlz 145 (M+), 100 (100%). 
0 
~co2Et 
NHBoc 
2 
E thy I endo-3-tert-butoxycarbonylamino-7 -oxabicyclo[2,2, 1 ]hept-5-ene-exo-2-
carboxylate 2: 
Concentrated HCl (28 cm3) was added to a solution of Diels-Alder adduct 123 (3.5 g, 
18 mmol) in EtOH (200 cm3) at room temperature and this was followed by 
portionwise addition of zinc powder (26.6 g, 407 mmol). The mixture was stirred at 
room temperature for 12 hours and then filtered. The filtrate was treated with iPr2Net 
(36.4 g, 282 mmol) and di-tert-butyldicarbonate (7 .0 g, 32mmol). The mixture was 
stirred at 25 °C for 20 hours. The solvent was removed at reduced pressure to about 
10 cm3. The reduced solution was partitioned between ethyl acetate (50 cm\ sat. 
NaHC03 (30 cm3) and water (30 cm\ The organic layer was separated, dried 
(MgS04) and removal of the solvent under reduced pressure gave a white solid which 
was purified by flash chromatography using petroleum ether/Et20 (7:3) as the eluent 
to give the title compound 2 (406 mg, 89%) as a white solid, mp 88-90°C; Dmax (KBr 
disk): 3353, 2982, 1737,1700 cm- 1; oH (500 MHz, CDCh): 1.27 (3H, t, J = 7.2 Hz, 
OCH2Cfu), 1.30 (9H, s, OC(CH3) 3), 2.05 (lH, d, J = 3.0 Hz, H-2), 4.20 (2H, q, J = 
7.2 Hz, OCfuCH3), 4.32 (lH, br, NH), 4.52 (lH, br, H-3), 5.08 (lH, br, H-4), 5.11 
(lH, s, H-1), 6.46 (lH, d, J = 5.7 Hz, H-5), 6.59 (1H, d, J = 5.7 Hz, H-6); oc (125 
MHz, CDCh): 14.5 (OCH2CH3), 28.7 (OC(CH3) 3), 52.6 (C-2), 53.6 (C-3), 61.6 
(OCH2CH3), 75.0 (C-4), 79.3 (OC(CH3)3), 82.4 (C-1), 134.7 (C-5), 138.0 (C-6), 157.4 
(NC02), 172 ( COzCzH5); m/z (El): 283 (M+), 57 ( 100% ). 
89 
(YC02Et 
Y''INHBoc 
OH 
3 
Ethyl trans -6-tert-butoxycarbonylamino-5-hydroxy -1 ,3-cyclohexadiene-1 
-carboxylate 3: 
To a solution of KHMDS (530 mg, 2.64 mmol) in THF (10 cm3) at -50 °C was added 
a solution of adduct 2 (250 mg, 0.88 mmol) in THF (2.5 cm\ The solution was then 
warmed up to room temperature (20 minutes) and quenched with a mixture of ethyl 
acetate and ethanol (50 cm3, 19:1). The mixture was washed with sat. NI-4Cl (25 
cm\ dried (MgS04) and concentrated under reduced pressure. The resulting residue 
was purified by flash chromatography eluting with petroleum ether/ethyl acetate 
mixture (3:2) to give cyclohexadiene 3 (359 mg, 72%) as a pale yellow gum. Vmax 
(KBr disk): 2979, 2931, 1716, 1700 1584 cm- 1; 8H (500 MHz, CDCh): 1.28 (3H, t, J = 
7.0 Hz, OCHzCfu), 1.42 (9H, s, OC(CH3)3), 4.20 (2H, q, J = 7.0 Hz, OCfuCH3), 4.36 
(lH, s, H-5), 4.48 (lH, br, NH), 4.76(1H, m, H-6), 6.26 (2H, m, H-3 and 4), 7.17 (lH, 
d, J = 4.8 Hz, H-2); 8c (125 MHz, CDCh): 14.1 (OCH2CH3), 28.3 (OC(CH3)3), 50.0 
(C-6), 60.8 (OCH2CH3), 67.7(C-5), 80.0 (OC(CH3)3), 124.5 (C-3), 132.6 (C-2), 133.5 
(C-4), 155.4 (NC02), 165.9 (C02C2H5); MS m/z (Cl): 284 (M++ 1); Anal. calcd. For 
C14H21 N05 : C, 59.35; H, 7.47; N, 4.94. Found: C, 59.20; H, 7.53; N, 4.80. The major 
by-product of the reaction was ethyl 2-hydroxybenzoate identified by comparison 
with authentic sample. 
Diels-Alder Reaction: 
0 £trco,Et 
N02 
123 
0 bN02 
I 
C02Et 124 
Furan (5.4 cm3, 74mmol) was added to a solution of a,~-unsaturated ester 1 (5.38g, 
37mmol) in chloroform (20 cm3) at -20°C. The reaction was stitTed at -20°C for five 
days. Removal of the solvent under reduced pressure afforded a mixture of the endo-
nitro isomer and the exo-nitro isomer (4:1) as a yellow oil. The oil was subjected to 
flash column chromatography using petroleum ether/diethyl ether (7:3) as the eluting 
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solvent to afford the Endo-nitro adduct 123 as a white solid (68%) and Exo-nitro 
isomer 124 as yellow oil (17% ). 
Ethyl endo-3-nitro-7 -oxa-bicyclo[2,2,1] hepta-5-ene-exo-2-carboxylate 123: 
mp 54-56°C; Umax (KBr disk): 2982, 1722, 1587 cm-1; 8H (300 MHz, CDCh): 1.32 
(3H, t, J = 7.2 Hz, OCH2C.fu), 3.23 (1H, d, J = 3.0 Hz, H-2), 4.27 (2H, q, J = 7.2, 
OCH2CH3), 5.34 (lH, s, H-1), 5.48 (1H, d, J = 5.0 Hz, H-3), 5.54 (lH, dd, J = 5.0 and 
4.0 Hz, H-4), 6.39 (lH, dd, J = 5.8 and 1.6 Hz, H-5), 6.73 (lH, dd, J = 5.8 and 1.6 Hz, 
H-6). 8c (75 MHz, CDCh): 14.4 (OCH2CH3), 49.2 (C-2), 62.4 (OCH2CH3), 79.3 (C-
4), 83.5 (C-1), 84.5 (C-3), 133.9 and 139.1 (C-5 and C-6), 169.9 ~02C2H5). 
Ethyl exo-3-nitro-7 -oxa-bicyclo[2,2,1] hepta-5-ene-endo-2-carboxylate 124: 
Umax (Liq. Film): 2990, 1733, 1549 cm- 1; 8H (300 MHz, CDCl3): 1.28 (3H, t, J = 7.2 
Hz, OCH2C.fu), 3.94 (lH, t, J = 3.8 and 2.8 Hz, H-2), 4.16 (2H, J = 7.2 Hz, 
OCfuCH3), 4.82 (1H, d, J = 2.8 Hz, H-1), 5.32 (lH, d, J = 3.8 Hz, H-3), 5.50 (lH, bs, 
H-4), 6.54 (2H, m, H-5 and H-6). 8c (75 MHz, CDCh): 14.3 (OCH2CH3), 49.9 (C-2), 
61.9 (OCHzCH3), 79.3 (C-4), 84.2 (C-1), 134.5 (C-6), 138.5 (C-5), 168.9 ~02C2H5 ); 
OH 
125 
Trans-6-tert-Butoxycarbony lamino-5-hydroxycyclohexa-1 ,3-diene-1-carboxylic 
acid 125: 
To a solution of ester 3 (300 mg, 1.06 mmol) in THF (10 cm3) was added KOH (595 
mg, 10.60 mmol) in H20 (2 cm\ The mixture was stirred at 40°C for six hours, then 
diluted with water (20 cm3) and extracted with ethyl acetate (20 cm\ The aqueous 
solution was adjusted to pH 1 with 5M HCl and further extracted with ethyl acetate (3 
x 30 cm\ The organic layers were mixed, dried (MgS04) and concentrated under 
reduced pressure to give 125 as a white powder (200 mg, 74%); m.p. 165-167°C; Vmax 
(KBr disk); 3361 (br), 2922, 1689, 1650 cm-1; 8H (500 MHz, (CD30D): 1.47 (9H, s, 
(OC(CH3)3), 4.19 (lH, d, J = 3.5 Hz, H-5), 4.75 (lH, d, J = 6.5 Hz, H-6), 5.72 (lH, d, 
J = 6.5 Hz, NH), 6.28 (2H, m, H-3 and 4), 7.15 (lH, d, J = 5.0 Hz, H-2). 8c (125 
MHz, CD30D): 28.4 (OC(CH3)3), 50.2 (C-6), 67.7 (C-5), 78.8 (OC(CH3)3), 124.9 (C-
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3), 128.0 (C-1), 134.5 (C-4), 156 (NC02), 167.4 (C02H); MS m/z (Cl): 256 (MW), 
217 (lOO%). 
Ethyl2-iodo-3-nitropropaniate 129: 
N20 4 (9.5 cm3, 271 mmol) was added to a stirred and cooled (0°C) mixture of ethyl 
acrylate 128 (44.5 cm3, 4l0 mmol) and iodine (31 g, 122 mmol) in diethyl ether (400 
cm\ The reaction mixture was stirred for 1 hour at 0°C and then at room temperature 
for 4 hours. The resulting dark solution was washed with saturated NazS20 3 solution 
(5 x 200 cm\ The aqueous layer was extracted with diethyl ether (200 cm3) and the 
organic layers were combined and dried over magnesium sulphate. The solvent was 
removed under reduced pressure and excess ethyl acrylate was distilled off under 
vacuo at room temperature to give the ti tie compound 129 (31.1 g, 93 %) as a yellow 
oil; Umax (Liq. film): 2984, 1731, 1560 cm- 1; OH (250 MHz, CDC13): 1.31 (3H, t, J = 
7.0 Hz, OCHzCfu), 4.27 (2H, m, OCf:IzCH3), 4.67 (lH, dd, J = 14.8 and 4.3 Hz, H-3), 
4.88 (lH, dd, J = 10.8 and 4.3 Hz H-3), 5.09 (lH, dd, J = 15.0 and 11.0 Hz, H-2); Oc 
(50 MHz, CDCI3): 8.5 (C-2), 14.1 (OCH2CH3), 63.4 (OCHzCH3), 77.4 (C-3), 169.6 
(C-1); MS (El): m/z 273 (M+), 227 (100%). 
0 
~co,H 
NHBoc 
130 
Endo-3-tert-butoxycarbonylamino-7 -oxabicyclo[2,2,1]hepta-5-ene-exo-2-
carboxylic acid 130; 
To a solution of racemic 2 (500 mg, 1.77 mmol) in diethyl ether (2.0 cm3) was added 
pH 8 phosphate buffer (50 cm\ Porcine Liver Esterase (100 mg) was then added and 
the mixture was stirred at room temperature for 5 days. Ethyl acetate (30 cm3) was 
then added to the reaction mixture and the layers were separated. The aqueous layer 
was further extracted with ethyl acetate (2 x 20 cm3) and the organic layers were 
mixed, dried (MgS04) and concentrated under reduced pressure. The residue was 
subjected to flash chromatography eluting with petroleum ether/ ethyl acetate (1: 1) to 
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give the ester (+)-2, [a]0 22 +136 (245 mg, 49%) and acid 130 (218 mg, 48 mg ); m.p. 
136-138°C; [a]o22 -58 (c,l; CHCh); Vmax (KBr disk): 3210 (br), 1712, 1526 cm-1; OH 
(500 MHz, CDCh): 1.44 (9H, s, OC(CH3) 3), 2.23 (1H, d, J = 3.2 Hz, H-2), 4.28 (lH, 
d, J = 4.8 Hz, H-3), 4.61 (lH, br, NH), 5.05 (1H, d, J = 2.9 Hz, H-4), 5.39 (lH, s, H-
1), 6.47 (1H, d, J = 4.5 Hz, H-5), 6.67 (1H, d, J = 4.5 Hz, H-6), 7.94 (1H, br, C02H); 
oc (125 MHz, CDC13): 28.3 (OC~H3)3), 53.6 (C-2), 54.1 (C-3), 78.6 (C-4), 79.2 
(OC(CH3)3), 82.0 (C-1), 133.4 (C-5), 139.1 (C-6), 157.4 (NC02), 173.9 (C02H); m/z 
(ES+): 256 (~, 100%), 278 (MNa+), 34%); Anal. cald for C12H 17N05: C, 56.46; H, 
6.71; N, 5.49. Found: C, 56.50; H, 6.74; N, 5.43. 
BocHN 
~ 
131 
C02 Et 
Ethyl (E)-3-tert-butoxycarbonylaminoacrylate 131: 
Racemic oxanorbomene adduct 2 was subjected to Prep. HPLC, column 2" x 20 cm 
chiralpak AD eluting with Hexane/ethanol (85:15) to give (+)-2; [a] 0 20·8 +143, (-)-2; 
[a] 0 208 -140 and Light yellow solid 131 as a by-product; m.p. 92-94°C; Vmax (KBr 
disk): 3298,2979, 1750, 1691, 1636, 1516 cm- 1; OH (500 MHz, CDC13): 1.25 (3H, t, J 
= 7.20 Hz, OCH2Cfu), 1.47 (9H, s, OC(CH3)3), 4.15 (2H, q, J = 7.20 Hz, OC_fuCH3), 
5.30 (1H, d, J = 13.8 Hz, H-2), 7.12 (lH, br, NH), 7.78 (1H, dd, J = 13.8 and 12.9 Hz, 
H-3); oc (125 MHz, CDCh): 14.6 (OCI-hCH3), 28.5 (OC~H3)3), 60.2 (OCHzCH3), 
82.5 (OC(CH3)3), 99.0 (C-2), 140.1 (C-3), 152.0 (NC02), 167.8 (C02); MS mlz (Cl): 
233 (MNH4+, 88%), 216 (MH+, 100%); Anal. calcd. For C10H 17N07 : C, 55.80; H, 
7.96; N, 6.51. Found: C, 56.27; H, 8.11; N, 6.14. 
OMs 
Aco2C(CH3h 
137 
t-Butyl (2R)-( + )-2-methanesulphonyloxypropionate 137: 
To a solution of t-butyl lactate 136 (400 mg, 2.74 mmol) in CH2C}z (10 cm3) was 
added triethylamine (496 111, 3.56 mmol). This solution was cooled (0 °C) and to it 
was added MsCl (233 110- The mixture was stirred at 0°C for 45 minutes and then 
partitioned between CH2Ch (20 cm3) and 1 M HCI (10 cm\ The aqueous layer was 
washed with CH2Clz (2 x 5 cm\ The organic extracts were combined, dried (MgS04) 
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and concentrated under reduced pressure to give mesylate 137 as a white solid (770 
mg, 99%); mp 41-42°C; [a]o20'5 +49 (c; 1.02 in CHCl3); Vmax (KBr disk): 2984, 1742, 
1459,1360 cm- 1; 8H (500 MHz, CDCb): 1.49 (9H, s OC(CH3)3), 1.57 (3H, d, J = 6.9, 
H-3), 3.14 (3H, s, SCH3), 5.00 (lH, q, J = 6.9 Hz, H-2); 8c (125 MHz, CDCb); 18.8 
(C-2), 28.2 (OC~H3)3 ), 39.4 (SCH3), 75.0 (C-2), 83.6 (OC(CH3)3), 168.7 (C02); MS 
rnlz (Cl (NH3)): 242 (MH+, 100%), 186 (25%), 102 (22%); Anal. cald. For 
C8H 160 5S: C, 42.84; H, 7.19. Found: C, 42.87; H, 7.23. 
OH 
138 
Tert-Butyl (- )-2-[trans-6' -tert-butoxycarbonylamino-5' -hydroxycyclohexa-1 ',3'-
diene-1 '-carboxyloxy ]propionate 138: 
CsF (240 mg, 1.57 mmol) was dried under vacuum at 150°C for 5 hours. A 
suspension of the dried CsF in DMF (5 cm3) was stirred at 25 °C for 30 minutes. To 
this suspension was added acid (-)-125 (200 mg, 0.78 mg) and the mixture was stirred 
at 25°C for 30 minutes. Mesylate 137 was then added and the reaction mixture was 
stirred at 50°C. After 24 hours the reaction mixture was partitioned between ethyl 
acetate (3 x 50 cm3) and water (50 cm\ The combined organic extracts were washed 
with brine, dried (MgS04) and concentrated under reduced pressure to give a yellow 
oil. This was subjected to column chromatography eluting with petrol/ethyl acetate 
(6:4) to give 138 as a white gum (204 mg, 68%); [a] 0 216 -171 (c 1, CHCI)); 8H (500 
MHz, CDCb): 1.43 and 1.46 (18H, s, 2 x OC(CH3)3), 1.51 (3H, d, J = 6.9 Hz, H-3), 
2.90 (lH, br, OH), 4.55 (1H, br, H-5'), 4.76 (lH, m, H-6') 5.06 1H, q, J = 6.9 Hz, H-
2), 6.30 (2H, m, H-3' and 4'), 7.22 (lH, d, J = 5.5 Hz, H-2'); 8c (125 MHz, CDC13): 
17.1 (C-3), 28.2 and 28.4 2 x OC~H3)3), 51.2 (C-6'), 68.9 (C-5'), 69.4 (C-2), 80.2 
and 80.4 (2 x OC(CH3)3), 125.3 (C-3'), 125.3 (C-1'), 133.5 (C-4'), 152.1 (NCOz), 
169.4 and 170.1 (2 x C02); MS rn/z (ES+): 406 (MNat. 
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(- )-2-[trans-6' -amino-5' -hydroxy-l' ,3' -cyclohexadiene-1 '-carboxyloxy ]propanoic 
acid 139: 
To a solution of ester 138 (140 mg, 0.37 mg) in dichloromethane (5 cm3) was added 
trifluoroacetic acid (112 ~tl, 1.46 mmol). This mixture was then stirred until all the 
starting material was consumed (TLC ea. 12 h). The solvent was removed under 
reduced pressure to give a brown gum which was dissolved in water (20 cm3) and 
washed with ethyl acetate (20 cm\ The aqueous phase was concentrated under 
reduced pressure to give 139 as a yellow gum (75 mg, 89%); [a] 0 208 -199 (c, 1; H20); 
HRMS (ES+): Calcd. For CtoH11NOs: M+ - HzO, 209.0688. Found: 209.0690; Vmax 
(KBr disk): 3413, 3550-2800 (br), 1726, 1679, 1580 1271 cm-1; 8H (500 MHz, DzO): 
1.57 (3H, d, J = 7.2 Hz, H-3), 4.42 (lH, m, H-6'), 4.45 (1H, d, J = 1.2 Hz, H-5'), 5.16 
(1H, q, J = 7.2 Hz, H-2), 6.49 (2H, m, H-3' and H-4'), 7.57 (lH, d, J = 1.5 Hz, H-2'); 
8c (125 MHz, D20): 16.4 (C-3), 48.4 (C-6'), 63.9 (C-5'), 71.2 (C-2), 121.2 (C-1'), 
125.3 (3'), 132.5 (C-4'), 138.8 (C-2'), 166.2 (C02), 176.3 (C-1), MS rn/z (Cl): 228 
(MH+). 
OTBS 
~C02H 
142 
(S)-2-Tert-Butylsilyloxypropanoic acid 142: 
To a stirring solution of (S)-lactic acid 141 (500 mg, 5.56 mmol) in CHzClz was 
added imidazole (760 mg, 11.10 mmol) and TBSCl (1.26 g, 8.33 mmol). The reaction 
mixture was stirred at room temperature for 24 h and then 1 M HCl (100 cm3) and 
ethyl acetate (100 cm3) were added. The organic layer was removed. The aqueous 
phase was washed with ethyl acetate (2 x 50 cm3) and the organic fractions were 
combined and concentrated. The residue was subjected to column chromatography 
eluting with petroleum ether/ethyl acetate (6:4) to give 142 as a yellow oil (996 mg, 
88%); Vmax (thin film): 3430, 2941, 1731, 1463 cm-1; ()H (400 MHz, CDCh): 0.10 (3H, 
s, CH3Si), 0.14 (3H, s, CH3Si), 0.91 (9H, s, (CH3) 3CSi), 1.45 (3H, d, J = 6.8 Hz, H-3), 
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4.36 (1H, q, J = 6.8 Hz, H-2); 8c (100 MHz, CDCh): 0.5 ((CH3)2Si), 1.62 
((CH3) 3CSi), 26.3 (C-3), 30.9 (~H3)3CSi), 73.8 (C-2), 180.9 (C-1); m/z (Cl): 205 
(MW, 75 %), 159 (lOO%). 
C:::CC02Et 
NHBoc 
144 
Ethyl N-tert-butoxycarbonylanthranilate 144: 
To a solution of 142 (240 mg, 1.18 mmol), EDCI (150 mg, 1.18 mmol) and DMAP 
(140 mg, 1.18 mg) in CH2Ch (10 cm3) was added cyclohexadiene 3 (220 mg, 0.78 
mmol) and the reaction mixture was stirred at room temperature and monitored by 
thin layer chromatography. After 6 h 144 was isolated as a yellow gum (169 mg, 82 
%); Ymax (thin film): 3255, 2975, 1728, 1693, 1598 cm3 , 8H (400 MHz, CDC13) 1.40 
(3H, t, J = 7.2 Hz, OCH2Cfu), 1.52 (9H, s, OC(CH3)3), 4.36 (2H, q, J = 7.2 Hz, 
OCfuCH3), 6.98 (1H, dt, J = 7.2 and 1.2 Hz, H-5), 7.49 (lH, dt, J = 7.2 and 2.0 Hz, 
H-4), 8.01 (lH, ddd, J = 7.2, 2.0 and 0.4 Hz, H-3), 8.44 (lH, dd, J = 7.2 and 1.2 Hz, 
H-6), 10.34 (1H, br, NH); 8c (100 MHz, CDC13): 14.4 (OCH2CH3), 28.5 (OC(CH3)3), 
61.4 (OCH2CH3), 80.7 (OC(CH3)3), 114.7 (C-2), 118.9 (C-6), 121.3 (C-5), 131.1 (C-
3), 134.6 (C-4), 142.5 (C-1), 153.1 (NC02), 168.3 (C02); m/z (ES+): 288 (MNa+, 
100%). 
Mitsunobu reaction: 
A solution of cyclohexadiene 3 (730 mg, 2.58 mg) and Ph3P (810 mg, 3.10 mmol) in 
THF (10 cm3) was added dropwise to a solution of 95% DIPAD (0.54 cm3, 3.10 
mmol) and benzoic acid (390 mg, 3.10 mmol) in THF (10 cm3) at room temperature. 
After stirring for 12 h, the reaction mixture was neutralised with NaHC03 solution 
and extracted with ethyl acetate (3 x 50 cm\ The combined organic layers were 
washed with H20 (10 cm\ dried MgS04) and concentrated under reduced pressure. 
The residue was subjected to flash chromatography eluting with petroleum ether/ 
ethyl acetate (7:3) to give 144 (320 mg, 47%) and an unidentified mixture 
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146 
Ethyl trans-6-tert-butoxycarbony lamino-5-iso-butoxyloxy -1 ,3-cyclohexadiene-1-
carboxylate 146: 
A solution of 142 (540 mg, 2.65 mmol) and thionyl chloride (0.19 cm3, 2.65 mmol) in 
(THF 10 cm3) was stirred at room temperature for 8 h and then cyclohexadiene 3 (250 
mg, 0.88 mmol) and triethylamine (0.61 cm3, 4.4 mmol) was added. The reaction 
mixture was stirred for 3 h and then poured into a conical flask with 1M HCl (20 
cm\ This was extracted with ethyl acetate (3 x 20 cm\ dried (MgS04) and 
concentrated. The residue was subjected to column chromatography eluting with 
petroleum ether/ ethyl acetate (4:1) to give 146 as pale yellow gum (280 mg, 90%); 
Vmax (KBr disk): 3353,2978, 1717, 1701, 1513 cm- 1; OH (400 MHz, CDCh): 1.09 (6H, 
m, (Cfu)zCH), 1.29 (3H, t, J = 7.2 Hz, OCH2Cfu), 1.41 (9H, s, OC(CH3)3), 2.46 (lH, 
m, (CH3)2Ctl), 4.23 (2H, q, 1= 7.2 Hz, OC.fuCH3), 4.37 (1H, d, J = 7.6 Hz, NH), 4.82 
(lH, d, J = 7.6 Hz, H-6), 5.22 (1H, br, H-5), 6.32 (2H, m, H-3 and 4), 7.16 (lH, m, H-
2); oc (100 MHz, CDCh): 14.4 (OCHzCH3), 19.1 (~H3)zCH), 28.5 (OC(CH3)3), 33.9 
((CH3)2CH), 46.5 (C-6), 61.2 (OCH2CH3), 68.8 (C-5), 80.2 (OC(CH3)3), 126.7 (C-4), 
128.2 (C-1), 129.2 (C-3), 133.3 (C-2), 154.9 (NC02), 166.8 (C02Et), 176 
((CH3)zCHCOz); rn/z (ES+): 376 (MNa+). 
~o_J._co2'B" 
Y''/NHBoc 
OH 
148 
Tert-Butyl ( + )-2-[trans -6' -tert -butoxycarbornylamino-5' -hydroxycyclohexa-
1 ',3' -diene-1 '-carboxyloxy ]propionate 148: 
Using acid (+)-125 (200 mg, 0.78 mmol) in the coupling procedure described for 138 
gave 148 as a yellow gum (205 mg, 68%); [a] 0 21.6 +181 (c, 1; CHCh); OH (500 MHz, 
CDC13): 1.43 and 1.46 (18H, s, 2 x OC(CH3)3), 1.49 (3H, d, J = 6.9 Hz, H-3), 2.78 
(1H, br, OH), 4.40 (lH, br, NH), 4.52 (lH, br, H-5'), 4.78 (1H, m, H-6'), 5.04 (lH, q, 
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J = 6.9 Hz, H-2), 6.27 (2H, m, H-3' and 4'), 7.24 (1H, d, J = 5.5 Hz, H-2'); oc (125 
MHz, CDCh): 17.2 (C-3), 28.2 and 28.6 (2 x OC(CH3)3), 50.6 (C-6'), 68.4 (C-5'), 
69.7 (C-2), 80.2 and 82.3 (2 x OC(CH3)3), 124.6 (C-3'), 125.2 (C-1), 133.5 (C-4'), 
134.5 (C-2'), 152 (NC02), 170.0 and 170.1 (C02); m/z (ES+): 406 (MNat. 
~20T:C02H 
OH 
149 
( + )-2-[trans-6' -amino-5' -hydroxy-l' ,3' -cyclohexadiene-1 '-carboxyloxy ]propanoic 
acid 149: 
Deprotection of 148 (140 mg, 0.37 mmol) using the procedure described for 139 
afforded 149 as a white solid (74 mg, 89%); m.p. 106-108°C, [a]n213 +165 (c, 1; 
CHCh) Vmax (KBr): 3425 (br), 2927, 1703, 1677, 1589 cm- 1; OH (500 MHz, DzO): 1.55 
(3H, d, J = 7.0 Hz, H-3), 4.39 (lH, d, J = H-6'), 4.43 (lH, dd, J = 3.0 and 1.5 Hz, H-
5'), 5.18 (lH, q, J = 7.0 Hz, H-2), 6.47 (2H, m, H-3' and 4'), 7.55 (lH, d, J = 5.5 Hz, 
H-2'); oc (125 MHz, D20): 16.2 (C-3), 48.5 (C-6'), 63.9 (C-5'), 70.5 (C-2), 121.0 (C-
l'), 125.3 (C-3'), 132.8 (C-4), 139.1 (C-2'), 166.1 (C02H), 175.3 (C-1); m/z (Cl): 228 
(MH+, 100%), 210 (96%), 138 (42%); Anal. Calcd. For C 10H 13N05.C2HOzF3: 
C,46.61; H, 4.96; N, 4.53; F, 25.87. Found: C, 46.60, H, 5.34; N, 4.64. 
(-)-Anti-anti-2-amino-3-hydroxycyclohexane-1-carboxylic acid TFA salt 151: 
A solution of 152 (100 mg, 0.39 mmol) in CH3CH20H was treated with catalytic 
amount of Pd/C and the solution was stirred for 48 h to give 151 as a colourless gum 
in 98% yield. [a] 0 21 - 32 (c, 1; H20); OH (500 MHz, D20): 1.40 (2H, m, H-6), 1.81 
(2H, m, H-5), 2.05 (2H, m, H-4), 2.58 (lH, m, J = 8.0 and 4.0 Hz, H-1), 3.18 (lH, t, J 
= 8.0 Hz, H-2), 3.58 (lH, m, H-3); oc (125 MHz, D20): 22.5 (C-6), 28.2 (C-5), 32.7 
(C-4), 45.6 (C-1), 56.7 (C-2), 70.1 (C-3), 176.4 (C02); mlz (Cl): 160 (MH+, 10 %), 
116 (100 %). 
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( + )-Trans-2,3-dihydro-2-amino-3-hydroxyanthranilic acid TF A salt 152: 
To a solution of (+)-125 (500 mg, 1.77 mg) in CH2Clz (20 cm3) was added TFA (1.40 
cm
3
, 14.12 mmol). The solution was stirred at room temperature for 4 h to give 152 
(273 mg, 100%) as a white solid; m.p. 137-139 °C;. [a]o21 + 339 (c, 1; H20); OH (500 
MHz, D20): 4.35 (1H, d, J = 3.0 Hz, H-6), 4.43 (lH, t, J = 3.0 Hz, H-5), 6.44 (2H, m, 
H-3 and 4), 7.44 (lH, d, J = 5.5 Hz, H-2); oc (125 MHz, D20): 48.8 (C-6), 64.1 (C-5), 
122.1 (C-1), 125.4 (C-3), 132.1 (C-2), 138.0 (C-4), 168.5 (C02), mlz (Cl): 156 (MH+, 
16 %), 138 (100%). 
0 bNHBoc 
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158 C02Et 
E thy I exo-3-tert-butoxycarbony lamino-7 -oxabicyclo[2.2.1 ]hept-5-ene-endo-2-
carboxylate 158: 
Employing the reduction and protection procedure described for the synthesis of 2, 
124 (5.00 g, 23.5 mmol) was elaborated to give 158 as a white solid (5.5 g, 83%) mp 
50-52 °C, Dmax (KBr disk): 3291, 2978, 1738, 1703 cm- 1; OH (500 MHz, CDCh): 1.24 
(3H, t, J = 7.2 Hz, OCH2CH3), 1.45 (9H, s, OC(Ctb)3), 2.69 (1H, t, J = 4.8 and 3.2 
Hz, H-2), 4.02 (lH, br, H-3), 4.12 (2H, q, J = 7.2 Hz, OCfuCH3), 4.78 (1H, s, H-4), 
4.82 (lH, br, NH), 5.12 (lH, d, J = 4.8 Hz, H-1), 6.37 (lH, dd, J = 5.2 and 1.6 Hz, H-
5), 6.46 (1H, dd, J = 5.2 and 1.6 Hz, H-6); oc (125 MHz, CDCh): 14.0 (OCH2CH3), 
28.2 (OC(CH3) 3), 52.1 (C-2), 54.3 (C-3), 60.8 (OCH2CH3), 78.4 (C-1), 79.6 (C-3), 
85.1 (C-4), 135.2 (C-6), 135.4 (C-5), 155.3 (NC02), 170.2 ([OC2Hs); mlz (El): 
283(M+), 57(100%). 
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Ethyl syn -6-tert-butoxycarbonylamino-5-hydroxy -1 ,3-cyclohexadiene-1 
-carboxylate 159: 
Employing the KHMDS mediated ~-elimination procedure described for the synthesis 
of 3, 158 (500 mg, 1.76 mmol) was used instead of 2 to give 159 as a yellow gum; 
(340 g, 68%) Vmax (KBr disk): 3389 (br), 2982, 1689, 1523 cm-1; OH (500 MHz, 
CDCh): 1.28 (3H, t, J = 7.0 Hz, OCH2CH3), 1.42 (9H, s, OC(CH3) 3), 3.48 (1H, br, 
OH), 4.22 (2H, q, J = 7.0 Hz, OCfuCH3), 4.64 (lH, t, J = 7.5 Hz, H-5), 4.67 (lH, br, 
NH), 4.77 (lH, d, J = 7.5 Hz, H-6), 6.05 (1H, t, J = 5.5 Hz, H-3), 6.11 (lH, d, J = 7.5 
Hz, H-4), 7.10 (1H, d, J = 5.5 Hz, H-2); oc (125 MHz, CDCh): 14.4 (OCH2CH3), 28.5 
(OC(CH3)3), 46.9 (C-6), 61.6 (OCH2CH3), 71.4 (C-5), 81.6 (OC(CH3)3), 122.2 (C-3), 
127.9 (C-1), 135.2 (C-2), 138.8 (C-4), 157.5 (NC02), 166.1 (C02); m/z (Cl): 284 
(MW, 13%), 182 (100%). 
General procedure for hydroxylation 
To a solution of substrate (1.0 equivalent) m acetone (15 cm3) was added 
Me3NO.H20 (1.1 equivalent) and 4 wt % Os04 in water (0.01 equivalent). The 
resulting mixture was stirred and monitored by TLC until all the starting material was 
consumed (12 hours). The solvent was then removed under reduced pressure and the 
residue was dissolved in ethyl acetate (10 cm\ The acetate solution was washed with 
saturated NaHS03 (5 cm3) and the aqueous phase was extracted with ethyl acetate (5 
cm3 x 3). The organic layers were combined, dried over MgS04 and the solvent was 
removed under reduced pressure to give the crude diol. 
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Ethyl syn-anti-anti-6-tert-butoxycarbonylamino-3,4,5-trihydroxycyclohex-1-ene-
1-carboxylate 166: 
Using the general procedure for Os04 dihydroxylation, Me3NO.H20 (93 mg, 0.84 
mmol), 4% wt. Os04 in water (50 !ll) and diene 3 (120 mg, 0.42 mmol) gave a crude 
product which was subjected to column chromatography eluting with petroleum 
ether/ethyl acetate (7:3) to give 166 as a colourless oil (104 mg, 78%); Vmax (thin 
film): 3424, 2980, 1710,1513 cm- 1; 8H (400MHz, CDCh): 1.26 (3H, t, J = 6.8 Hz, 
OCH2Cfu), 1.40 (9H, s, OC(CH3)3), 3.83 (1H, br, H-4), 4.05 (lH, br, H-5), 4.18 (2H, 
q, J = 6.8 Hz, OC_fuCH3), 4.35 (lH, m, H-6), 4.45 (lH, br, H-3), 5.61 (1H, br, NH), 
6.82 (1H, s, H-2); 8c (100 MHz, CDCh): 14.3 (OCH2CH3), 28.6 (OC(CH3)3), 51.5 
(C-6), 61.3 (OCH2CH3), 66.0 (C-3), 70.5 (C-4), 71.7 (C-5), 80.2 (OC(CH3)3), 131.7 
(C-1), 132.2 (C-2), 156.3 (NC02), 166.3 (C02Et); mlz (Cl): 318 (MW, 49%), 182 
(100%). 
AcO//t.Q:C02Et 
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Ethyl syn-anti-anti-3,4,5-triacetoxy-6-tert-butoxycarbonylamino-cyclohex-1-ene-
1-carboxylate 167: 
166 (lOOmg, 0.30 mmol) was dissolved in pyridine (2.5 cm3, 31.0 mmol) and acetic 
anhydride (2.5 cm3, 26.5 mmol) and stirred at room temperature for 16 h. Water (20 
cm3) was then added and the mixture was stirred for further 3 h. The mixture was 
extracted with ethyl acetate (3 x 20 cm\ The combined organic extracts were washed 
with 2M HCl (30 cm\ sat. NaHC03 (30 cm3) and water (30 cm\ dried (MgS04) and 
concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with petroleum ether/ethyl acetate (7:2) to give tri-acetate 
167 as a thick yellow oil (127 mg, 68%). 8H (500 MHz, CDCh): 1.28 (3H, t, J = 7.2 
Hz, OCH2CH3), 1.42 (9H, s, OC(CH3)3), 2.07 (9H, s, 3 x CH3CO), 4.23 (2H, q, J = 
7.2 Hz, OC_fuCH3), 4.42 (lH, br, NH), 4.70 (lH, br, H-6), 5.26 (lH, br, H-5), 5.32 
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(1H, dd, J = 6.6 and 4.2 Hz, H-4), 5.67 (lH, t, J = 3.6 Hz, H-3), 6.76 (lH, br, H-2); be 
(125 MHz, CDCh): 14.0 (OCH2CH3), 20.5 and 20.7 (3 x CH3CO), 28.2 (OC~H3)3), 
48.3 (C-6), 61.4 (OCH2CH3), 65.6 (C-3), 66.1 (C-4), 70.2 (C-5), 79.9 (OC(CH3)3), 
133.0 (C-1), 134.3 (C-2), 154.4 (NC02), 164.6 (C02C2H5), 169.1, 169.3 and 169.8 (3 
x CH3CO); m/z (Cl): 444 (MW); Anal. calcd. For C2oHz9NOw: C, 54.42; H, 6.59; N, 
3.16. Found: C, 54.23; H, 6.52; N, 3.18. 
AcOff,,Q:co2Et 
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Ethyl anti-anti-anti-syn-3,4,5-triacetoxy-2-tert-butoxycarbonylaminocyclo 
hexanecarboxylate 168: 
Using the general acetylation procedure, ttiol169 (400 mg, 1.41 mmol) in pyridine (5 
cm
3) and acetic anhydride (5 cm3) afforded triacetate 168 as a pale yellow gum (502 
mg, 90%); bH (500 MHz, CDCl3): 1.29 (3H, t, J = 7.0 Hz, OCH2Cfu), 1.40 (9H, s, 
OC(CH3)3), 1.74 and 1.96 (2H, m, 6-HH), 2.93 (lH, dd, J = 8.5 and 4.4 Hz, H-1), 3.94 
(1H, br, H-5), 4.11 (2H, q, J = 7.0 Hz, OCfuCH3), 4.22 (1H, br, H-4), 4.53 (lH, br, 
H-3), 4.59 (1H, br, H-2), 5.64 (lH, br, NH); be (125 MHz, CDCh): 14.4 (OCH2CH3), 
21.0 (3 X CH3CO), 24.9 (C-6), 28.4 (OC(CH3)3), 41.8 (C-1), 48.5 (C-5), 54.1 (C-2), 
61.5 (OCHzCH3), 77.0 (C-4), 79.8 (H-3), 81.2 (OC(CH3) 3), 155.0 (NC02), 169.8 
(COz), 171.1, 172.8 and 173.2 (3 x CH3CO); m/z (Cl): 463 (MNH/, 3%), 446 (MH+, 
5%), 346 (100%), 232 (93%). HRMS (ES+): C 17H25N09Na requires M+ 468.1846 
Found: 468.1849. 168 was also prepared from 167 by Pd/C catalysed hydrogenation. 
HO/lt·f(C02Et 
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169 
Ethyl anti-anti-anti-syn-2-tert-butoxycarbonylamino-3,4,5-trihydroxycyclo 
hexanecarboxylate 169: 
To a solution of ester 166 (500 mg, 1.57 mmol) in ethanol (20 cm3) was added 10% 
Pd/C (lOO mg) and the suspension was stirred under hydrogen for 48 h. The 
suspension was then filtered and the filtrate was concentrated under reduced pressure 
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to give 169 as a white solid (490 mg 98%); m.p. 36-38°C; Vmax (K.Br disk): 3420 (br), 
2979, 1722, 1515 cm-1; 8H (500 MHz, (CD3)2CO): 1.21 (3H, t, J = 7.0 Hz, OCH2Cfu), 
1.37 (9H, s, OC(CH3)3), 1.64 and 1.96 (2H, m, 6-HH), 2.50 (lH, dt, J = 12.0 and 3.5 
Hz, H-1), 2.90 (1H, br, H-5), 3.31(1H, t, J = 3.6 Hz, H-3), 3.46 (1H, br, H-4), 3.58 
(1H, m, H-2), 4.05 (2H, q, J = 7.0 Hz, OCfuCH3), 5.98 (lH, br, NH); 8c (125 MHz, 
(CD3)2CO): 13.9 (OCH2CH3), 25.3 (C-6), 28.0 (OC(GH3)3), 42.9 (C-5), 48.3 (C-1), 
55.9 (C-2), 60.2 (OCH2CH3), 75.2 (C-4), 77.5 (H-3), 81.2 (OC(CH3)3), 155.3 (NC02), 
173.1 (C02); MS mlz (Cl): 320 (MH+, 62%), 264 (100%); Anal. calcd for C,4H2sN07: 
C, 52.65; H, 7.89; N, 4.39. Found: C, 52.48; H,7.75; N, 4.25. 
{-2trC02Et 
174 
NHBoc 
Ethyl endo-3-tert-butoxycarbonylamino-5,6-0,0-isopropylidine-5,6-dihydroxy-7-
oxabicyclo[2,2,1]heptane-exo-2-carboxylate 174: 
Diol 173 (500 mg, 1.58 mmol) was dissolved in acetone and to this solution was 
added dimethoxypropane (221 mg, 2.51 mmol) and p-TsOH (15 mg, 0.08 mmol). The 
mixture was stirred and monitored by TLC. The solvent was removed under reduced 
pressure and the residue was dissolved in ethyl acetate (15 cm\ The solution was 
then washed with saturated NaHC03 (5 cm3) and the aqueous layer was extracted with 
ethyl acetate (10 cm3 x 3). The combined organic layers were washed with brine (10 
cm\ dried over MgS04 and concentrated under reduced pressure. The resulting 
residue was purified by flash column chromatography eluting with a 
(CH3CH2)20/petroleum ether mixture (7:3) to give the title compound 174 (390 mg, 
61 %) as a white solid, mp 118-120°C; Umax (K.Br disk): 3269, 2983, 1741, 1683, 
1667,1546 cm-1; 8H (500 MHz, CDCh): 1.23 (3H, t, J = 7.2 Hz, OCH2CH3), 1.39 (6H, 
s, C(CH3) 2), 1.42 (9H, s, OC(CH3) 3), 2.13 (1H, d, J = 5.4 Hz, H-2), 4.15 (3H, m, 
OCfuCH3 and H-3), 4.32 (lH, d, J = 5.4 Hz, H-5), 4.43 (lH, br, H-6), 4.56 (1H, s, H-
1), 4.72 (1H, br, H-4), 4.97 (1H, br, NH); 8c (125 MHz, CDCh): 14.3 (OCH2CH3), 
26.0 (C(GH3)2), 28.5 (OC(CH3)3), 49.8 (C-2), 53.2 (C-3), 61.7 (OCH2CH3), 78.4 (C-
4), 80.8 (C-6), 81.9 (C-5), 82.6 (C-1), 111.8 ((CH3)2C02), 155.5 (NC02), 171.5 
(G02C2H5); mlz (El): 357 (M+), 57 (100%); Anal. Calcd for CnH1sN07: C, 57.13; H, 
7.61; N, 3.92. Found: C, 57.05; H, 7.66; N, 3.81. 
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TBSO-riYC02Et 
TBSO~ 
NHBoc 
175 
Ethyl endo-3-tert-butoxycarbonylamino-5,6-0,0-bis(tert-butyldimethylsilyl)-5, 6-
dihydroxy-7 -oxabicyclo[2,2,1]heptane-exo-2-carboxylate 175: 
To a solution of diol 173 (500 mg, 1.58 mmol) in anhydrous DMF (20 cm3) were 
added DMAP (583 mg, 4.78 mmol) and TBSCl (600 mg, 4.00 mmol). The mixture 
was then stirred over night, quenched with sat. N~Cl solution (10 cm3), and 
extracted with ethyl acetate (10 cm3 x 3). The combined organic extracts were washed 
with water (10 cm\ dried (MgS04) and concentrated to leave a residue, which was 
purified by flash chromatography eluting with petroleum ether/(CH3CH2hO (7:3) to 
give disilyl ether 175 as a white solid (860 mg, 86%), mp 150-152°C; Dmax (KBr disk): 
3372, 2959, 1737, 1699, 1677, 1520 cm·'; OH (500 MHz, CDCh): 0.09, 0.12 (12H, s, 
2 x Si(CH3])2), 0.91 (18H, s, 2 x SiC(CH3) 3), 1.26 (3H, t, J = 7.0 Hz, OCH2Cfu), 1.44 
(9H, s, OC(CH3)3), 2.08 (lH, d, J = 4.6 Hz, H-2), 3.92 (lH, d, J = 5.3 Hz, H-6), 4.09 
(1H, br, H-3), 4.18 (lH, q, J = 7.0 Hz, OC_fuCH3), 4.25 (lH, br, H-5), 3.47 (1H, s, H-
1), 4.52 (lH, br, H-4), 4.63 (1H, br, NH); oc (125 MHz, CDCh): -4.9, -5.0 (2 x 
Si(CH3h), 14.1 (OCH2CH3), 18.5, 18.6 (2 X SiC(CH3)3), 26.0 (SiC(CH3)3), 28.3 
(OC(£:.H3)3), 49.8 (C-2), 53.2 (C-3), 61.4 (OCH2CH3), 71.6 (C-5), 77.3 (C-6), 80.3 (C-
4), 80.4 (OC(CH3)3), 85.4 (C-1), 155.4 (NC02), 171.1 (C02C2H5); m/z (El): 547(M+), 
376 (100 %); Anal. calcd. for C26Hs 1N07Si2: C, 57.21; H, 9.42; N, 2.57. Found: C, 
57.14; H, 9.38; N, 2.59. 
TBSO~C02Et 
TBSo~'ljNH2 
OH 
176 
Ethyl syn-syn-anti-6-amino-3,4-bis-(tert-butyldimethylsilyloxy)-5-hydroxycyclo 
hex-1-ene-1-carboxylate 176: 
To a solution of LiHMDS (231 mg, 1.38 mmol) in THF (20 cm3) at -50°C was added 
a solution of oxanorbornene 175 (250 mg, 0.46 mmol) in THF (5 cm\ The solution 
was stirred at 25°C for 2 hours. The reaction mixture was then quenched with ethyl 
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acetate/ethanol (9: 1) and stirred for 5 minutes. Saturated Nf4Cl solution was added to 
the reaction mixture and the resulting two layers were separated. The organic layer 
was dried (MgS04) and concentrated under reduced pressure to give the crude 
product. Flash chromatography eluting with ethyl acetate/petroleum ether (3:2) 
afforded 176 as a light yellow oil (98 mg, 48%); Ymax (KBr disk): 3410, 2985, 1734, 
1538 cm- 1; oH (400 MHz, CDCh): 0.14 (12H, s, 2 x Si(CH3)3), 0.90 (9H, s, 
SiC(CH3)3), 0.91 (9H, s, SiC(CH3)3), 1.33 (3H, t, J = 7.2Hz, OCH2Cfu), 3.25 (1H, br, 
OH), 4.02 (lH, dd, J = 5.6 and 5.0 Hz, H-5), 4.08 (1H, dd, J = 7.4 and 5.6 Hz, H-6), 
4.13 (IH, t, J = 2.4 Hz, H-4), 4.26 (2H, q, J = 7.2 Hz, OCfuCH3), 4.41 (1H, dd, J = 
3.2 and 2.4 Hz, H-3), 4.68 (2H, br, NH2), 6.87 (lH, d, J = 3.2 Hz, H-2); oc (lOO MHz, 
CDCb): 0.1 (Si(CH3)2), 18.8 (OCHzCH3), 23.0 (SiC(CH3)3), 30.6 (SiC~H3)3), 55.8 
(C-6), 66.3 (OCH2CH3), 73.8 (C-3), 76.4 (C-4), 77.4 (C-5), 118.7 (C-1), 132.1 (C-2), 
170.2 (C02). mlz (Cl): 446 (MH+, 8%), 297 (100%). 
AcO~C02Et 
'IJ AcO NHAc 
OAc 
177 
Ethyl syn-syn-anti-3,4,5-triacetoxy-6-N -acetylaminocyclohex-1-ene-1-carboxylate 
177: 
Tetra-n-butylammonium fluoride (0.5 cm3 of 1M solution in THF, 0.5 mmol) was 
added to a stirred solution of disilyl ether 176 (90 mg, 0.20 mmol) in THF (2.5 cm\ 
After 16 hours, the mixture was concentrated under reduced pressure to afford yellow 
oil. The oil was dissolved in pytidine (1.5 cm3, 18.6 mmol) and acetic anhydride (1.5 
cm3, 15.9 mmol) and the solution was stirred for 20 hours. Water (5 cm3) and ethyl 
acetate (10 cm3) were added to the reaction mixture and the resulting layers were 
separated. The aqueous layer was extracted with ethyl acetate (2 x 10 cm\ The 
organic extracts were combined, washed with 2M HCl (10 cm\ saturated NaHC03 
(10 cm\ water (lOcm\ dried (MgS04) and concentrated under reduced pressure. 
The residue was purified by flash chromatography eluting with petroleum ether/ethyl 
acetate (7:3) to give tri-acetate 177 as a yellow gum (41 mg, 52%). Ymax (KBr disk): 
3343, 2977, 1711, 1639, 1521 cm-1; oH (500 MHz, CDC13): 1.27 (3H, t, J = 7.2 Hz, 
OCH2CH3), 1.97 (3H, s, CH3CO), 2.03 (3H, s, CH3CO), 2.06 (3H, s, CH3CO), 2.15 
(3H, s, CH3CO), 4.25 (2H, q, J = 7.2 Hz, OCfuCH3), 5.13 (IH, dd, J = 5.5 and 2.0 
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Hz, H-5), 5.44 (lH, br H-6), 5.62 (lH, br, H-4), 5.65 (2H, m, H-3 and NH), 6.79 (lH, 
br, H-2); oc (125 MHz, CDCh): 14.3 (OCH2CH3), 20.7 ~H3CO), 20.8 (CH3CO), 
21.2 (!;;:_H3CO), 23.5 (!;;:_H3CO), 43.6 (C-6), 61.8 (OCH2CH3), 66.4 (C-5), 67.8 (C-3), 
68.8 (C-4), 132.0 (C-1), 136 (C-2), 164.3, 169.2, 169.6, 169.8 (carbonyls); m/z (Cl): 
386 (MW, 100%). 
AcO¥C02Et 
'lj AcO NHAc 
OAc 
178 
Ethyl anti-anti-syn-syn-3,4,5-triacetoxy-2-N-acetylaminocyclohexane-1-
carboxylate 178: 
To a solution of cyclohexene 177 (100 mg, 0.26 mmol) in ethanol (10 cm3) was added 
10% Pd/C (20 mg) and the suspension was stirred under hydrogen for 24 h. The 
suspension was then filtered and the filtrate was concentrated under reduced pressure 
to give 178 as a colourless gum (98 mg, 99%); Vmax (KBr disk): 3408, 2982, 1741, 
1668, 1538 cm- 1; oH (400 MHz, CDCh): 1.23 (3H, s, J = 7.2 Hz, OCH2CH3), 1.97 
(3H, s, CH3CO), 2.00 (3H, s, CH3CO), 2.01 (3H, s, CH3CO), 2.10 (2H, m, HH-6), 
2.19 (3H, s, CH3CO), 2.75 (1H, dd, J = 10.2 and 9.2 Hz, H-1), 4.12 (2H, q, J = 7.2 Hz, 
OCH2CH3), 4.91 (lH, m, H-3), 4.92 (lH, m, H-2), 4.96 (lH, m, H-4), 5.54 (lH, m, H-
5), 6.24 (lH, br, NH); oc (100 MHz, CDC13): 14.2 (OCH2CH3), 20.9 (CH3CO), 21.0 
(!;;:_H3CO), 21.2 (2 X CH3CO), 23.7 (C-6), 38.5 (C-1), 47.2 (C-2), 61.7 (OCH2CH3), 
68.0 (C-4), 68.6 (C-3), 70.6 (C-5), 169.1, 169.6, 169.8, 170.0, 170.9 (carbonyls); m/z 
(Cl): 388 (MW, 100%). HRMS (ES+): C 17H25N09Na requires M+ 410.1427. Found: 
410.1388. 
AcO~C02Et 
AcO~NHAc 
OAc 
179 
Ethy I syn -syn -sy n -3,4,5-triacetoxy-6-N -acetylaminocyclohex -1-ene-1-carboxy late 
179: 
Using the same procedure as that employed for the preparation of compound 166, 
diene 159 (120 mg, 0.23 mmol) in acetone (10 cm\ Me3NO.H20 (52 mg, 0.47 
106 
mmol), 4% wt Os04 in water (50 ~-tl), pyridine (2.5 cm3, 31.0 mmol), and acetic 
anhydride (2.5 cm3, 26.5 mmol) gave a crude product. The cmde product was purified 
by flash chromatography eluting with petroleum ether/ethyl acetate (7:3) to afford 
compound 179 (llO mg, 75%) as a white gum; Vmax (KBr disk): 3463, 2980, 1755, 
1721, 1507 cm- 1; oH (500 MHz, CDCh): 1.28 (3H, t, J = 7.0 Hz, OCHzCfu), 1.44 
(9H, s, OC(CH3)3), 2.04 (3H, s, CH3CO), 2.06 (3H, s, CH3CO), 2,14 (3H, s, CH3CO), 
4.26 (2H, q, J = 7.0 Hz, OCfuCH3), 4.85 (lH, br, NH), 5.07 (2H, m, H-4 and 6), 5.61 
(2H, m, H-3 and 5), 6.75 (lH, br, C-2); oc (125 MHz, CDC13): 14.3 (OCH2CH3), 20.8 
(2 x CH3CO), 21.1 ~H3CO), 28.5 (OC~H3)3), 45.1 (C-6), 61.7 (OCHzCH3), 66.8 
(C-4), 67.9 (C-3), 68.7 (C-5), 79.7 (OC(CH3)3), 132.2 (C-1), 136.1 (C-2), 155.2 
(NC02), 164.5 (C02), 169.6, 169.7, 169.9 (3 x CH3CO); m/z (ES+): 466 (MNa+). 
TBSO'\.._ I)..__ 
TBso--.L-l-L1-NHBoc 
I 
Et02C 
180 
Ethyl exo-3-tert-butoxycarbonylamino-5,6-0,0-bis(tert-butyldimethylsilyl)-5, 6-
dihydroxy-7 -oxobicyclo[2,2,1]heptane-endo-2-carboxylate 180: 
By employing the general procedure for dihydroxylation, adduct 158 (500 mg, 1.77 
mmol) afforded a diol which was treated with imidazole (324 mg, 4.78 mmol) and 
TBSCI (600 mg, 4.00 mmol). The mixture was then stirred over night, quenched with 
2M HCI (10 cm\ and extracted with ethyl acetate (10 cm3 x 3). The combined 
organic extracts were washed with water (10 cm\ dtied (MgS04) and concentrated to 
leave a residue, which was purified by flash chromatography eluting with petroleum 
ether/(CH3CH2) 20 (7:3) to give disilyl ether 180 as a white solid (860 mg, 86%), mp 
108-ll0°C; Umax (KBr disk): 3368, 2951, 1730, 1698, 1672, 1528 cm-1; OH (500 MHz, 
CDCh): 0.11, 0.12 (12H, s, 2 x Si(CH3])2), 0.91 (18H, s, 2 x SiC(CH3)3), 1.28 (3H, t, 
J = 7.0 Hz, OCH2Cfu), 1.42 (9H, s, OC(CH3)3), 2.63 (lH, d, J = 4.6 Hz, H-2), 3.95 
(1H, d, J = 5.3 Hz, H-6), 3.97 (lH, s, H-1), 4.09 (lH, q, J = 7.0 Hz, OCfuCH3), 4.22 
(lH, br, H-5), 4.48 (lH, dd, J = 6.5 and 1.5 Hz, H-3), 4.52 (lH, br, H-4), 4.78 (lH, 
br, NH); Oc (125 MHz, CDCh): -4.9, -5.0 (2 x Si(CH3)2), 14.1 (OCH2CH3), 18.5, 18.6 
(2 X SiC(CH3)3). 26.0(SiC(CH3)3), 28.3 (OC(CH3)3). 49.8 (C-2), 53.2 (C-3), 61.4 
(OCH2CH3), 71.6 (C-5), 77.3 (C-6), 80.3 (C-4), 80.4 (OC(CH3)3), 85.4 (C-1), 155.4 
(NC02), 171.1 (C02C2Hs); mlz (El): 547(M+). 376 (100 %). 
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TBSO~C02Et 
TBSO~NHBoc 
OH 
181 
Ethyl syn-syn-syn-6-tert-butoxycarbonylamino-3,4-bis(tert-butyldimethyl 
silyloxy )-5-hydroxycyclohex-1-ene-1-carboxylate 181: 
To a solution of LiHMDS (231 mg, 1.38 mmol) in THF (20 cm3) at -50°C was added 
a solution of oxanorbomene 180 (250 mg, 0.46 mmol) in THF (5 cm\ The solution 
was stirred at 25°C for 2 hours. The reaction mixture was then quenched with ethyl 
acetate/ethanol (9: 1) and stirred for 5 minutes. Saturated Nf4Cl solution was added to 
the reaction mixture and the resulting two layers were separated. The organic layer 
was dried (MgS04 ) and concentrated under reduced pressure to give the crude 
product. Flash chromatography eluting with ethyl acetate /petroleum ether (3:2) 
afforded 181 as a pale yellow oil (129 mg, 56%); Vmax (KBr disk): 3412, 2987, 1732, 
1688, 1534 cm-1; oH (400 MHz, CDCh): 0.12 (12H, s, 2 x Si(CH3)3), 0.92 (9H, s, 
SiC(CH3) 3), 0.93 (9H, s, SiC(CH3)3), 1.28 (3H, t, J = 7.2Hz, OCH2Cfu), 1.43 (9H, s, 
OC(CH3)3), 3.70 (1H, br, OH), 4.05 (lH, m, H-5), 4.08 (lH, m, H-6), 4.13 (lH, t, J = 
2.4 Hz, H-4), 4.26 (2H, q, J = 7.2 Hz, OCfuCH3), 4.52 (lH, dd, J = 3.2 and 2.4 Hz, 
H-3), 4.84 (2H, br, NH2), 6.72 (lH, d, J = 3.2 Hz, H-2); Oc (100 MHz, CDCh): 0.1 
(Si(CH3)z), 18.8 (OCH2CH3), 23.0 (SiC(CH3)3), 30.6 (SiC~H3)3), 55.8 (C-6), 66.3 
(OCH2CH3), 73.8 (C-3), 76.4 (C-4), 77.4 (C-5), 118.7 (C-1), 132.1 (C-2), 170.2 
(C02). m/z (ES+): 568 (MNa+). 
AcO~C02Et 
AcO~NHBoc 
OAc 
182 
Ethyl syn-syn-syn-syn-3,4,5-triacetoxy-2-tert-butoxycarbonylamino-cyclo 
hexanecarboxylate 182: 
To a solution of cyclohexene 179 (100 mg, 0.26 mmol) in ethanol (10 cm3) was added 
10% Pd/C (20 mg) and the suspension was stirred under hydrogen for 24 h. The 
suspension was then filtered and the filtrate was concentrated under reduced pressure 
to give 182 as a yellow oil (98 mg, 98%); Vmax (thin film): 3455, 2979, 1747, 1513 cm· 
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; 8H (500 MHz, CDCb): 1.22 (3H, t, J = 7.5 Hz, OCH2Cfu), 1.41 (9H, s, OC(CH3)3), 
2.00 (3H, s, CH3CO), 2.01 (6H, s, 2 x CH3CO), 2.06 (2H, m, HH-6), 2.16 (3H, s, 
CH3CO), 2.73 (lH, m, H-1), 4.22 (2H, q, J = 7.5 Hz, OC_fuCH3), 4.63 (1H, m, H-2), 
4.87 (2H, m, H-4 and 5), 5.16 (lH, d, J = 11.0 Hz, NH), 5.53 (lH, s, H-3); Be (125 
MHz, CDCh): 14.2 (OCH2CH3), 20.8 ~H3CO), 21.0 (2 x CH3CO), 22.8 (C-6), 28.5 
(OC(CH3)3), 41.8 (C-1), 48.7 (C-2), 61.5 (OCH2CH3), 68.6 (C-4), 68.7 (C-5), 70.5 (C-
3), 79.7 (OC(CH3)3), 155.8 (NC02), 169.4, 169.7, 170.1, 170.8 (carbonyls); m/z 
(ES+): 468 (MNa+). 
·y.C02Et 
ot' 
''· .,, ~"NHBoc 
OH 
183 
Epoxidation of diene 3: 
0<;xC02Et 
''If NHBoc 
OH 
184 
To a solution of diene 3 (1.00 g, 3.53 mmol) in CH2Ch (20 cm3) was added mCPBA 
(1.23 g, 7.06 mmol) and NaHC03 (890 mg, 10.6 mmol). The mixture was stirred at 
room temperature for 36 hr. The mixture was then partitioned between concentrated 
NaHC03 solution (25 cm3) and ethyl acetate (25 cm3) and the layers were separated. 
The aqueous layer was extracted with ethyl acetate (2 x 25 cm3) and the organic 
extractions were mixed, dried (MgS04) and concentrated under reduced pressure to 
give the crude product of 9:1 mixture of epoxides 183 as a colourless oil (721 mg, 
68%) and 184 as a white gum (90 mg, 9% ). The two isomers were separated by flash 
chromatography eluting with petroleum ether/ethyl acetate (7:4). 
Ethyl anti-anti-6-tert-butoxycarbonylamino-3,4-epoxy-5-hydroxycyclohex-1-ene-
1-carboxylate 183: 
Vmax (thin film): 3439 (br), 2979, 1718, 1499 cm- 1; 8H (500 MHz, CDCl3): 1.27 (3H, t, 
J = 7.0 Hz, OCH2Cfu), 1.40 (9H, s, OC(CH3)3), 3.54 (lH, t, J = 4.0 Hz, H-3), 3.74 
(lH, br, H-4), 4.24 (2H, q, J = 7.0 Hz, OCfuCH3), 4.41 (1H, br, H-5), 4.73 (lH, d, J = 
10.0 Hz, NH), 4.87 (1H, d, J = 10.0 Hz, H-6), 7.32 (1H, d, J = 4.0 Hz, H-2); Be (125 
MHz, CDCb): 14.3 (OCH2CH3), 28.6 (OC(CH3)3), 46.4 (C-3), 49.3 (C-6), 58.1 (C-4), 
61.4 (OCH2CH3), 67.0 (C-5), 80.2 (OC(CH3)3), 133.0 (C-1), 137.3 (C-2), 155.3 
(NC02), 165 (C02); mlz (Cl): 300 (Mft, 25%), 261 (100%). 
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Ethyl syn-anti-6-tert-butoxycarbonylamino-3,4-epoxy-5-hydroxycyclohex-1-ene-
1-carboxylate 184: 
Ymax (thin film): 3435 (br), 2972, 1725, 1492 cm-1; bH (500 MHz, CDCh): 1.28 (3H, t, 
J = 7.0 Hz, OCH2Cfu), 1.41 (9H, s, OC(CH3)3), 3.50 (lH, t, J = 4.0 Hz, H-3), 3.70 
(1H, dd, J = 4.0 and 1.5 Hz, H-4), 4.18 (4H, m, OCfuCH3, H-5, and H-6), 5.49 (lH, 
br, NH), 6.92 (1H, d, J = 4.0 Hz, H-2); be (125 MHz, CDCh): 14.3 (OCHzCH3), 28.5 
(OC(CH3)3), 48.3 (C-3), 52.5 (C-6), 55.6 (C-4), 61.5 (OCH2CH3), 71.6 (C-5), 80.6 
(OC(CH3)3), 130.1 (C-1), 133.4 (C-2), 156.7 (NCOz), 165.5 (COz); mlz (Cl): 300 
(MH+, 20%), 166 (100%). 
OAc 
185 
Ethyl anti-5-acetoxy-6-tert-butoxycarbonylamino-1,3-cyclohexadiene-1-
carboxylate 185: 
To a solution of cyclohexadiene 3 (500 mg, 1.77 mmol) in anhydrous pyridine (5 cm3, 
64.5 mmol) was added acetic anhydride (5 cm3, 53.0 mmol). The reaction mixture 
was then stirred at room temperature for 20 hours. 2M HCl (20 cm3) and ethyl acetate 
(20 cm3) were added and the resulting layers were separated. The aqueous layer was 
extracted with ethyl acetate (2 x 20 cm3) and the organic layers were combined, dried 
(MgS04) and concentrated under reduced pressure. The crude product was purified by 
flash chromatography eluting with petroleum ether/ethyl acetate (4:1) to give acetate 
185 as a white solid (550 mg, 96% ), mp 42-44°C; Umax (KBr disk): 3285, 2983, 1737, 
1717, 1679, 1648, 1527 cm-1; bH (500 MHz, CDCh): 1.30 (3H, t, J = 7.0 Hz, 
OCH2Cfu), 1.42 (9H, s, OC(CH3)3), 2.00 (3H, s, CH3CO), 4.28 (2H, q, J = 7.0 Hz, 
OCfuCH3), 4.37 (1H, br, NH), 4.46 (lH, br, H-6), 5.25 (lH, br, H-5), 6.34 (2H, br, 
H-3 and 4), 7.17(1H, br, H-2); be (125 MHz, CDCh): 14.1 (OCH2CH3), 20.8 
(GH3CO), 28.2 (OC(GH3)3), 46.2 (C-6), 61.0 (OCH2CH3), 68.8 (C-5), 80.0 
(OC(CH3) 3), 126.6 and 127.8 (C-3 and 4) 128.7 (C-2), 133.1 (C-1), 154.6 (NC02), 
165.5 (CH3CO), 169.8 (C02C2H5); m/z (Cl): 326 (MW, 100%) Anal. calcd. For 
C 16H23N06: C, 59.06; H, 7.13; N, 4.31. found: C, 58.79; H, 7.11; N, 4.30. 
110 
·y.C02Et ~,, 
o,,,. 
.,/. 
i'NHBoc 
OAc 
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Ethyl anti-anti-5-acetoxy-6-tert-butoxycarbonylamino-3,4-epoxy-5-
acetoxycyclohex-1-ene-1-carboxylate 186: 
To a solution of diene 185 (200 mg, 0.59 mmol) in CH2Ch (10 cm3) was added 
mCPBA (310 mg, 1.77 mmol) and NaHC03 (300 mg, 3.52 mmol). The mixture was 
stirred at room temperature for 36 hours. The mixture was then partitioned between 
concentrated NaHC03 solution (25 cm3) and ethyl acetate and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (2 x 25 cm3) and the 
organic extractions were combined, dried (MgS04) and concentrated under reduced 
pressure to give the crude product. Flash chromatography eluting with petroleum 
ether/ethyl acetate (7:3) gave epoxide 186 as a colourless oil (136 mg, 65% ); Vmax 
(thin film): 3442, 2979, 1653, 1494 cm-1; 8H (400 MHz, CDC13): 1.25 (3H, t, J = 7.2 
Hz, OCH2Cfu), 1.38 (9H, s, OC(CH3)3), 2.00 (3H, s, CH3CO), 3.50 (lH, dd, J = 7.5 
and 3.9 Hz, H-3), 3.79 (lH, br, H-4), 4.19 (2H, q, J = 7.2 Hz, OCfuCH3), 4.16 (lH, 
d, J = 9.9 Hz, NH), 4.87 (lH, d, J = 9.9 Hz, H-6), 5.32 (lH, br, H-5), 7.28 (1H, br, H-
2); 8c (100 MHz, CDCh): 14.3 (OCH2CH3), 21.0 (CH3CO), 28.5 (OC~H3)3), 46.3 
(C-3), 46.8 (C-6), 55.6 (C-4), 61.5 (OCH2CH3), 68.7 (C-5), 80.0 (OC(CH3)3), 133.4 
(C-1), 136.6 (C-2), 154.4 (NC02), 164.8 ~02C2Hs), 169.9 (CH3CO); m/z (CD: 342 
(MH+), 303 (100%); Anal. Calcd. For C 16H23N07 : C, 56.30; H, 6.79; N, 4.10. Found: 
C, 56.27; H, 6.85; N, 4.11. 
AcO~C02Et 
Aco~''Y''INHAc 
OAc 
187 
Ethyl anti-anti-anti-3,4,5-triacetoxy-2-N -acetylaminocyclohex-1-ene-1-
carboxylate 187: 
A solution of epoxide 186 (270 mg, 0.79 mmol) in H20/Acetone (1:1) was treated 
with HC104 (5 fll, 0.08 mmol). The solution was stirred at room temperature for 24 h 
and the solvent was removed under reduced pressure. The residue was stirred in 
pyridine (5 cm3) and acetic anhydride (5 cm3) for 24 h and then partitioned between 
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2M HCl (20 cm3) and ethyl acetate (20 cm\ The organic layer was washed with 
saturated NaHC03 (20 cm\ dried (MgS04) and concentrated under reduced pressure. 
The resulting residue was columned using petroleum ether/ ethyl acetate (7:3) as the 
eluting solvent to give 187 as a pale yellow gum (226 mg, 74% ); Vmax (KBr disk): 
3387, 2935, 1752, 1663, 1537 cm-3; bH (500 MHz, CDCh): 1.27 (3H, t, J = 7.0 Hz, 
OCH2Ctb), 1.93 (3H, s, CH3CO), 2.05 (3H, s, CH3CO), 2.06 (3H, s, CH3CO), 2.08 
(3H, s, CH3CO), 4.21 (2H, q, J = 7.0 Hz, OCfuCH3), 5.01 (lH, m, H-6), 5.32 (2H, m, 
H-4 and H-5), 5.58 (lH, br, NH), 6.72 (lH, d, J = 4.5 Hz, H-2); be (125 MHz, 
CDCb): 14.3 (OCH2CH3), 20.9, 21.0 and 23.4 (4 x CH3CO), 49.7 (C-6), 61.7 
(OCH2CH3), 69.7 (C-3), 70.4 and 71.3 (C-4 and C-5), 132.0 (C-1), 135.0 (C-2), 164.6 
(C02), 169.6, 169.7, 170.1 and 170.4 (4 x CH3CO); m/z (Cl): 386 (MW), 208 
(100%). 
AcO~~C02Et 
Aco~''Y''INHAc 
OAc 
188 
Ethyl anti-anti-anti-anti-3,4,5-triacetoxy-2-N -acetylaminocyclohexane-1-
carboxylate 188: 
To a solution of ester 187 (100 mg, 0.26 mmol) in ethanol (10 cm3) was added 10% 
Pd/C (20 mg) and the suspension was stirred under hydrogen for 24 h. The suspension 
was then filtered and the filtrate was concentrated under reduced pressure to give 188 
as a white gum (98 mg, 98%); Vmax (KBr disk): 3247, 2947, 1741, 1660, 1565 cm- 1; bH 
(500 MHz, CDCb): 1.23 (3H, t, J = 7.0 Hz, OCH2Cfu), 1.88 (lH, m, H-6), 1.90 (3H, 
s, CH3CON), 2.01 (3H, s, CH3CO), 2,03 (3H, s, 2 x CH3CO), 2.28 (1H, t, J = 13.0 Hz, 
H-6), 2.57 (lH, dt, J = 13.0 and 3.5 Hz, H-1), 4.12 (2H, q, J = 7.0 Hz, OCfuCH3), 
4.33 (lH, q, J = 10.0 Hz, H-2), 4.88 (lH, m, H-5), 4.96 (1H, t, J = 10.0 Hz, H-3), 5.21 
(lH, t, J = 10.0 Hz, H-4), 5.49 (1H, d, J = 10.0 Hz, NH); be (125 MHz, CDCh): 14.3 
(OCH2CH3), 20.9 and 21.1 (3 x CH3CO), 23.4 (GH3CON), 30.3 (C-6), 44.4 (C-1), 
52.5 (C-2), 61.8 (OCH2CH3), 70.6 (C-5), 72.9 (C-4), 73.2 (C-3), 169.8, 170.4, 170.8 
and 171.3 (carbonyls); m/z (Cl): 388 (MH+, 100%); HRMS (ES+): C 17H25N09Na 
requires M+, 410.1427. Found: 410.1467. 
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CIYYC02Et 
Ho~''Y''/NHBoc 
OAc 
189 
Ethyl anti-anti-anti-5-acetoxy-6-tert-butoxycarbonylamino-3-chloro-4-hydroxy-1-
cyclohexene-1-carboxylate 189: 
To solution of epoxide 186 (240 mg, 0.75mmol) in dichloromethane was added acetic 
acid (120 111, 2.10 mmol) and ZnC}z (102mg, 0.75mmol). The mixture was stirred at 
room temperature until all the starting material was consumed (TLC ea. 12 h). The 
solvent was remove under reduced pressure and the residue was subjected to column 
chromatography eluting with petroleum ether/ethyl acetate (7:3) to give 189 as a 
white solid (200 mg, 83%); m.p 158-160°C; Vmax (KBr disk): 3447 (br), 2979, 1765, 
1703, 1652, 1536 cm- 1; oH (500 MHz, CDCh): 1.30 (3H, t, J = 7.0 Hz, OCH2CH3), 
1.42 (9H, s, OC(CH3)3), 2.10 (3H, s, CH3CO), 2.86 (lH, br, OH), 4.12 (lH, m, H-4), 
4.24 (2H, q, J = 7.0 Hz, OCfuCH3), 4.61 (2H, m, H-3 and 6), 4.80 (lH, br, NH), 5.16 
(lH, br, H-5), 6.81 (lH, s, H-2); 8c (125 MHz, CDCh): 14.3 (OCH2CH3), 21.1 
~H3CO), 28.5 (OC~H3)3), 50.3 (C-3), 57.3 (C-6), 61.7 (OCH2CH3), 72.8 (C-4), 
73.7 (C-5), 80.9 (OC(CH3)3), 131.7 (C-1), 136.5 (C-2), 155.2 (NC02), 165.0 (C02), 
170.9 (CH3CO); m/z (ES+): 400 (MNa+). 
0 
0~C02Et 
NHBoc 
190 
Ethyl endo-3-tert-butoxycarbonylamino-5,6-epoxy-7 -oxabicyclo[2,2,1]hexane-2-
carboxylate 190: 
To a stirred solution of the bicyclic alkene 2 (500 mg, 1.77 mmol) in CH2C}z(10 cm3) 
was added solid NaHC03(300 mg, 3.54 mmol) and mCPBA (305 mg, 1.77 mmol). 
After 28 hours the reaction was quenched with 20% aqueous solution of Na2S03 (5 
cm
3) and the resulting layers were separated. The aqueous layer was extracted with 
CH2C}z (10 cm3 x 2) and the combined organic extracts were washed with H20, dried 
(MgS04) and evaporated under reduced pressure. The resulting residue was purified 
by flash chromatography eluting with (CH3CH2)z0/petroleum ether (7:3) to give 
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epoxide 190 as a white solid (322 mg, 61 %), mp 34-36°C; Dmax (KBr disk): 3378, 
2979, 1717, 1521 cm-1; oH (500MHz, CDCh): 1.28 (3H, t, J = 7.0 Hz, OCH2CH3), 
1.44 (9H, s, OC(CH3)3), 2.25 (lH, d, J = 4.5, H-2), 3.47 (lH, d, J = 3.5, H-6), 3.59 
(lH, d, J = 3.5, H-5), 4.21 (2H, q, J = 7.0 Hz, OCfuCH3), 4.42 (1H, m, H-3), 4.74 
(3H, br, C-1, C-4, NH). oc (125 MHz, CDCh): 14.4 (OCH2CH3), 28.5 (OC(CH3)3), 
48.4 (C-5), 49.5 (C-6), 52.4 (C-2), 57.8 (C-3), 61.9 (OCH2CH3), 75.0, 77.0 (C-1, C-
4), 81.0 (OC(CH3)3), 155.4 (NC02), 170.8 (C02C2Hs); mlz (El): 299 (M+), 57 
(100%); Anal. Calcd. for C 14H21 N06: C, 56.18; H, 7.07; N, 4.68. Found: C, 56.17; H, 
7.21; N, 4.47. 
0 
HO~C02Et 
OYNH 
0 
191 
Ethyl 2-hydroxy-5-oxo-4,9-dioxa-6-azatricyclo[3,3,1,11'8]decane-10-carboxylate 
191: 
A solution of epoxide 190 (200 mg, 1.01 mmol) in Ac0H/H20 (9:1, 10 cm3) was 
stirred at room temperature for 30 minutes. The reaction was quenched with sat. 
NaHC03 (10 cm\ The resulting solution was extracted with ethyl acetate (10 cm3 x 
3). The combined organic layers were dried (MgS04) and concentrated under reduced 
pressure to afford the crude product. Purification of the crude product by flash 
chromatography eluting with ethyl acetate/hexane (7:3) gave 191 (120 mg, 75%) as a 
white solid, mp 37-39°C; Dmax (KBr disk): 3448 (br), 2979, 1733, 1681, 1463 cm-1; OH 
(400 MHz, CDCh): 1.29 (3H, t, J = 7.2 Hz, OCH2Cfu), 2.59 (lH, d, J = 2.4 Hz, H-
10), 3.83 (lH, d, J = 1.2 Hz, H-2), 4.21 (2H, q, J = 7.2 Hz, OCfuCH3), 4.32 (1H, m, 
H-7), 4.54 (lH, t, J = 1.2 and 1.5 Hz, H-8), 4.61 (2H, m, H-1 and 3), 5.98 (lH, br, 
NH); oc (100 MHz, CDCI3): 14.1 (OCH2CH3), 53.1 (C-7), 54.3 (C-10), 61.9 
(OCH2CH3), 67.2 (C-8), 75.6 (C-2), 79.1 (C-2), 85.1 and 85.5 (C-1 and 3), 150.1 (C-
5), 170.1 (C02C2H5); m/z (El): 243 (M+), 98 (100%); Anal. Calcd. For C 10H 13N06: C, 
49.38; H, 5.39; N, 5.76. Found: C, 49.22; H, 5.15; N, 5.84. 
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AcO:Q:f,, ~ C02Et 
'If AcO NHAc 
OAc 
194 
Ethyl anti-syn-anti-3,4,5-triacetoxy-6-N-acetylaminocyclohex-1-ene-1-
carboxylate 194: 
A solution of epoxide 184 (270 mg, 0.79 mmol) in H20/Acetone (1:1) was treated 
with HCI04 (5 !J.l, 0.08 mmol). The solution was stirred at room temperature for 24 h 
and the solvent was removed under reduced pressure. The residue was stirred in 
pyridine (5 cm3) and acetic anhydride (5 cm3) for 24 h and then partitioned between 
2M HCl (20 cm3) and ethyl acetate (20 cm\ The organic layer was washed with 
saturated N aHC03 (20 cm\ dried (MgS04) and concentrated under reduced pressure. 
The resulting residue was columned using petroleum ether/ ethyl acetate (7:3) as the 
eluting solvent to give 194 as a pale yellow gum (226 mg, 74% ); Vmax (KBr disk): 
3379, 2996, 1744, 1663, 1543 cm-1; 8H (500 MHz, CDCb): 1.26 (3H, t, J = 7.0 Hz, 
OCH2Cfu), 1.97 (3H, s, CH3CO), 2.01 (3H, s, CH3CO), 2.06 (3H, s, CH3CO), 2.08 
(3H, s, CH3CO), 4.27 (2H, q, J = 7.0 Hz, OC_fuCH3), 4.97 (lH, dd, J = 8.5 and 3.5 
Hz, H-6), 5.28 (1H, dd, J = 8.5 and 2.5 Hz, H-4), 5.39 (lH, dd, J = 8.5 and 3.5 Hz, H-
5), 5.57 (lH, dd, J = 8.5 and 2.5 Hz, H-3), 5.85 (lH, d, J = 8.5 Hz, NH), 6.87 (1H, d, J 
= 2.5 Hz, H-2); be (125 MHz, CDCh): 14.3 (OCH2CH3), 21.0 (CH3CO), 21.1 (2 x 
CH3CO), 23.3 (CH3CO), 47.7 (C-6), 61.8 (OCH2CH3), 68.9 (C-4), 69.0 (C-3), 70.4 
(C-5), 130.5 (C-1), 138.0 (C-2), 164.6, 169.6, 169.7 and 170.5 (carbonyls); m/z (Cl): 
386 (Nllr, 100%). 
AcO/:x;c'· C02Et 
.,, 
AcO NHAc 
OAc 
195 
E thy I anti-anti-syn -anti-3,4,5-triacetoxy-2-N -acetylaminocyclohexane-1-
carboxylate 195: 
To a solution of cyclohexene 194 (100 mg, 0.26 mmol) in ethanol (10 cm3) was added 
10% Pd/C (20 mg) and the suspension was stirred under hydrogen for 48 h. The 
suspension was then filtered and the filtrate was concentrated under reduced pressure 
to give 195 as a colourless gum (98 mg, 99%); Vmax (KBr disk): 3379, 2981, 1743, 
115 
1549 cm- 1; 8H (500 MHz, CDCl3):1.24 (3H, t, J = 7_0 Hz, OCH2Cfu), 1.90 (3H, s, 
CH3CO), 2.00 (3H, s, CH3CO), 2.03 (lH, m, H-6), 2.10 (3H, s, CH3CO), 2.16 (3H, s, 
CH3CO), 2.17 (lH, m, H-6), 2.71 (1H, dt, J = 11.5 and 4.0 Hz, H-1), 4.14 (2H, q, J = 
7.0 Hz, OCfuCH3), 4.52 (lH, q, J = 11.5 Hz, H-2), 5.04 (lH, m, H-5), 5.14 (lH, dd, J 
= 11.5 and 3.0 Hz, H-3), 5.25 (1H, t, J = 3.0 Hz, H-4), 5.50 (lH, d, J = 11.5 Hz, NH); 
&c (125 MHz, CDCl3): 14.4 (OCH2CH3), 21.0 ~H3CO), 21.3 ~H3CO), 23.5 
~H3CO), 27.8 (C-6), 43.8 (C-1), 49.4 (C-2), 61.6 (OCH2CH3), 68.6 (C-5), 68.8 (C-
4), 70.3 (C-3), 169.4, 169.8, 170.0, 171.3 and 171.8 (carbonyls); mlz (Cl): 388 (MW, 
100%); HRMS (ES+): Found M+, 410.1417. C17H25N09 requires 410.1427. 
~CO?Et 
0~NHDoc 
OH 
196 
Ethyl syn-syn-6-tert-butoxycarbonylamino-3,4-epoxy-5-hydroxycyclohex-1-ene-1-
carboxylate 
To a solution of diene 159 (1.00 g, 3.53 mmol) in CH2Ch (20 cm3) was added 
mCPBA (1.23 g, 7.06 mmol) and NaHC03 (890 mg, 10.6 mmol). The mixture was 
stirred at room temperature for 36 hr. The mixture was then partitioned between 
concentrated NaHC03 solution (25 cm3) and ethyl acetate (25 cm3) and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (2 x 25 cm3) and 
the organic extractions were mixed, dried (MgS04) and concentrated under reduced 
pressure to give the crude product 196 as a white gum (865 mg, 82% ); Ymax (KBr 
disk): 3437, 2979, 1720, 1498 cm-1; 8H (500 MHz, CDCh): 1.27 (3H, t, J = 7.5 Hz, 
OCH2Cfu), 1.41 (9H, s, OC(CH3)3), 3.24 (lH, br, OH), 3.53 (1H, dd, J = 4.5 and 4.0 
Hz, H-3), 3.67 (lH, m, H-4), 4.21 (3H, m, OCfuCH3 and H-5), 4.80 (lH, d, J = 8.5 
Hz, NH), 4.98 (lH, dd, J = 8.5 and 4.5 Hz, H-6), 7.16 (lH, d, J = 4.0 Hz, H-2); &c 
(125 MHz, CDCi}): 14.3 (OCH2CH3), 28.5 (OC~H3)3), 47.8 (C-6), 48.3 (C-2), 59.0 
(C-4), 61.6 (OCH2CH3), 68.4 (C-5), 80.2 (OC(CH3)3), 135.6 (C-1), 136.8 (C-2), 156.9 
(NC02), 164.7 (C02); m/z (ES+): 322 (MNa+, 100%). 
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AcOn,,(Yco2Et 
AcO~NHAc 
OAc 
197 
Ethyl anti-syn -syn -3,4,5-triacetoxy-2-N -acetylaminocyclohex -1-ene-1-carboxylate 
197: 
A solution of epoxide 196 (270 mg, 0.79 mmol) in H20/Acetone (1:1) was treated 
with HC104 (5 ~tl, 0.08 mmol). The solution was stirred at room temperature for 24 h 
and the solvent was removed under reduced pressure. The residue was stirred in 
pyridine (5 cm3) and acetic anhydride (5 cm3) for 24 h and then partitioned between 
2M HCl (20 cm3) and ethyl acetate (20 cm\ The organic layer was washed with 
saturated NaHC03 (20 cm\ dried (MgS04) and concentrated under reduced pressure. 
The resulting residue was columned using petroleum ether/ ethyl acetate (7:3) as the 
eluting solvent to give 197 as a pale yellow gum (218 mg, 72%); Vmax (KBr 
disk):3377, 2989, 1745, 1675, 1535 cm-1; oH (500 MHz, CDCh): 1.26 (3H, t, J = 7.0 
Hz, OCH2CH~), 1.96 (3H, s, CH3CON), 2.08 (3H, s, CH3CO), 2.09 (3H, s, CH3CO), 
2.10 (3H, s, CH3CO), 4.23 (2H, q, J = 7.0 Hz, OCfuCH3), 5.22 (lH, dd, J = 5.5 and 
2.0 Hz, H-4), 5.46 (2H, m, H-5 and 6), 5.58 (2H, m, H-3 and NH), 6.82 (1H, d, J = 2.5 
Hz, H-2); Oc (125 MHz, CDCh): 14.3 (OCH2CH3), 21.0 (CH3CO) 21.1 (2 x CH3CO), 
23.4 (CH3CON), 44.8 (C-6), 61.8 (OCH2CH3), 68.0 (C-3), 68.4 (C-5), 70.6 (C-4), 
133.2 (C-1), 135.0 (C-2), 164.9 (CH3CON), 169.1, 169.3, 169.9, 170.0 (carbonyls); 
m/z (ES+): 408 (MNa+, 100%). 
AcOn,,(I·'~C02Et 
AcO~NHAc 
OAc 
198 
Ethyl anti-syn-syn-anti-3,4,5-triacetoxy-2-N -acetylaminocyclohexane-1-
carboxylate 198: 
To a solution of cyclohexene 197 (100 mg, 0.26 mmol) in ethanol (10 cm3) was added 
10% Pd/C (20 mg) and the suspension was stirred under hydrogen for 24 h. The 
suspension was then filtered and the filtrate was concentrated under reduced pressure 
to give 198 as a white solid (98 mg, 98 %); m.p. 196-198°C; Vmax (KBr disk): 3271, 
2986, 1747, 1651, 1556 cm- 1; oH (500 MHz, CDCh): 1.23 (3H, t, J = 7.0 Hz, 
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OCH2Cfu), 1.79 (2H, m, H-6), 1.91 (3H, s, CH3CO), 1.97 (3H, s, CH3CON), 2.03 
(3H, s, CH3CO), 2.16 (3H, s, CH3CO), 2.77 (1H, m, H-1), 4.12 (2H, q, J = 7.0 Hz, 
OCfuCH3), 4.50 (1H, m, H-2), 5.05 (2H, m, H-4 and 5), 5.50 (lH, br, H-3), 5.56 (lH, 
d, J = 8.0 Hz, NH); 8c (125 MHz, CDCh): 14.3 (OCH2CH3), 20.8 ~H3CO), 21.2 
(CH3CO), 21.2 (CH3CO), 23.3 ~H3CON), 30.0 (C-6), 42.7 (C-1), 49.6 (C-2), 61.7 
(OCH2CH3), 68.5 (C-5), 71.5 (C-3), 71.8 (C-4), 169.3, 169.9, 170.0, 170.7, 171.4 
(carbonyls); mlz (ES+): 410 (MNa+). 
0 d:(co2Et 
NHBoc 
201 
Ethyl endo-3-tert-butoxycarbonylamino-7-oxabicyclo[2,2,1]heptane-exo-2-
carboxylate 201: 
Bicyclic alkene 2 (400 mg, 1.40 mmol) was stirred with 10% Pd/C (80 mg) in ethanol 
(15 cm3) under hydrogen over night. After the reaction, Pd/C was filtered off and the 
filtrate was concentrated under reduced pressure to give the saturated adduct 201 (390 
mg, 98%) as a white solid, mp 92-94°C; Dmax (KBr disk): 3346 (br), 2992, 1739, 1709, 
1523 cm- 1; 8H (500 MHz, CDC13): 1.26 (3H, t, J = 7.2 Hz, OCH2Cfu), 1.43 (9H, s, 
OC(CH3)3), 1.84 (4H, m, H-5 and 6), 2.14 (lH, d, J = 5.0 Hz, H-2), 4.17 (2H, q, J = 
7.2 Hz, OCfuCH3), 4.22 (lH, br, H-3), 4.72 (2H, br, H-1 and 4), 5.40 (1H, br, NH); 
8c (125 MHz, CDCh): 14.1 (OCH2CH3), 30.0 (C-5 and 6), 28.3 (OC~H3)3), 55.0 (C-
2), 56.2 (C-3), 61.1 (OCH2CH3), 78.3 and 79.6 (C-l and 4), 80.1 (OC(CH3) 3), 155.2 
(NC02), 172.0 (C02C2H5); mlz (El): 285 (M+), 57 (100%); Anal. calcd. for 
C 14H23N05: C, 58.93; H, 8.12; N, 4.91. Found: C, 58.23; H, 8.07; N, 4.74. 
(YC02Et 
Y'''INHBoc 
OAc 
202 
Ethyl trans-5-acetoxy-6-tert-butoxycarbonylaminocyclohex-1-ene-1-carboxylate 
202: 
To a solution of KHMDS (530 mg, 2.64 mmol) in THF (10 cm3) at -50 °C was added 
a solution of adduct 201 (250 mg, 0.88 mmol) in THF (2.5 cm\ The solution was 
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then warmed up to room temperature (20 minutes) and quenched with a mixture of 
ethyl acetate and ethanol (50 cm3, 19:1). The mixture was washed with sat. ~Cl (25 
cm3), dried (MgS04) and concentrated under reduced pressure. The resulting residue 
was purified by flash chromatography eluting with petroleum ether/ethyl acetate 
mixture (3:2) to give cyclohexene 202 as a pale yellow gum (359 mg, 68% ). Vmax 
(KBr disk): 3361, 2969, 1713, 1652, 1515 cm- 1; oH (500 MHz, CDCh): 1.28 (3H, t, J 
= 7.0 Hz, OCH2Cfu), 1.44 (9H, s, OC(CH3) 3), 1.71 (2H, m, H-4), 2.03 (3H, s, 
CH3CO), 2.25 (2H, m, H-3), 4.20 (2H, q, J = 7.0 Hz, OCfuCH3), 4.40 (1H, br, NH), 
4.49 (lH, br, H-6), 5.08 (lH, br, H-5), 7.19 (1H, dd, J = 4.2 and 2.3 Hz, H-2); oc (125 
MHz, CDCiJ): 14.1 (OCH2CH3), 20.7 (C-4), 21.1 (C-3), 21.3 (CH3CO), 28.3 
(OC~H3)3), 47.0 (C-6), 60.7 (OCH2CH3), 70.5 (C-5); 79.7 (OC(CH3) 3), 128.1 (C-1), 
143.0 (C-2), 154.5 (NC02), 165.9 (CH3CO), 170.0 (C02); m/z (Cl): 328 (MH+, 
100%). 
(!C02 Et 
Y''JNHBoc 
OAc 
203 
Ethyl anti-anti-3-acetoxy-2-tert-butoxycarbonylaminocyclohexanecarboxylate 
203: 
To solution of cyclohexene 202 (500 mg, 1.77 mmol) in ethanol (20 cm3) was added 
10% Pd/C (100 mg) and the solution was stined under hydrogen for 48 h. The 
reaction mixture was then filtered and the filtrate was concentrated under reduced 
pressure to give ACHC derivative 203 as a colourless oil (498 mg, 99%); Vmax (liq. 
film): 3367 (br), 2938, 1727, 1688, 1535 cm- 1; oH (500MHz, CDCh): 1.23 (3H, t, J = 
7.5 Hz, OCH2Cfu), 1.40 (9H, s, OC(CH3) 3), 1.52 and 1.77 (2H, m, HH-5), 1.54 and 
1.87 (2H, m, HH-6), 1.55 and 2.05 (2H, m, HH-4), 2.08 (3H, s, CH3CO), 2.36 (1H, dt, 
J = 12.3 and 3.9 Hz, H-1), 3.22 (lH, br, OH), 3.42 (lH, br, H-3), 3.49 (1H, br, H-2), 
4.12 (2H, q, J = 7.5 Hz, OCfuCH3), 4.81 (lH, br, NH); oc (125 MHz, CDCh): 14.4 
(OCH2Cfu), 23.1 (C-6), 28.5 (OC~H3)3), 28.8 (C-5), 33.9 (C-4), 48.6 (C-1), 58.3 (C-
2), 60.9 (OCH2CH3), 74.1 (C-3), 80.2 (OC(CH3) 3), 157.0 (NC02), 173.4 ~OzEt); m/z 
(Cl): 330 (MH+, 53%), 232 (100%). 
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205 
Ethyl anti-anti-3-acetoxy-2-N-benzoylaminocyclohexane-1-carboxylate 205: 
To a solution of 202 (200 mg, 0.61 mmol) in CH2Ch (10 cm3) was added TFA (0.1 
cm3, 1.31 mmol) and the mixture was stirred at 25 °C for 5 h. The solvent was then 
removed under pressure and the residue was suspended in CH2Cl2, treated with 
triethylamine (1.0 cm3, 7.22 mmol), benzoic acid (lOO mg, 0.73 mmol) and PyBop 
(455 mg, 0.875 mmol) and the mixture was stirred for 16 h. The reaction mixture was 
then washed with 1 M HCl (20 cm3) and the solvent was removed under pressure. The 
residue was recrystalized from CHC13 to give 205 as colourless crystals (171 mg, 84 
%); m.p. 176-178°C; Vmax (KBr disk): 3268, 2943, 1731, 1645, 1558 cm- 1; DH (500 
MHz, CDC13): 1.11 (3H, t, J = 7.0 Hz, OCH2Cfu), 1.40 (lH, m, H-5), 1.63 (lH, m, H-
4), 1.70 (lH, m, H-6), 1.86 (lH, m, H-5), 1.93 (lH, m, H-6), 1.95 (3H, s, CH3CO), 
2.01 (lH, m, H-4), 2.48 (lH, dt, J = 11.5 and 3.0 Hz, H-1), 4.07 (2H, q, J = 7.0 Hz, 
OCfuCH3), 4.40 (1H, m, H-2), 4.87 (1H, dt, J = 11.5 and 4.5 Hz, H-3), 6.20 (lH, d, J 
= 9.5 Hz, NH), 7.38 (2H, t, J = 7.5 Hz, H-3' and 5'), 7.45 (lH, t, J = 7.5 Hz, H-4'), 
7.67 (2H, d, J = 7.5 Hz, H-2' and 6'); De (125 MHz, CDCl3): 14.3 (OCH2CH3), 21.3 
~H3CO), 23.1 (C-5), 28.3 (C-6), 31.0 (C-4), 49.6 (C-1), 54.5 (C-2), 61.3 
(OCH2CH3), 74.1 (C-3), 127.1 (C-2' and 6'), 128.8 (C-3'and 5'), 131.7 (C-4'), 134.8 
(C-1'), 167.0 (C02), 171.9 (CH3CO), 172.7 (PhCON); m/z (ES+): 356 (MNa+, 100%); 
Anal. calcd. For C18H25N05 : C, 64.85; H, 6.95; N, 4.20. Found: C, 64.88; H, 6.96; N, 
4.21. 
0 
A eO~ 
BocHN ~v 
207 
N-Benzyl-[anti-anti-3-acetoxy-2-tert-butoxycarbonylamino-cyclohexane-1-
carboxyl]amide 207: 
A solution of 206 (250 mg, 1.09 mmol), benzylamine (0.14 cm3, 1.31 mmol), and 
triethylamine in CH2Ch (10 cm3) was treated with HATU (501 mg, 1.31 mmol) and 
the reaction was stirred for 16 h. 1 M HCI (20 cm3) was added to the reaction mixture 
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and the layers were separated. The orgamc layer was then dried (MgS04), 
concentrated under reduced pressure and recrystalisation from ethyl acetate afforded 
207 as a white solid (360 mg, 87%); m.p. 182-184 QC; Ymax (K.Br disk): 3450, 2933, 
1734, 1689,1644 cm-1; 8H (500 MHz, CD30D): 1.39 (9H, s, OC(CH3)3), 1.45 (2H, m, 
HH-4), 1.57 (2H, m, HH-5), 1.83 (2H, m, HH-6), 2.00 (3H, s, CH3CO), 2.45 (1H, dt, J 
= 11.6 and 3.2 Hz, H-1), 3.74 (1H, t, J = 11.6 Hz, H-2), 4.25 (1H, d, J = 14.8 Hz, 
NCH2Ph), 4.47 (1H, d, J = 14.8 Hz, NCH2Ph), 4.75 (1H, m, H-3), 7.28 (5H, m, 
aromatic protons); 8c (100 MHz, CD30D): 19.9 (CH3CO), 22.8 (C-5), 27.6 
(OC~H3)3), 29.1 (C-6), 30.8 (C-4), 42.9 (NCH2Ph), 49.4 (C-1), 54.6 (C-2), 74.9 (C-
3), 78.7 (OC(CH3) 3), 126.9, 127.3, 128.4, 138.7 (Ph carbons), 156.5 (NC02), 174.1 
(NCO), 174.4 (CH3CO); m/z (ES+): 413 (MNa+) 
4 o D AcO~ 4' 
BocHN 1 ~ 1' 
208 
N-CyclohexyD-[anti-anti-3-acetoxy-2-tert-butoxycarbonylamino-
cydohexanecarboxyl]amide 208: 
Employing the same procedure as that described for the synthesis of 207, 206 (250 
mg, 1.09 rnmol) afforded 208 as a white solid (292 mg, 72%); m.p. 260-262 QC; Ymax 
(KBr disk): 3311, 2933, 1738, 1693, 1645, 1547 cm-1; 8H (400 MHz, DMSO): 1.12 
(lH, m, H-4'), 1.23 (4H, m, HH-3' and 5'), 1.35 (9H, s, OC(CH3)3), 1.41 (2H, m, HH-
5), 1.63 (4H, m, HH-2' and 6'), 1.84 (4H, m, HH-4 and 6), 2.01 (3H, s, CH3CO), 2.53 
(lH, dd, J = 9.0 and 10.2 Hz, H-1), 3.48 (2H, m, H-1' and H-2), 4.57 (lH, m, H-3); 8c 
(lOO MHz, DMSO): 21.4 (C-3'), 23.2 (C-6), 23.6 (C-4'), 24.8 (C-5'), 25.9 (C-5), 28.8 
(OC~H3)3), 31.2 (C-2'), 31.5 (C-6'), 32.8 (C-4), 38.9 (C-1), 46.4 (C-2), 48.3 (C-1 '), 
76.0 (C-3), 79.3 (OC(CH3)3), 152.3 (NCOz), 166.3 (NCO), 170.5 (CH3CO); m/z 
(ES+): 405 (MNa+). 
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(YC02Et 
~NHBoc 
OAc 
209 
Ethyl syn-5-acetoxy-6-tert-butoxycarbonylamino-1,3-cyclohexadiene-1-
carboxylate 209: 
To a solution of cyclohexadiene 159 (500 mg, 1.77 mmol) in CH2Clz anhydrous 
pyridine (0.5 cm3, 6.45 mmol) was added acetic anhydride (0.5 cm3, 5.30 mmol). The 
reaction mixture was then stirred at room temperature for 20 hours. The solvent was 
removed under reduced pressure and the crude product was purified by flash 
chromatography eluting with petroleum ether/ethyl acetate (4: 1) to give acetate 209 as 
a yellow solid (449 mg, 78%); m.p. 76-78°C; Vmax (KBr disk): 3330, 2984, 1710,1522 
cm-
1
; ()H (500 MHz, CDCh): 1.27 (3H, t, J = 7.0 Hz, OCH2Cfu), 1.41 (9H, s, 
OC(CH3)3), 2.09 (3H, s, CH3CO), 4.25 (2H, q, J = 7.0 Hz, OC.fuCH3), 4.56 (lH, d, J 
= 10.0 Hz, NH), 5.00 (lH, dd, J = 10.0 and 7.5 Hz, H-6), 5.66 (lH, d, J = 7.5 Hz, H-
5), 6.00 (lH, d, J = 9.5 Hz, H-4), 6.16 (lH, dd, J = 9.5 and 5.5 Hz, H-3), 7.12 (lH, d, J 
= 5.5 Hz, H-2), be (125 MHz, CDCh): 14.3 (OCH2CH3), 21.2 (CH3CO), 28.5 
(OC~H3)3 ), 43.7 (C-6), 61.2 (OCH2CH3), 71.6 (C-5), 79.7 (OC(CH3)3), 124.0 (C-3), 
128.6 (C-1), 134.0 (C-2), 134.3 (C-4), 155.2 (NC02), 165.8 (C02), 170.5 (CH3CO); 
m/z (Cl): 326 (MH+, 100% ). 
IIC02Et 
~NHBoc 
OAc 
210 
Ethyl syn-syn-3-acetoxy-2-tert-butoxycarbonylaminocyclohexanecarboxylate 210: 
To solution of cyclohexene 209 (250 mg, 0.77 mmol) in ethanol (20 cm3) was added 
10% Pd/C (100 mg) and the solution was stin·ed under hydrogen for 48 h. The 
reaction mixture was then filtered and the filtrate was concentrated under reduced 
pressure to give ACHC derivative 210 as a white solid (243 mg, 96%); m.p. 53-55 °C; 
Vmax (KBr disk): 3373,2982, 1744, 1715, 1524 cm- 1; ()H (500 MHz, CDCh): 1.23 (3H, 
t, J = 7.0 Hz, OCHzCH3), 1.40 (9H, s, OC(CH3)3), 1.56 (2H, m HH-5), 1.72 (2H, m, 
HH-4), 1.81 (2H, m, HH-6), 1.99 (3H, s, CH3CO), 2.62 (lH, dd, J = 10.5 and 5.5 Hz, 
H-1), 4.16 (2H, q, J = 7.0 Hz, OC.fuCH3), 4.47 (1H, m, H-2), 4.83 (lH, m, H-3), 4.98 
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(1H, br, NH); 8c (125 MHz, CDCl3): 14.3 (OCH2CH3), 21.2 (C-6), 21.3 ~H3CO), 
22.9 (C-4), 26.5 (C-5), 28.5 (OC~H3)3), 43.9 (C-1), 49.8 (C-2), 60.9 (OCH2CH3), 
72.4 (C-3), 79.6 (OC(CH3) 3), 155.6 (NC02), L 70.5 and 172.7 (carbonyls); m/z (ES+): 
352 (MNa+, 100%). 
0 
1~co2Et 
OYNH 
0 
215 
Ethyl exo-2-iodo-5-oxo-4,9-dioxa-6-azatricyclo[3,3,1,11'8]decane-exo-10-
carboxylate 215: 
To a solution of bicyclic adduct 2 (500 mg, 1.77 mmol) in acetonitrile (15 cm3) was 
added iodine (1.35 g, 5.31 mmol). The reaction was stirred at room temperature and 
monitored by TLC (16 hours). The reaction was quenched with ethyl acetate (100 
cm
3) and then washed with sat. NaS20 4 (100 cm3) The resulting two layers were 
separated and the aqueous layer was extracted with ethyl acetate (50 cm3 x 2). The 
organic layers were combined, dried (MgS04) and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography eluting with 
Et20/petroleum ether (6:4) to give the tricyclic iodocarbamide 215 (298 mg, 48%) as 
a white solid, mp 164-166°C; Dmax (K.Br disk): 3448, 2979, 1733 cm-1; 8H (400 MHz, 
CDCi]): 1.29 (3H, t, J = 7.2 Hz, OCH2Cfu), 2.59 (1H, d, J = 2.4 Hz, H-10), 3.83 (lH, 
d, J = 1.2 Hz, H-2), 4.21 (2H, q, J = 7.2 Hz, OCfuCH3), 4.32 (lH, m, H-7), 4.54 (lH, 
t, J = 5.1, H-8), 4.61 (2H, m, H-1 and H-3), 5.98 (1H, d, J = 5.2Hz, NH); 8c (100 
MHz, CDCh): 14.1 (OCH2CH3), 53.1 (C-7), 54.3 (C-10), 61.9 (OCH2CH3), 67.2 (C-
8), 75.6 (C-2), 79.1 (C-2), 85.1, 85.5 (C-1 and C-3), 150.1 (C-5), 170.1 (C02C2H5); 
mlz (El): 353 (M+), 194 (100%); Anal. calcd for C 10H 12N051: C, 34.01; H, 3.43; N, 
3.97. Found: C, 34.19; H, 3.50; N, 3.81. 
Prevost Reaction: 
A mixture of AcOAg (620 mg, 3.6 mmol) and iodine (450 mg, 1,77mmol) in glacial 
acetic acid(lO cm3) was stirred at room temperature until all the iodine was consumed. 
At this point, the bicyclic alkene 2 (500 mg, 1.77 mmol) in CH3COOH (5 cm3) was 
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added. The reaction mixture was heated at 60°C for 30 minutes before a mixture of 
CH3COOH/H20 (50:1, 5 cm3) was added. The reaction mixture was then heated at 
80°C for 5 hours. The reaction was quenched with sat. NaHC03 (15 cm3) and the 
yellow precipitate of Agl was filtered off. The filtrate was extracted with AcOEt (10 
cm
3 
x 3), dried (MgS04) and concentrated under reduced pressure. The resulting 
residue was purified by flash chromatography eluting with (CH3CH2)20/Petroleum 
ether (6:4) to give tricyclic carbamide 215 as a white solid (470 mg, 76%). 
0 p::rco,Et 
OYNH 
0 
216 
Ethyl 5-oxo-4,9-dioxa-6-azatricyclo3,3,1,11'8]decane-exo-10-carboxylate 216: 
To a solution of the tticyclic iodocarbamide 215 (500 mg, 1.42 mmol) in benzene was 
added (Me3Si)3SiH (525 mg, 2.12 mmol) and ATBN (20 mg, 0.014mmol) at 60°C. 
The reaction mixture was stirred and monitored by TLC (48 hours) and then quenched 
with water (50 cm\ The solution was then extracted with ethyl acetate (50 cm3 x 3). 
The organic layers were combined, dried (MgS04) and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography eluting with 
ethyl acetate/petroleum ether (7: 1) to give tricyclic carbamide 216 (150 mg, 46%) as a 
white solid; mp 156-158°C; 8H (500 MHz, CDCb): 1.29 (3H, t, J = 7.5 Hz, 
OCH2CH3), 1.74 (lH, dd, J = 14.1 and 3.4 Hz, H-2), 2.53 (1H, m, H-2), 2.68 (1H, d, J 
= 2.5 Hz, H-10), 4.21 (2H, q, J = 7.5 Hz, OCfuCH3), 4.38 (lH, m, H-7), 4.54 (lH, t, J 
= 4.5 Hz, H-8), 4.87 (2H, m, H-1 and 3), 6.30 (lH, br, NH); 8c (125 MHz, CDCh): 
14.1 (OCH2CH3), 37.6 (C-2), 53.5 (C-7), 57.6 (C-10), 61.7 (OCH2CH3), 68.0 (C-8), 
75.7 and 79.2 (C-1 and 3), 150.5 (NC02), 170.6 (C02C2H5); mlz (El): 227 (M+), 115 
(100%); Anal. calcd. For C 10H 13N05: C, 52.86; H, 5.77; N, 6.16. Found: C, 52.66; H, 
5.84; N, 6.05. 
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OAc 
217 
Ethyl anti-anti-anti-3,4-diacetoxy-2-tert-butyicarbonylaminocyclohexane-1-
carboxylate 217: 
To a solution of epoxide 186 (100 mg, 0.29 mmol) in ethanol (10 cm3) was added 
10% Pd/C (20 mg) and the suspension was stirred under hydrogen for 48 h. The 
suspension was then filtered and the filtrate was concentrated under reduced pressure. 
The residue was dissolved in pyridine (2.5 cm3) and treated with Ac20 (2.5 cm\ 
After stirring for 24 h, 1 M HCl (10 cm3) was added and the layers were separated. 
The organic layer was dried (MgS04), concentrated under pressure and subjected to 
column chromatography eluting with petroleum ether/ethyl acetate (7:3) to give 217 
as a colourless gum (98 mg, 99%); Vmax (KBr disk): 3319, 2979, 1732, 1692, 1543 cm· 
1
; oH (500 MHz, CDCl3): 1.23 (3H, t, J = 7.0 Hz, OCHzCfu), 1.37 (9H, s, OC(CH3)3), 
1.70 ( LH, m, H-6), 1.94 (lH, m, H-6), 2.00 (3H, s, CH3CO), 2.02 (3H, s, CH3CO), 
2.14 (2H, m, HH-5), 2.47 (1H, dt, J = 9.0 and 3.0 Hz, H-1), 3.88 (lH, m, H-2), 4.13 
(2H, q, J = 7.0 Hz, OCfuCH3), 4.88 (lH, d, J = 9.5 Hz, H-3), 4.98 (1H, m, H-4); oc 
(125 MHz, CDCb): 14.3 (OCH2CH3), 20.9 and 21.2 (2 x CH3CO), 24.9 (C-6), 28.4 
(OC(CH3)3), 28.8 (C-5), 48.5 (C-1), 54.1 (C-2), 61.3 (OCH2CH3), 72.6 (C-3), 75.0 (C-
4), 79.9 (OC(CH3)3), 155.0 (NC02), 170.3, 171.0, 172.2 (C02 and 2 x CH3CO); m/z 
(Cl): 405 (MNH/, 71 %), 388 (MH+, 36%), 349 (100%). 
~~C02Et 
Aco~''INHBoc 
OAc 
218 
Ethy I anti-anti-syn -3,4-diacetoxy-2-tert-butylcarbony laminocyclohexane-1-
carboxylate 218: 
To a solution of epoxide 184 (100 mg, 0.33 mmol) in ethanol (10 cm3) was added 
Pd/C (20 mg) under a hydrogen atmosphere and the mixture was stirred for 48 h. The 
solvent was then removed under reduced pressure and the residue was dissolved in 
pyridine (2.5 cm3) and treated with Ac20 (2.5 cm\ After stirring for 24 h, 2 M HCl 
(10 cm3) was added to the reaction mixture and the layers were separated. The organic 
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layer was dried (MgS04), concentrated under reduced pressure and subjected to 
column chromatography eluting with petroleum ether/ethyl acetate (7:3) to give 218 
as a white gum (107 mg, 84%); Vmax (KBr disk): 3385, 2975, 1737, 1525 cm-1; bH (500 
MHz, CDCh): 1.25 (3H, t, J = 7.2 Hz, OCH2Cfu), 1.39 (9H, s, OC(CH3)3), 1.64 (lH, 
m, H-5), 1.81 (lH, m, H-6), 1.95 (2H, m, H-5 and 6), 2.01 (3H, s, CH3CO), 2.13 (3H, 
s, CH3CO), 2.51 (lH, t, J = 11.5 Hz, H-1), 4.16 (3H, m, OCfuCH3 and H-2), 4.45 
(lH, d, J = 9.5 Hz, NH), 4.86 (lH, dd, J = 11.5 and 2.5 Hz, H-3), 5.32 (1H, br, H-4); 
be (125 MHz, CDCh) 14.4 (OCHzCH3), 21.0 (CH3CO), 21.5 (CH3CO), 23.1 (C-6), 
27.8 (C-5), 28.5 (OC(CH3)3), 48.8 (C-1), 50.7 (C-2), 61.2 (OCH2CH3), 69.4 (C-4), 
73.3 (C-3), 79.7 (OC(CH3)3), 155.1 (NC02), 170.6, 171.0, 172.8 (carbonyls); mlz 
(Cl): 388 (MH+, 100%). 
"C02 Et 
HO~NHBoc 
OAc 
226 
Ethyl syn -syn-syn -3-acetoxy-2-tert-butylcarbonylamino-4-hyd roxycyclohexane-1-
carboxylate 226: 
To a solution of epoxide 196 (R = Ac) (100 mg, 0.29 mmol) in ethanol (10 cm3) was 
added 10% Pd/C (20 mg) and the suspension was stirred under hydrogen for 48 h. The 
suspension was then filtered and the filtrate was concentrated under reduced pressure 
to give 226 as a colourless gum (97 mg, 97%) Vmax (KBr disk): 3438, 3374, 2975, 
1729, 1699, 1513 cm-1; bH (500 MHz, CDC13): 1.23 (3H, t, J = 7.0 Hz, OCH2Cfu), 
1.40 (9H, s, OC(CH3)3), 1.57 (lH, m, H-5), 1.63 (lH, m, H-6), 2.02 (2H, m, H-5 and 
6), 2.07 (3H, s, CH3CO), 2.60 (lH, m, J = 11.5 and 3.5 Hz, H-1), 4.07 (2H, m, H-4 
and OH), 4.13 (2H, q, J = 7.0 Hz, OCfuCH3), 4.52 (lH, br, H-2), 4.85 (lH, m, H-3), 
5.72 (lH, br, NH); be (125 MHz, CDCh): 14.3 (OCH2CH3), 17.4 (C-6), 21.2 
~H3CO), 28.5 (OC~H3)3), 28.9 (C-5), 44.4 (C-1), 50.0 (C-2), 61.0 (OCH2CH3), 
68.9 (C-4), 72.6 (C-3), 79.4 (OC(CH3)3), 155.9 (NC02), 170.2 (C02), 172.3 
(CH3CO); m/z (ES+): 368 (MNa+). 
General procedure for PdCh catalysed transfer hydrogenation 
To a solution of substrate (1.0 equivalent) was added an organic acid (3.0 equivalent), 
PdCh (0.1 equivalent) and zinc (3.0 equivalent). The reaction mixture was stirred for 
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16 h and then filtered. The filtrate was concentrated under reduced pressure to give 
the product. 
3-phenylpropanoic acid 238: 
Using the general procedure for PdCh catalysed transfer hydrogenation, cinnamic 
acid (250 mg, 1.69 mmol) was reduced in the presence of acetic acid (0.29 cm3, 5.07 
mmol) to give 238 as a white solid (213 mg, 84%); Vmax (KBr): 3029-2290 (br), 1697, 
1415 cm-1; 8H (400 MHz, CDCI3): 2.61 (2H, t, J = 8.4, HH-3), 2.89 (2H, t, J = 8.4 Hz, 
H-2), 7.15 (5H, m, PhH); 8c (100 MHz, CDCh): 30.8 (C-3), 35.9 (C-2), 126 (C-4), 
128.5 (C-2 and 6), 128.8 (C-3 and 5), 140.4 (C-1), 179.6 (C02H); m/z (ES-): 150 (M-) 
HO 
2-rnethoxy-4-propylphenol: 
OMe 
240 
Using the general procedure for PdCh catalysed transfer hydrogenation, eugenol (430 
mg, 2.82 rnmol) was reduced in the presence of acetic acid (0.48 cm3, 8.46 mmol) to 
give 240 as a yellow oil (459 mg, 98%); Vmax (KBr disk): 3450, 2959, 1607, 1516 cm-
1; 8H (400 MHz, CDCh): 0.95 (3H, t, J = 7.6 Hz, CfuCH2CH2), 1.63 (3H, m, 
CH3CfuCH2), 2.53 (2H, t, J = 7.6 Hz, CH3CH2Cfu), 3.87 (3H, s, OCH3), 5.55 (lH, s, 
OH), 6.70 (2H, m, H-3 and H-6), 6.85 (1H, d, J = 7.2 Hz, H-5); 8c (lOO MHz, 
CDCh): 14.1 (CH3CH2CH2), 25.1 (CH3CH2CH2), 38.0 (CH3CH2CH2), 56.1 (OCH3), 
111.3 (C-3), 114.3 (C-5), 121.2 (C-6), 134.9 (C-4), 143.7 (C-2), 146.5 (C-1); m/z 
(El+): 166 (M+, 43 %), 137 (100 %). 
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6.1 APPENDIX 1 
XaRAY DATA FOR OXANORBORNENE ADDUCT 2 
129 
I ( 
N 
0 
X-ray structure of oxanorbomene adduct 2 
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Table I. Crystal data and structure refinement for 03RMDO 19. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta= 27.49° 
Absorption correction 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on p2 
Final R indices [1>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
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03rrnd0 I 9 
Ct4 H21 NOs 
283.32 
120(2) K 
0.710731\ 
Monoclinic 
P2( I )In 
a= 8.5458(2) A 
b = 11.2435(2) A. 
c = 15.3706(3) A 
1468.51(5) f\3 
4 
1.281 Mglm3 
0.097 mm· 1 
608 
0.32 x 0.24 x 0.18 mm3 
2.25 to 27 .49a. 
~= 96.1040(10) 0 • 
y = 90°. 
-ll<=h<=lO, -14<=k<=14, -19<=1<=19 
14755 
3367 [R(int) = 0.02721 
99.9% 
None 
Full-matrix least-squares on F2 
3367101265 
1.056 
RI = 0.0402, wR2 = 0.1050 
RI= 0.0439, wR2 = 0.1072 
0.410 and -0.284 e.t\-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103) 
for 03RMD019. U(eq) is defined as one third of the trace of the onhogonalized Uii tensor. 
X y z U(eq) 
N(1) -803(1) 3909(1) 2016(1) 21(1) 
0(1) -442(1) 3119(1) 4483( I) 37( I) 
C(8) -2167(2) 4290(2) 5543(1) 40(1) 
C(13) 1968(2) 6500(1) 539(1) 31 (I) 
0(2) -2695(1) 4077( 1) 4616(1) 33(1) 
C(12) 2674(2) 4385( I) 267( I) 31( I) 
0(4) 805(1) 4990(1) 1296( I) 21(1) 
C(5) -3415(2) 2088( I) 1652(1) 25(1) 
0(5) -2399(1) 1275( I) 2969(1) 20(1) 
C(7) -1699(1) 3481(1) 4168(1) 22(1) 
0(3) 1638(1) 3190(1) 1863( I) 26(1) 
C(ll) 2308(1) 5287( I) 952(1) 21 (I) 
C(l4) 3611(2) 5396( I) 1700(1) 27( I) 
C(2) -2389(1) 3318(1) 3226(1) 19(1) 
CO) -3507(1) 2206(1) 3117(1) 20(1) 
C(6) -4431(1) 2323(1) 2224( I) 24( I) 
C(lO) 650(1) 3964(1) 1736( I) 19(1) 
C(4) -1871(1) 1806(1) 2191(1) 21( l) 
C(3) -1147(1) 2973( I) 2613(1) 18( l) 
C(9) -3176(3) 5220(2) 5854( I) 61( I) 
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Table 3. Bond lengths [A] and angles [0 ] for 03RMD0!9. 
N(l)-C(10) 1.3572(14) C(l)-0(5)-C(4) 95.61(8) 
N(I)-C(3) 1.4479(14) 0(1 )-C(?)-0(2) 123.73(1 1) 
0(1)-C(7) 1.2013(15) 0( I )-C(7)-C(2) 125.81(11) 
C(8)-C(9) 1.467(2) 0(2)-C(7)-C(2) 1 10.46(10) 
C(8)-0(2) 1.4677(16) 0(4)-C(l 1)-C(l2) I 10.39(9) 
C(l3)-C( 11) 1.5197(17) 0(4)-C(l1)-C(l4) 110.03(9) 
0(2)-C(7) 1.3312(15) C(12)-C(l 1)-C(14) 1 12.98(1 I) 
C(I2)-C(11) l.5 I 77(17) 0( 4 )-COl)-C(l3) 102.55(9) 
0(4)-C(10) 1.3505(13) C(l2)-C(l I )-C(l3) 110.77( 11) 
0(4)-C(l1) 1.4788(12) C(l4)-C(ll)-C(l3) 109.62(11) 
C(5)-C(6) 1.3270( 18) C(7)-C(2)-C(3) 113.00(9) 
C(5)-C(4) 1.5161(17) C(7)-C(2)-C( I) 111.61(9) 
0(5)-C(l) 1.4454( 13) C(3)-C(2)-C( 1) 100.60(9) 
0(5)-C(4) 1.4503(13) 0(5)-C(l)-C(6) 102.00(9) 
C(7)-C(2) 1.5154(16) 0(5)-C( I )-C(2) 101.10(8) 
0(3)-C(IO) 1.2143(14) C(6)-C(l )-C(2) 106.26(9) 
C(l1)-C(l4) 1.5179(17) C(5)-C(6)-C( 1) 105.59(10) 
C(2)-C(3) 1.5427(15) 0(3)-C( 10)-0(4) 126.10(10) 
C(2)-C(1) 1.5722(15) 0(3)-C(lO)-N(l) 124.11(10) 
C(l)-C(6) 1.5 138( 16) 0(4)-C(l 0)-N(l) 109.79(9) 
C(4)-C(3) 1.5614(16) 0(5)-C(4)-C(5) 101.99(9) 
0(5)-C(4)-C(3) 98.54(8) 
CO 0)-N( I )-C(3) 119.17(10) C(5)-C(4)-C(3) 109.57(9) 
C(9)-C(8)-0(2) 107.58(14) N(l )-C(3)-C(2) 113.79(9) 
C(7)-0(2)-C(8) 115.90(11) N(l)-C(3)-C(4) !16.49(9) 
C(10)-0(4)-C(Il) 120.49(9) C(2)-C(3)-C(4) 101.36(8) 
C( G)-C(5)-C( 4) 105.75(10) 
Symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacemem parameters (A2x 1Q3) for 03RMD019. The anisotropic 
displacement factor exponent takes the form: -2:rr2[ h2 a* 2U11 + ... + 2 h k a* b* U12 J 
U" U22 U33 U23 uu u12 
N(l) 18(1) 18(1) 27(1) 6(1) 6(1) 2(1) 
0(1) 27(1) 54(1) 27(1) -3(1) -3(1) 7(1) 
C(8) 53(1) 42(1) 24(1) -7(1) 2(1) 6(1) 
C(l3) 26(1) 31( I) 38(1) 11(1) 9(1) -4( I) 
0(2) 37(1) 37(1) 23(1) -5(1) 4(1) 12(1) 
C(l2) 30(1) 36(1) 29(1) -9(1) 12(1) -8(1) 
0(4) 17(1) 20(1) 26(1) 5(1) 7(1) -1 (I) 
C(5) 27(1) 24(1) 22(1) 2(1) -2(1) -4(1) 
0(5) 21(1) 17(1) 24(1) 4(1) 5(1) 0(1) 
C(7) 24( I) 19( I) 24( I) 0(1) 5(1) -2(1) 
0(3) 21{1) 23(1) 37(1) 5(1) 9(1) 4(1) 
C(ll) 17(1) 24(1) 24(1) 0(1) 7(1) -5( I) 
C(l4) 22(1) 28(1) 31 (I) -2(1) I (I) -6( I) 
C(2) 18(1) 17(1) 21( I) 2(1) 3(1) I ( 1) 
C(l) 16( I) 20( I) 24(1) 3(1) 4(1) 0(1) 
C(6) 20(1) 23( 1) 29(1) 3(1) -2(1) -2(1) 
C(IO) 19( I) 18(1) 20( I) -1 (I) 3(1) -2(1) 
C(4) 23(1) 19( I) 22(1) 2(1) 6(1) 0( I) 
CO) 17(1) 17(1) 21(1) 3( I) 4( I) I (I) 
C(9) 98(2) 53(1) 31( I) -10(1) 5(1) 27(1) 
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Table 5. Hydrogen coordinates (X 104) and isotropic displacement parameters cA2x 10 3) 
for 03RMD019. 
X 
H(8B) -990(30) 
H(8A) -2280(20) 
I-I(13C) 1090(20) 
H(l3B) 1710(20) 
H(l3A) 2930(20) 
H(12C) 1770(20) 
H(l213) 2920(20) 
H(12A) 3580(20) 
H(5) -3562(19) 
H(14C) 3850(20) 
H(14B) 4520(20) 
H(14A) 3326( 19) 
H(2) -2983( 17) 
H(l) -4070(16) 
H(6) -55! 0(20) 
H(4) -1114(18) 
H(3) -177(16) 
H(9C) -2800(20) 
H(9B) -4220(40) 
H(9A) -3260(30) 
H(1N) -1370(19) 
Table 6. Torsion angles [0 ] for 03RNID019. 
C(9)-C(8)-0(2)-C(7) 
C(8)-0(2)-C(7)-0( 1) 
C(8)-0(2)-C(7)-C(2) 
y 
4550(20) 
3548(19) 
6466(16) 
7091(16) 
6782(15) 
4279(16) 
3616(18) 
4660(16) 
2124(15) 
4651(17) 
5679(15) 
5997( 15) 
4028(13) 
2039(12) 
2581(14) 
1290(14) 
2761(12) 
5420(19) 
4910(30) 
5910(30) 
4543(15) 
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z 
5597(15) 
5832(13) 
82(12) 
995(12) 
299(11) 
-179(12) 
526(12) 
-21(11) 
1037(11) 
1990( 11) 
1467(10) 
2143(11) 
3036(9) 
3610(9) 
2117(10) 
1945(10) 
2970(9) 
6460(14) 
5810(20) 
5470(20) 
1987( 10) 
164.31(16) 
0.45( 19) 
179.74(11) 
U(eq) 
80(7) 
54(5) 
43(5) 
43(5) 
38(4) 
45(5) 
46(5) 
40(4) 
36(4) 
42(5) 
34(4) 
33(4) 
21(3) 
18(3) 
31(4) 
26(4) 
16(3) 
59(6) 
101(10) 
100(9) 
29(4) 
C( 1 0)-0( 4 )-C( I 1 )-C( 12) 
C( 10)-0(4)-C( 11)-C( 14) 
C(10)-0(4)-C(l1)-C(13) 
0( 1)-C(7)-C(2)-C(3) 
0(2)-C(7)-C(2)-C(3) 
0( 1 )-C(7)-C(2)-C( 1) 
0(2)-C(7)-C(2)-C( 1) 
C(4)-0(5)-C( 1 )-C(6) 
C(4)-0(5)-C( 1)-C(2) 
C(7)-C(2)-C( 1 )-0(5) 
C(3)-C(2)-C( 1 )-0(5) 
C(7)-C(2)-C( 1 )-C(6) 
C(3 )-C(2)-C( 1 )-C( 6) 
C(4)-C(5)-C(6)-C( 1) 
0(5)-C( I )-C( 6)-C(5) 
C(2)-C( 1 )-C(6)-C(5) 
C( 11 )-0( 4 )-C( 1 0)-0(3) 
C(l1 )-0( 4 )-C(l 0)-N ( 1) 
C(3)-N( 1 )-C( 1 0)-0(3) 
C(3 )-N(l )-C(l 0)-0( 4) 
C( 1 )-0(5)-C( 4 )-C(5) 
C( 1 )-0(5)-C( 4 )-C(3) 
C(6)-C(5)-C( 4 )-0(5) 
C( 6)-C(5)-C( 4 )-C(3) 
C(lO)-N(l )-C(3)-C(2) 
C(lO)-N(l )-C(3)-C(4) 
C(7)-C(2)-C(3)-N(l) 
C(1)-C(2)-C(3)-N(l) 
C(7)-C(2)-C(3)-C( 4) 
C(l )-C(2)-C(3)-C( 4) 
0(5)-C( 4)-C(3)-N(l) 
C(5)-C( 4 )-C(3)-N( 1) 
0(5)-C( 4 )-C(3)-C(2) 
C(5)-C( 4 )-C(3)-C(2) 
Symmetry transformations used to generate equivalent atoms: 
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63.40(13) 
-61.97(13) 
-178.55(10) 
-17.54(17) 
163.18(10) 
94.99(14) 
-84.28(11) 
50.10(9) 
-59.38(9) 
-88.23(10) 
31.90(10) 
165.64(9) 
-74.24(10) 
0.89(13) 
-33.03(12) 
72.46(12) 
-3.00( 17) 
177.65(9) 
9.81(17) 
-170.82(9) 
-49.49( 10) 
62.74(9) 
3 1.36( 12) 
-72.33(12) 
150.80(10) 
-91.80(13) 
-109.15(11) 
131.74(10) 
125.00(10) 
5.88(10) 
-165.77(9) 
-59.73(12) 
-41.72(10) 
64.32(11) 
6.2 APPENDIX 2 
CHIRAL HPLC CHROMATOGRAM 
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Current Chromatogram(s) __ ---·---
1 
DAD1 C, Sig=215,4 Ref=550,100 (HPTEST'iiPTEST13.D) 
DAD1 C, Sig=215.4 Ref=550,100 (HPTEST'iiPTEST15 D) 
Norm 
400 ' 
Prep Method 
Heptane : EtOH 
350 95 : 5 
f=20ml/min 
300 · Column 2cm x 25cm Chiralpak AD 
No.ADOOCJ-JA001 
250 ~ 
200 -
R4012-70-1 
484mg 
150 -
100 
50-
0 1 
-----~2 4 6 
Chiral HPLC chromatogram 
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R4012-7 
777mg 
I 
! I 
·V 
I 
\ 
8 j _O _ 12 14 
6.3 APPENDIX 3 
XaRAY DATA FOR CHLOROHYDRIN 189 
139 
• 
X-ray structure of chlorohydrin 189 
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Table l. Crystal data and structure refinement for 02srv008. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
8 range for data collection 
Index ranges 
Reflections collected 
T ndcpendent reflections 
Reflections with 1>2a(I) 
Completeness to 8 = 29.00° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data I restraints I parameters 
Largest final shift/e.s.d. ratio 
Goodness-of-fit on r 
Final R indices [l>2a(I)l 
R indices (all data) 
Largest diff. peak and hole 
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fiei.-l:fa(;(str 101 
C16 H24 Cl N 07 
377.81 
120(2) K 
o.7to73 A 
Monoclinic 
P211c (No. 14) 
a= 9.927(1) A 
h=S.811(1)A 
c = 22.579(3) A 
1963.6(4) A3 
4 
1.278 g/cm3 
0.229 mm· 1 
800 
0.38 x 0.11 x 0.09 mm3 
1.81 to 29.000. 
B= 96.14(1) 0 
y= 90° 
-13S hS 1L-12S kS 12.-29-<: lS 30 
17291 
5173 [R(int) = 0.0408] 
3731 
99.3% 
Integration 
0.9843 and 0.9380 
Full-matrix least-squares on F2 
5173 I Of 322 
0.001 
1.024 
R1 = 0.0372. wR2 = 0.0784 
R1 = 0.0642, wR2 = 0.0895 
0.317 and -0.232 e.A-3 
Table 2. Atomic coordinates ( xl04) and equivalent isotropic displacement parameters (A2 x104) 
for 02srv008. U(cq) is defined as one third of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
Cl 2589.0(4) 4612.1(5) 3163.1(2) 280(1) 
0(1) 4429(1) 6939(1) 5178.2(4) 190(2) 
0(2) 3477(1) 9237(1) 5280.8(6) 412(3) 
0(3) 4113(1) 7215(1) 3940.9(5) 224(2) 
0(4) -129(1) 2345(1) 4815.3(5) 266(2) 
0(5) 1604(1) 2345(1) 5543.7(5) 239(2) 
0(6) 3678( 1) 4358(1) 6391.8(5) 255(2) 
0(7) 1918(1) 5778(1) 6661.0(4) 248(2) 
N 2169(1) 5553( l) 5708.3(5) 187(2) 
C(l) 1689(1) 4122(2) 4776.4(6) 179(3) 
C(2) 1453(2) 4338(2) 4188.9(6) 200(3) 
C(3) 2223(2) 5463(2) 3857.0(6) 202(3) 
C(4) 3545(2) 5956(2) 4212.4(6) 176(3) 
C(5) 3215(1) 6390(2) 4836.1(6) 170(3) 
C(6) 2724(2) 5025(2) 5173.9(6) 169(3) 
C(7) 4410(2) 8387(2) 5392.0(7) 245(3) 
C(8) 5689(2) 8714(2) 5784.6(10) 389(4) 
C(9) 942(2) 2859(2) 5041.2(7) 200(3) 
C(IO) 1008(2) 1025(2) 5813.9(8) 313(4) 
C(l1) 1883(3) 685(2) 6384.5(9) 454(5) 
C(l2) 2684(2) 5157(2) 6264.2(6) 194(3) 
C(13) 2393(2) 5771(2) 7304.1(6) 269(3) 
C(l4) 2467(3) 4157(2) 7541.9(9) 415(5) 
C(15) 3728(2) 6618(3) 7407.7(9) 440(5) 
C(16) 1264(2) 6635(2) 7562.8(8) 351(4) 
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Table 3. Selected bond lengths [A] and angles [0 ] for 02srv008. 
Cl-C(3) 1.8084(15) C(1)-C(2) 1.336(2) 
0( I)-C(7) 1.3649(1 7) C(I)-C(9) 1.497(2) 
0( I)-C(5) 1.4439(17) C(l)-C(6) 1.515(2) 
0(2)-C(7) 1.1967(19) C(2)-C(3) 1.500(2) 
0(3)-C(4) 1.4139(17) C(3)-C(4) 1.527(2) 
0(4}-C(9) 1.2157(18) C(4)-C(5) 1.5281(19) 
0(5)-C(9) 1.3284(18) C(5)-C(6) 1.5315( 19) 
0(5)-C(lO) 1.4672(18) C(7)-C(8) 1.497(2) 
0(6)-C( 12) 1.2212(18) C(10)-C(11) 1.505(3) 
0(7)-C(l2) 1.3515(17) C(13)-C(I5) 1.517(3) 
0(7)-C(13) 1.4780(18) C(I3)-C(14) 1.519(3) 
N-C(12) 1.3496(18) C(I3)-C(I6) 1.523(2) 
N-C(6) 1.4552(18) 
C(7)-0( 1)-C(5) 1 17.39(11) N-C(6)-C(5) 109.31(11) 
C(9)-0(5)-C( I 0) 1 16.15(12) C( 1 )-C( 6)-C(5) 110.43(1 I) 
C( 12)-0(7)-C( 13) 120.42(12) 0(2)-C(7 )-0( 1) 123.41( 14) 
C(I2)-N-C(6) 123.32(12) 0(2)-C(7)-C(8) 126.30(15) 
C(2)-C( I )-C(9) 117.43(13) 0( I )-C(7)-C(8) 110.28(14) 
C(2)-C( I)-C(6) 123.30(13) 0(4)-C(9)-0(5) 124.19(13) 
C(9)-C( l)-C(6) 119.17(12) 0( 4 )-C(9)-C( I) 123.88(14) 
C( I )-C(2)-C(3) 123.08(13) 0(5)-C(9)-C( I) 111.91(12) 
C(2)-C(3)-C(4) 112.37(12) 0(5)-C( 1 0)-C( 11) 107.00(15) 
C(2)-C(3)-Cl 108.63(10) 0(6)-C( 12)-N 125.77(14) 
C( 4 )-C(3 )-Cl 109.40(10) 0(6)-C( 12)-0(7) 125.10(13) 
0(3)-C( 4 )-C(3) 110.87(12) N-C( 12)-0(7) 109. 13( 12) 
0(3)-C( 4 )-C(5) 109.76(11) 0(7)-C( 13 )-C( 15) 109.33(14) 
C(3)-C(4)-C(5) 107.37(12) 0(7)-C(13)-C(14) 110.47(13) 
0(1 )-C(5)-C(4) 109.14(11) C(15)-C( 13)-C(l4) 113.43(17) 
0( I)-C(5)-C(6) 106.77(11) 0(7)-C(l3)-C(I6) 101.77(13) 
C(4)-C(5)-C(6) 111.93(11) C(l5)-C( 13)-C( 16) 111.23(15) 
N-C(6)-C(l) 111.49(12} C(14)-C(l3)-C(l6) 109.99(15) 
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Table 4. Anisotropic displacement parameters (f\2 x104) for 02srv008. The anisotropic 
displacement factor exponent takes the form: -2n2[ h2 a*2U11 + ... + 2 h k a* b* U12 ] 
U11 U22 u33 U2J Un ul2 
Cl 349(2) 336(2) 156(2) -41(2) 29( I) -23(2) 
0(1) 207(5) 164(5) 192(5) -11(4) -13(4) -7(4) 
0(2) 343(7) 263(6) 605(9) -158(6) -63(6) 65(5) 
0(3) 253(6) 204(5) 225(5) 37(4) 76(5) 0(5) 
0(4) 209(5) 210(5) 370(6) 20(5) -12(5) -21(4) 
0(5) 293(6) 205(5) 216(5) 41(4) 9(4) -44(4) 
0(6) 247(6) 319(6) 194(5) -4(4) -2(4) 61(5) 
0(7) 270(6) 329(6) 148(5) -16( 4) 36(4) 54(5) 
N 195(6) 216(6) 151 (6) 3(5) 25(5) 44(5) 
C(l) 164(7) 166(6) 207(7) -8(5) 23(5) 18(5) 
C(2) 175(7) 223(7) 196(7) -22(6) -8(6) -1(6) 
C(3) 231(7) 230(7) 144(6) 3(6) 13(5) 33(6) 
C(4) 199(7) 166(6) 163(7) 17(5) 15(5) 8(6) 
C(5) 171(7) 175(6) 160(6) -9(5) 1(5) 4(6) 
C(6) 180(7) 190(7) 139(6) 0(5) 20(5) 17(5) 
C(7) 289(8) 193(7) 249(8) -38(6) 14(6) -10(6) 
C(8) 422(11) 267(9) 439(11) -99(8) -133(9) -39(8) 
C(9) 203(7) 164(7) 239(7) -8(5) 51(6) 27(6) 
C(10) 387(10) 206(8) 356(9) 72(7) 79(8) -31 (7) 
C(11) 737(17) 321(10) 298(10) 100(8) 25(10) -57(10) 
C(12) 201(7) 210(7) 172(7) -22(5) 27(6) -26(6) 
C(l3) 337(9) 333(9) 135(7) -45(6) 15(6) 1(7) 
C(14) 616(14) 423( 11) 216(9) 55(8) 92(9) 104(10) 
C(l5) 370(11) 624(14) 327(10) -209(10) 38(8) -76(10) 
C(I6) 424(11) 40 I (I 0) 244(9) -89(8) 109(8) -6(9) 
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Table 5. Hydrogen coordinates ( xl03) and isotropic displacement parameters (A2 x 103) for 02srv008. 
X y z U(iso) 
H(03) 481 (2) 690(2) 383.2(9) 38(6) 
H(lN) 151(2) 617(2) 567.1(8) 32(5) 
H(2) 83(2) 376(2) 395.5(7) 24(4) 
H(3) 167(2) 634(2) 375.1(7) 17(4) 
H(4) 416(2) 510(2) 424.3(6) 11(4) 
H(5) 254(2) 718(2) 481.4(6) 11(4) 
H(6) 347(2) 438(2) 529.6(7) 14(4) 
H(81) 573(2) 976(2) 589.2(9) 43(6) 
H(82) 645(3) 852(3) 557.2(11) 65(8) 
H(83) 575(3) 804(3) 614.6(12) 80(8) 
H(l01) 99(2) 20(2) 552.3(8) 31(5) 
H(l02) 7(2) 132(2) '585.6(8) 36(5) 
H(lll) 286(3) 48(3) 631.3(12) 81(9) 
H(ll2) 149(2) -19(3) 655.0(10) 52(6) 
H(113) 185(2) 149(3) 666.0( 11) 65(7) 
H(141) 155(2) 364(3) 741.9(10) 56(7) 
H(142) 258(2) 417(3) 796.2( 12) 69(7) 
H(143) 323(2) 361 (3) 739.9(10) 53(6) 
H(151) 444(2) 604(2) 726.8(9) 45(6) 
H(l52) 398(2) 680(3) 782.5( 11) 62(7) 
H(153) 364(2) 766(3) 721.1( 11) 72(8) 
H(l61) 121 (2) 769(3) 741.6(9) 46(6) 
H(162) 148(2) 671(2) 800.4(9) 43(5) 
H(l63) 41(2) 611(3) 748.2(10) 52(6) 
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Table 6. Torsion angles [0 ] for 02sn•008. 
C(9)-C( 1)-C(2)-C(3) -174.18(13) 0(1)-C{5)-C(6)-N 72.10(14) 
C(6)-C( I )-C(2)-C(3) 2.2(2) C(4)-C(5)-C(6)-N -168.54(11) 
C(I)-C(2)-C(3)-C(4) 17.6(2) 0( 1)-C(5)-C(6)-C( I) -164.90(11) 
C( I )-C(2)-C(3)-CI 138.74(13) C(4)-C(5)-C(6)-C( I) -45.54( 16) 
C(2)-C(3)-C(4 )-0(3) -168.84(12) C(5)-0( I )-C(7)-0(2) -4.5(2) 
CI-C(3)-C(4)-0(3) 70.41(13) C(5)-0( I)-C(7)-C(8) 174.33(14) 
C(2)-C(3 )-C( 4)-C(5) -48.95(15) C( I 0)-0(5)-C(9)-0( 4) 3.2(2) 
Cl-C(3 )-C( 4 )-C(5) -169.69(9) C(l 0)-0(5)-C(9)-C( I) -1 75.35(13) 
C(7)-0(1 )-C(5)-C(4) 120.16(13) C(2)-C( 1 )-C{9)-0(4) -24.0(2) 
C(7)-0( l)-C(5)-C(6) -118.68(13) C( 6 )-C( l )-C(9)-0( 4) 159.46(14) 
0(3)-C(4)-C{5)-0( l) -56.49(14) C(2)-C( I )-C(9)-0(5) 154.46(13) 
C(3)-C(4)-C(5)-0( 1) -177.09(11) C(6)-C( I )-C(9)-0(5) -22.03(17) 
0(3)-C( 4)-C{5)-C(6) -17 4.46(12) C(9)-0(5)-C(l 0)-C(ll) -177.70(15) 
C(3)-C( 4 )-C(5)-C( 6) 64.95(15) C(6)-N-C( 12)-0(6) 2.0(2) 
C( 12)-N-C(6)-C( I) 119.19(15) C(6)-N-C( 12)-0(7) -177.58(12) 
C(I2)-N-C(6)-C(5) -118.44(14) cc 13)-0(7)-C( 12)-0(6) 12.0(2) 
C(2)-C{l)-C(6)-N 133.47(14) C( 13)-0(7)-C( 12)-N -168.48(12) 
C(9)-C( 1)-C(6)-N -50.25( 17) C( 12)-0(7)-C( 13)-C( 15) 59.71(19) 
C(2)-C( 1)-C(6)-C(5) I 1.75(19) C(I2)-0(7)-C( 13)-C( 14) -65.80(19) 
C(9)-C( 1)-C(6)-C(5) -171.97(12) C(l2)-0(7)-C(13)-C( 16) 177.43( 14) 
Table 7. Hydrogen bonds for 02srv008 [A and 0 ]. 
D-1-I...A d(D-H) d(H ... A) d(D ... A) <(DHA) 
0(3)-1-1(03) ... 0(6)# I 0.81(2) 1.97(2) 2.765(2) 166(2) 
N-H(lN) ... 0(4)#2 0.85(2) 2.11(2) 2.902(2) 154(2) 
Symmetry transformations used to generate equivalent atoms: # 1 -X+ 1.-y+ 1 ,-Z+ I #2 -x,-y+1,-z+1 
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6.4 APPENDIX 4 
XDRAY DATA FOR ACHC DERIVATIVE 198 
AcO,,,,,_(J···'''C02Et 
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X-ray structure of ACHC derivative 198 
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Table 1. Crystal data and structure refinement for 03rmd015. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Retlections collected 
Independent ret1ections 
Completeness to theta= 27 .so a 
Absorption correction 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(I)j 
R indices (all data) 
Largest diff. peak and hole 
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2,3-cistriol 
C17 H25 N 09 
387.38 
120(2) K 
0.71073 A 
Orthorhombic 
Pbca 
a= 19.3864(7) A 
b = 9.4800(4) A 
c = 21.6482(8) A 
3978.6(3) 'A3 
8 
1.293 Mgfm3 
0.105 mm·1 
1648 
0.44 x 0.36 x 0.24 mmJ 
1.88 to 27.50°. 
-25<=h<=25, -12<=k<=l2, -28<=1<=28 
41625 
4566 [R(int) = 0.0820] 
100.0% 
None 
Full-matrix least-squares on F2 
4566/ 0 I 344 
1.070 
Rl = 0.0498, wR2 = 0.1116 
RI= 0.0752, wR2 = 0.1267 
0.553 and -0.260 e.A-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (r\2x 103) 
for 03rmd015. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
0(4) 546(1) 4088(1) 1121(1) 25(1) 
0(1) 1594(1) 3920(2) 3234(1) 36(1) 
0(6) 1270(1) 2016(1) 466(1) 27(1) 
0(8) 2612( I) 2522(2) 922(1) 30(1) 
0(2) 2001(1) 5946(2) 2831(1) 34(1) 
N(l) 307(1) 3784(2) 2398(1) 22(1) 
0(7) 864(1) -153(2) 687(1) 41(1) 
C(2) 929( I) 3232(2) 2111 (I) 21(1) 
0(9) 2660( I) 3909(2) 74(1) 44( 1) 
0(3) -42(1) 1660(2) 2740(1) 43(1) 
CO) 1516(1) 4310(2) 2133(1) 22( I) 
C(3) 769(1) 2820(2) 1439(1) 22(1) 
C(4) 1411( I) 2258(2) 1115(1) 24(1) 
C(5) 2014(1) 3270(2) 1151(1) 25(1) 
C(IO) -153(1) 2930(2) 2671(1) 27(1) 
C(7) 1694(1) 4686(2) 2798(1) 25(!) 
C(6) 2164(1) 3691(2) 1819(1) 25(1) 
0(5) -542( I) 3251 (2) 1059(1) 59(1) 
C(l2) -134( I) 4186(2) 978(1) 33(1) 
C(14) 996( I) 747(2) 313(1) 30( I) 
C(16) 2863( I) 2903(2) 358(1) 30(1) 
C(l5) 873(1) 649(3) -371(1) 39(1) 
C(l1) -815(1) 36l3(3) 2881(1) 40(1) 
C(9) 2916(2) 5793(3) 3611(1) 49(1) 
C(S) 2228(1) 6394(3) 3449( I) 41( I) 
C(l3) -303(1) 5626(3) 741(1) 39(1) 
C(l7) 3400(1) 1881(3) 155(1) 41(1) 
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Table 3. Bond lengths [AJ and angles [0 ) for 03rmd0 15. 
0(4)-C(l2) 1.359(2) N(l )-C(2)-C(l) 111.30( 14) 
0(4)-C(3) 1.451(2) N(l )-C(2)-C(3) 109.21{14) 
0(1)-C(7) 1.208(2) C(l)-C(2)-C(3) 110.43(14) 
0(6)-C(I4) 1.356(2) C(7)-C( 1 )-C(2) 110.76(14) 
0(6)-C(4) 1.449(2) C(7)-C(l )-C(6) 108.70(14) 
0(8)-C(16) 1.363(2) C(2)-C( 1 )-C(6) 109.71(15) 
0(8)-C(5) 1.447(2) 0(4)-C(3)-C{4) 108.32(14) 
0(2)-C(7) 1.337(2) 0(4)-C(3)-C(2) 107.34(14) 
0(2)-C(S) 1.472(2) C(4)-C(J)-C(2) 111.10(14) 
N(l)-C(10) 1.341(2) 0(6)-C(4)-C(5) 107 .20(14) 
N( 1 )-C(2) 1.453(2) 0(6)-C(4)-C(3) 110.36(14) 
0(7)-C(l4) 1.204(2) C(5)-C(4)-C(3) 112.62(15) 
C(2)-C(l) 1.531(2) 0(8)-C(5)-C( 4) 106.88(15) 
C(2)-C(3) 1.538(2) 0(8)-C(5)-C(6) 107.48(14) 
0(9)-C(16) 1.201(2) C(4)-C(5)-C(6) 111.22(15) 
0(3)-C(IO) 1.232(2) 0(3)-C{IO)-N(l) 121.83(18) 
C(I)-C(7) 1.52 1(2) 0(3)-C(IO)-C(ll) 122.11(18) 
C(l)-C(6) !.544(2) N(I)-C(10)-C(11) 116.06(18) 
C(3)-C(4) 1.524(2) 0(1 )-C(7)-0(2} 124.53(17) 
C(4)-C(5) 1.515(3) 0( I )-C(7 )-C( I) 124.27( 17) 
C(5)-C(6) 1.528(2) 0(2)-C(7)-C( 1) 111.15(15) 
C( I 0)-C{Il) 1.508(3) C(5)-C(6)-C{ I) 111.16(15) 
0(5)-C(l2) 1.200(3) 0(5)-C(l2)-0(4) 123.73(19) 
C(12)-C( 13) 1.494(3) 0(5)-C( 12)-C(l3) 125.5(2) 
C(l4)-C(l5) 1.501(3) 0( 4)-C(12)-C( 13) 110.71( 18) 
C(16)-C(17) 1.488(3) 0(7)-C( 14)-0(6) 123.19(17) 
C(9)-C(8) 1.491(4) 0(7)-C(l4 )-C(l5) 125.7(2) 
0(6)-C(l4)-C(I5) 111.05( 17) 
C( 12)-0(4)-C(3) 117.00(15) 0(9)-C( 16)-0(8) 123.49(18) 
C(14)-0(6)-C(4) 116.83(14) 0(9)-C( 16)-C(I7) 126.53(19) 
C( 16)-0(8)-C(5) 117.6S(14l 0(8)-C(l6)-C{ 17) 109.97(18) 
C(7)-0(2)-C{8) 116.10(16) 0(2)-C(8)-C(9) 111.82(19) 
eo OJ-NO )-CC2l 121.49(16) 
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Symmetry transformations used to generate equivalent atoms: 
------------------------------------- ----------------------------- ---------------------------------------------------
Table 4. Anisotropic displacement parameters CA2 x 103) for 03rmd015. The anisotropic 
displacement factor exponent takes the form: -2n2[ h2 a*2U 11 + ... + 2 h k a* b* u12] 
u11 un UJ3 u23 u13 u12 
0(4) 24( I) 29(1) 21( 1) 3(1) 0(1) 5(1) 
0(1) 51(1) 38(1) 20(1) 1(1) -1(1) -10( I) 
0(6) 36(1) 31(1) 16( I) -2(1) 1(1) 3(1) 
0(8) 29(1) 36( L) 25(1) 4(1) 8(1) 9(1) 
0(2) 42(1) 32(1) 29( 1) -3( L) -2(1) -8(1) 
N(l) 27(1) 17( I) 21(1) 0(1) 6(1) I (I) 
0(7) 60(1) 37( I) 28(1) 0(1) 2(1) -8(1) 
C(2) 25(1) 20(1) 18( I) 0(1) 2( I) 2(1) 
0(9) 48(1) 49(1) 35(1) 14(1) 15(1) 10(1) 
0(3) 54(1) 23(1) 51(1) I (I) 20(1) -7(1) 
C(l) 25( I) 22(1) 20(1) 2(1) I (I) 0(1) 
C(3) 25(1) 20(1) 20( I) 0(1) 1(1) 1(1) 
C(4) 30( I) 27(1) 14( I) -I (l) I (I) 6( I) 
C(5) 26(1) 28(1) 20( I) 3(1) 4(1) 6(1) 
C(IO) 34(1) 23( I) 25(1) -5(1) 7( I) -7(1) 
C(7) 25(1) 26(1) 24(1) -3(1) 1(1) 0(1) 
C(6) 23(1) 31(1) 23(1) 0( I) 0(1) I (I) 
0(5) 42(1) 59(1) 77(1) 18(1) -30( 1) -14(1) 
C(12) 31( I) 42(1) 27(1) 3(1) -9(1) 1(1) 
C(l4) 32(1) 33(l) 25(1) -5( I) 2{1) 5( I) 
C(16) 30(1) 35(1) 26(1) I (I) 8(1) -2(1) 
C{IS) 52(1) 42(1) 23( I) -5(1) -3( I) 3(1) 
C( 11) 40(1) 34(1) 45(1) -7( I) 20(1) -6(1) 
C(9) 58(2) 49(2) 40(1) -4( 1) -12( 1) -9(1) 
C(8) 48(1) 39(1) 35(1) -14( 1) -1(1) -12( I) 
C(13) 33(1) 49(1) 34(1) 7(1) -5(1) 10(1) 
C(17) 40(1) 40( I) 44(1) 1(1) 20(1) 4(1) 
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A.lx 10 3) 
for 03m1d015. 
X y z U(eq) 
H(3) 41 0( 10) 2150(20) 1414(9) 20(5) 
H(5) 1925(9) 4070(20) 917(9) 17(4) 
H(2) 1076(9) 2370(20) 2321(8) 16(4) 
H(l) 1378(9) 5160(20) 1913(9) 20(5) 
H(4) 1536(10) 1370(20) 1308(9) 24(5) 
H(lN) 209(10) 4640(20) 2364(9) 24(5) 
H(6B) 2294(10) 2850(20) 2039(10) 26(5) 
H(6A) 2546(11) 4360(20) 1829(9) 26(5) 
H(8B) 2227(12) 7400(30) 3399(11) 47(7) 
H(l1B) -848(14) 4590(30) 2802(13) 63(9) 
H(l1C) -1203(18) 3100(40) 2720(16) 81 (I 0) 
H(15C) 1252(15) 1050(30) -591(13) 58(8) 
H(l5B) 821(14) -340(30) -482( 14) 61(8) 
H(l7C) 3177(14) 1040(30) 29(12) 50(7) 
H(8A) 1849(15) 6140(30) 3728(13) 58(8) 
H(l7B) 3644(14) 2250(30) -174(14) 58(8) 
H(l5A) 436(15) 1150(30) -465(13) 58(8) 
H(l7A) 3691(17) 1620(30) 466(16) 72( l 0) 
H(9C) 2907(14) 4750(40) 3640(13) 64(8) 
H(9B) 3271(15) 6050(30) 3291(14) 61 (8) 
H(IIA) -864(18) 3320(40) 3272(18) 86( ll) 
H(9A) 3094(16) 6190(30) 40 16(15) 70(9) 
H(l3C) -700(15) 5570(30) 481(14) 61(8) 
I-I(l3B) 69(14) 6040(30) 504(13) 54(7) 
H(l3A) -382( 15) 6210(30) 1084(15) 68(9) 
153 
Table 6. Torsion angles [0 ] for 03rmd015. 
C(10)-N(1)-C(2)-C(1) 
C( 10)-N( 1)-C(2)-C(3) 
N( 1)-C(2)-C(1)-C(7) 
C(3)-C(2)-C( 1 )-C(7) 
N(l)-C(2)-C(l)-C(6) 
C(3 )-C(2)-C( 1 )-C( 6) 
C( 12)-0( 4 )-C(3 )-C( 4) 
C(l2)-0( 4)-C(3)-C(2) 
N(l )-C(2)-C(3)-0( 4) 
C( 1 )-C(2 )-C(3 )-0( 4) 
N(l )-C(2)-C(3)-C( 4) 
C( 1 )-C(2)-C(3 )-C( 4) 
C( 14)-0(6)-C(4)-C(5) 
C( 14)-0(6)-C(4)-C(3) 
0( 4 )-C(3 )-C( 4)-0( 6) 
C(2)-C(3)-C( 4 )-0(6) 
0(4)-C(3)-C( 4)-C(5) 
C(2)-C(3)-C( 4 )-C(5) 
C(l6 )-0(8)-C(5)-C( 4) 
C( 16)-0(8)-C(5)-C(6) 
0(6)-C( 4 )-C(5)-0(8) 
C(3)-C( 4 )-C(5)-0(8) 
0( 6)-C( 4 )-C(5)-C( 6) 
C(3 )-C( 4 )-C(5)-C( 6) 
C(2)-N(l)-C(l 0)-0(3) 
C(2)-N(l)-C(l 0)-C( 11) 
C(8)-0(2)-C(7)-0( 1) 
C(8)-0(2)-C(7)-C( 1) 
C(2)-C( 1 )-C(7)-0( 1) 
C( 6)-C( 1 )-C(7)-0( 1) 
C(2)-C( 1)-C(7)-0(2) 
C( 6 )-C( 1 )-C(7)-0(2) 
0(8)-C(5)-C( 6)-C( 1) 
C(4 )-C(5)-C(6)-C(l) 
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-150.78(16) 
87.03(19) 
60.51 (19) 
-178.02(14) 
-179.48(14) 
-58.0 I (18) 
132.31(16) 
-107 .65(17) 
60.76(17) 
-61.94(17) 
179.02(15) 
56.31(19) 
150.68(15) 
-86.34(18) 
-56.26(18) 
-173.93(14) 
63.49(18) 
-54.18( 19) 
1 08.03(17) 
-132.49( 17) 
-67.79(17) 
170.65(13) 
175.18(14) 
53.6(2) 
6.4(3) 
-172.71(18) 
0.3(3) 
-177 .13( 16) 
25.8(2) 
-94.8(2) 
-156.75( 15) 
82.64(!8) 
-171.98(15) 
-55.3(2) 
C(7)-C( 1 )-C(6)-C(5) 
C(2)-C( 1 )-C( 6)-C(5) 
C(3 )-0(4)-C(12)-0(5) 
C(3 )-0( 4 )-C( 12 )-C( 13) 
C( 4 )-0(6)-C( 14 )-0(7) 
C(4)-0(6)-C( 14)-C( 15) 
C(5)-0(8)-C( 16)-0(9) 
C(5)-0(8)-C( 16)-C( 17) 
C(7)-0(2)-C(8)-C(9) 
Symmetry transformations used to generate equivalent atoms: 
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179.06(16) 
57.8(2) 
-5.6(3) 
171.42(16) 
0.7(3) 
179.49(16) 
7.8(3) 
-170.96(18) 
83.4(2) 
